Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,glutamate receptor activity (GO:0008066),-0.8423402742095062,-2.232344059419234,0.0,0.0,0.0,13/19,9.15%,GRID2;GRIK2;GRIA4;GRM7;GRM5;GRM3;GRIK1;GRIA1;GRIA2;GRM8;GRIK4;GRM1;GRID1
prerank,retinoid binding (GO:0005501),0.8798306538648052,2.178604629414953,0.0,0.0010247876615565549,0.001,9/22,7.88%,PTGDS;ALDH1A2;ABCA4;RBP1;NR2F2;CRABP2;CYP26B1;CRABP1;RBP4
prerank,transmitter-gated ion channel activity (GO:0022824),-0.7720034075414504,-2.176115616705848,0.0,0.0,0.0,21/29,16.86%,GRID2;GRIK2;GRIA4;GABRG3;GRIK1;GABRB3;GRIA2;GABRB1;GABRA3;GABRA2;GRIK4;GABRB2;GLRA3;GABRG2;GRID1;GABRA4;GABRG1;GLRA2;GRIK3;GABRA5;GABRE
prerank,ligand-gated channel activity (GO:0022834),-0.7356995083896306,-2.158786283052899,0.0,0.0,0.0,13/29,9.15%,GRID2;GRIK2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;GABRB1;GRIA3;GRIK4;GRIN3A;GRIN2A;GRID1
prerank,ligand-gated ion channel activity (GO:0015276),-0.732339176087166,-2.1502142648669405,0.0,0.0,0.0,13/30,9.15%,GRID2;GRIK2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;GABRB1;GRIA3;GRIK4;GRIN3A;GRIN2A;GRID1
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.8321539783208677,-2.1447339617179804,0.0,0.0,0.0,11/16,8.76%,PTPRB;PTPRM;PTPRD;PTPRG;PTPRK;PTPRT;PTPRN2;PTPRC;PTPRF;PTPRZ1;PTPRE
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.8321539783208677,-2.1447339617179804,0.0,0.0,0.0,11/16,8.76%,PTPRB;PTPRM;PTPRD;PTPRG;PTPRK;PTPRT;PTPRN2;PTPRC;PTPRF;PTPRZ1;PTPRE
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.82859275235089,-2.1437408005247125,0.0,0.0,0.0,11/17,7.25%,GRIK2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;PTK2B;GRIA3;GRIK4;GRIN3A;GRIN2A
prerank,cell adhesion mediator activity (GO:0098631),-0.7617679421287983,-2.1119458805423217,0.0,0.0,0.0,12/24,9.33%,LRRC4C;BSG;CNTN4;ESAM;NPTN;NTNG1;DSCAML1;CNTN6;BCAM;ROBO4;EMB;CD47
prerank,anion channel activity (GO:0005253),-0.6173169765825547,-2.0919965922957284,0.0,0.00010709638002379832,0.001,30/61,17.01%,SLC26A7;CLIC4;ANO4;GABRG3;ANO1;GABRB3;GABRB1;LRRC8C;GABRA3;LRRC8D;GLRB;GABRA2;ANO3;GABRB2;GLRA3;LRRC8B;SLC1A4;GLRA1;VDAC1;GABRG2;GABRA4;GABRG1;GLRA2;ANO5;CLCN3;ANO2;GABRA5;GABRE;GPR89B;GPR89A
prerank,ligand-gated anion channel activity (GO:0099095),-0.7916483516483516,-1.99370521258995,0.0,0.0014458011303212772,0.013,17/17,20.93%,GABRG3;GABRB3;GABRB1;GABRA3;GLRB;GABRA2;GABRB2;GLRA3;GLRA1;GABRG2;GABRA4;GABRG1;GLRA2;GABRA5;GABRE;CFTR;GABRA1
prerank,chloride channel activity (GO:0005254),-0.5847114361849614,-1.9869386744629738,0.0,0.0015772375967141206,0.016,27/59,16.86%,SLC26A7;CLIC4;ANO4;GABRG3;ANO1;GABRB3;GABRB1;GABRA3;GLRB;GABRA2;ANO3;GABRB2;GLRA3;SLC1A4;GLRA1;GABRG2;GABRA4;GABRG1;TTYH2;GLRA2;CLCN1;ANO5;TTYH1;CLCN3;ANO2;GABRA5;GABRE
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.673549226700332,-1.9451591853820747,0.0,0.004257081105945984,0.045,15/28,16.86%,GRID2;GRIK2;GABRG3;GRIK1;GABRA3;GABRA2;GRIK4;GABRG2;GRID1;GABRA4;GABRG1;GRIK3;GABRA5;CHRNA7;GABRE
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.7533180258954265,-1.942655765030616,0.0,0.00430033156710944,0.048,14/19,16.86%,GRID2;GRIK2;GABRG3;GRIK1;GABRA3;GABRA2;GRIK4;GABRG2;GRID1;GABRA4;GABRG1;GRIK3;GABRA5;GABRE
prerank,cell-cell adhesion mediator activity (GO:0098632),-0.6102748698814063,-1.9322254202762512,0.0,0.004681641755326041,0.057,15/42,9.33%,STXBP6;LRRC4C;BSG;CD200;CNTN4;ESAM;NPTN;NTNG1;DSCAML1;CNTN6;ANXA1;ROBO4;EMB;PDLIM1;CD47
prerank,GABA receptor activity (GO:0016917),-0.7110559119614518,-1.9216988906523471,0.0,0.005590431037242272,0.073,13/21,16.86%,GABRG3;GABRB3;GABRB1;GABRA3;GABRA2;GABRB2;GABRG2;GPR156;GABBR2;GABRA4;GABRG1;GABRA5;GABRE
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),0.8210085961814193,1.9124273633462037,0.0,0.0727599239705154,0.121,7/15,8.41%,ALDH1A2;ALDH7A1;ALDH1A1;ALDH4A1;ALDH3B1;ALDH2;ALDH1L1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.7958249597791129,-1.8826547365271475,0.0,0.00993988277095878,0.14,12/13,16.86%,GABRG3;GABRA3;GLRB;GABRA2;GLRA3;GLRA1;GABRG2;GABRA4;GABRG1;GLRA2;GABRA5;GABRE
prerank,monocarboxylate:sodium symporter activity (GO:0140161),0.8833945968716408,1.878428187970919,0.0,0.08710695123230716,0.199,4/10,5.18%,SLC6A13;SLC6A1;SLC6A12;SLC10A4
prerank,GABA-A receptor activity (GO:0004890),-0.7241780965510456,-1.870404649875446,0.0,0.011112824374234132,0.163,11/18,16.86%,GABRG3;GABRB3;GABRB1;GABRA3;GABRA2;GABRB2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.7967348903055649,-1.8595788656055685,0.0,0.0126373728428082,0.196,11/12,16.86%,GABRG3;GABRB3;GABRB1;GABRA3;GABRA2;GABRB2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE
prerank,AMP binding (GO:0016208),0.8422846019711921,1.8387868676588506,0.007662835249042145,0.1350157744100761,0.357,3/11,2.85%,PRKAG2;MPPED2;PRKAG3
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.6057903290592821,-1.833665298982243,0.0,0.017451073292298926,0.272,12/31,15.94%,SLC12A7;HCN1;ABCC9;KCNK5;SLC12A2;KCNK9;SLC12A8;SLC12A4;KCNK1;SLC12A6;TMEM38A;SLC12A5
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),0.8039660605811849,1.829441359370992,0.0036231884057971015,0.12420426458065445,0.395,6/13,8.41%,ALDH1A2;ALDH7A1;ALDH1A1;ALDH4A1;ALDH2;ALDH1L1
prerank,glutamate receptor binding (GO:0035254),-0.7098655954796719,-1.8273628353085218,0.0,0.01845806109710164,0.297,10/17,13.66%,HIP1;SHANK3;GNAS;IGSF11;SYNDIG1;SHISA6;NSF;SHANK2;HOMER1;SHANK1
prerank,semaphorin receptor binding (GO:0030215),-0.6375662348622677,-1.7941936763051658,0.004694835680751174,0.027768561391884845,0.422,11/23,15.07%,SEMA3C;SEMA6A;SEMA6D;RIT2;SEMA5A;SEMA7A;SEMA3E;SEMA4D;SEMA3D;SEMA3G;SEMA4C
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.8379038824908032,1.7901395397079445,0.005747126436781609,0.18958571738796265,0.629,1/11,0.03%,PPP1R1A
prerank,cAMP binding (GO:0030552),-0.7925430687741063,-1.7823461689497195,0.002109704641350211,0.031150442535103882,0.469,5/11,2.08%,PDE4D;PDE4B;PDE10A;RAPGEF4;HCN1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.6211496273947085,1.7744538674869257,0.0015313935681470138,0.20041918695298908,0.692,12/55,6.19%,SLC16A6;SLC13A3;SLC6A13;SLC6A12;SLC16A12;SLC16A11;SLC38A4;SLC38A3;SLC7A2;PDPN;SLC16A13;SLC19A1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),0.6932132036756017,1.7721402279767857,0.0017241379310344827,0.18100312072242647,0.706,6/26,1.47%,SLC16A6;SLC6A13;SLC6A1;SLC6A12;SLC16A12;SLC16A11
prerank,store-operated calcium channel activity (GO:0015279),-0.7888787022845634,-1.7699849032698223,0.006382978723404255,0.03415443249889394,0.509,7/10,15.04%,STIM2;TRPC3;TRPC4;TRPC1;TRPC6;TRPC5;TRPC7
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.7415388773442271,-1.7509550445444098,0.0,0.04132581564168318,0.596,9/12,15.43%,PDE4D;PDE4B;PDE3A;PDE8A;PDE3B;PDE7B;PDE2A;PDE8B;PDE4C
prerank,cadherin binding (GO:0045296),-0.4052199304068074,-1.7314570770980158,0.0,0.049465676005391965,0.677,110/315,17.41%,STXBP6;CDH11;COBLL1;CTNND2;DOCK9;CTNNA2;SPTBN1;PTPRB;PTPRM;FMNL2;PTPRJ;MRTFB;AHNAK;CDH2;CDH8;CDH13;ITGA6;BSG;ANK3;CTNNA3;BMPR2;MYO1B;FNBP1L;ESYT2;RTN4;NOTCH3;LRRFIP1;PTPRT;PROM1;IQGAP1;FXYD5;CDH10;CLINT1;CDH12;F11R;EHD4;HSP90AB1;EPN2;YWHAE;MYH9;SHTN1;KDR;TRPC4;ANXA1;OLA1;DAB2IP;YWHAB;CDH6;FLNA;LIMA1;SH3GLB1;HSPA8;CD2AP;ITGB1;PSEN1;CDH7;CDH20;CDH19;TAGLN2;RPL34;BZW2;RDX;RPL14;BZW1;ANLN;HSPA5;PDLIM1;RPL7A;ABI1;RPS2;EFHD2;RPL23A;PCBP1;ERC1;RPL29;CDH1;MB21D2;MARK2;HNRNPK;PAICS;CALD1;AHSA1;CTNNB1;RANBP1;TES;RPL6;ARGLU1;TNKS1BP1;GAPVD1;GCN1;TMPO;CDK5R1;ACVR1;RPS26;ALDOA;CDH9;USP8;NCK1;PKM;SEPTIN9;APC;WASF2;CCT8;SCYL1;PPP1CA;CBL;PRDX1;SCRIB;EMD;CAPZA1
prerank,chemorepellent activity (GO:0045499),-0.5987931011003708,-1.7282990754624443,0.004784688995215311,0.049416741197904165,0.682,11/25,12.23%,NRG3;SEMA3C;SEMA6A;SEMA6D;SEMA5A;SEMA7A;SEMA3E;SEMA4D;EPHA7;SEMA3D;SEMA3G
prerank,frizzled binding (GO:0005109),0.6498154809152951,1.7203761234859398,0.0034129692832764505,0.3229219786860433,0.911,4/34,1.99%,WNT5B;RNF43;WNT4;WNT6
prerank,histone demethylase activity (GO:0032452),0.6755174830911193,1.7203687592012935,0.0034482758620689655,0.29062978081743895,0.911,10/27,12.29%,KDM7A;JARID2;FBXL19;KDM2B;KDM2A;JMJD6;HR;KDM3B;RIOX2;PHF2
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.7780827881463075,-1.7105827467757861,0.0,0.05801053917955742,0.759,9/10,20.93%,GABRG3;GABRA3;GABRA2;GABRG2;GABRA4;GABRG1;GABRA5;GABRE;GABRA1
prerank,diacylglycerol kinase activity (GO:0004143),-0.733937639926962,-1.6962902665391209,0.010548523206751054,0.06702320954132206,0.815,6/11,12.72%,DGKH;DGKB;DGKI;DGKK;DGKG;DGKZ
prerank,amyloid-beta binding (GO:0001540),-0.477136171793362,-1.691381991379142,0.0,0.06773661387574169,0.83,32/79,19.03%,NLGN1;APBB2;GRIA4;COL25A1;CST3;GRIN2B;GRIA1;GRIA2;TGFB2;GRIA3;APBA2;FZD4;ITM2A;GSAP;APOE;LDLR;CACNA1B;GRIN2A;SORL1;EPHB2;HSPG2;BCHE;ITM2B;ITGA2;CLU;GRIN1;CHRNA7;IAPP;CD74;ITGB2;LDLRAP1;C1QA
prerank,pentosyltransferase activity (GO:0016763),0.629503934772458,1.684669369981456,0.018425460636515914,0.3966859875370737,0.972,19/36,14.73%,LACC1;LARGE1;ART5;PARP10;PARP14;TIPARP;SIRT5;PARP4;TNKS2;SIRT3;PARP9;ZC3HAV1;SIRT1;PARP11;PARP6;LARGE2;SIRT4;ART4;QPRT
prerank,CoA-ligase activity (GO:0016405),0.7546945008951235,1.683470207253531,0.013059701492537313,0.3686673612449706,0.975,3/14,4.39%,ACSL1;ACSS3;ACSBG2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.7274608075124106,1.6616345937277457,0.015444015444015444,0.43048964767387277,0.988,9/15,19.83%,KMT2A;CXXC1;ASH2L;KMT2C;WDR82;KMT2D;SETD1B;SETD3;SETD1A
prerank,phosphatidylcholine transporter activity (GO:0008525),-0.6502336336379831,-1.6432388787307395,0.011337868480725623,0.10602541622356035,0.941,10/17,14.38%,ATP10A;ATP8B1;PITPNC1;PLTP;ABCG1;PITPNB;MTTP;PITPNA;ABCB4;ATP8B2
prerank,lysine-acetylated histone binding (GO:0070577),0.6779620398076545,1.6392205638119512,0.021621621621621623,0.4611544477004497,0.995,7/20,12.95%,KMT2A;ZMYND8;PHIP;ATAD2B;SMARCA4;BRD7;BRD9
prerank,acetylation-dependent protein binding (GO:0140033),0.6779620398076545,1.6392205638119512,0.021621621621621623,0.4611544477004497,0.995,7/20,12.95%,KMT2A;ZMYND8;PHIP;ATAD2B;SMARCA4;BRD7;BRD9
prerank,sulfotransferase activity (GO:0008146),0.615898550907775,1.6329796028999173,0.03177257525083612,0.46006561081004577,0.996,5/33,3.28%,HS3ST3A1;UST;CHST15;CHST11;HS2ST1
prerank,amino acid:sodium symporter activity (GO:0005283),0.7741436433275429,1.6239925101147814,0.02111324376199616,0.46911162248430055,0.998,5/11,8.07%,SLC6A13;SLC6A1;SLC6A12;SLC1A3;SLC38A1
prerank,histone acetyltransferase binding (GO:0035035),0.6801744450302177,1.618525226779175,0.022222222222222223,0.46582292482531845,0.998,6/21,8.12%,EPAS1;GLI3;KANSL1L;TP53;BCAS3;MEF2A
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.6507952276491389,1.6066167091180439,0.025408348457350273,0.49119690704187086,0.998,15/25,13.51%,ART5;PARP10;PARP14;TIPARP;SIRT5;PARP4;TNKS2;SIRT3;PARP9;ZC3HAV1;SIRT1;PARP11;PARP6;SIRT4;ART4
prerank,BMP binding (GO:0036122),-0.706923818714076,-1.6033691598356956,0.026476578411405296,0.1505809650353967,0.989,3/11,1.84%,GREM2;BMPR2;ENG
prerank,voltage-gated sodium channel activity (GO:0005248),-0.5935369772161687,-1.6029026194955989,0.008928571428571428,0.1465680895863195,0.989,10/22,16.92%,HCN1;SCN1A;SCN2A;CACNA1G;SCN7A;SCN3A;SCN9A;SCN8A;CACNA1H;SCN2B
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.7312126564985918,-1.602066791407053,0.016129032258064516,0.14314891595362786,0.989,7/10,13.66%,SHANK3;GNAS;IGSF11;SHISA6;NSF;SHANK2;SHANK1
prerank,protein phosphatase inhibitor activity (GO:0004864),0.6384599984231613,1.5981048851488184,0.015463917525773196,0.5037343750381246,1.0,1/26,0.03%,PPP1R1A
prerank,fatty acid synthase activity (GO:0004312),-0.7167190331159541,-1.5848363177805613,0.02178217821782178,0.16059732163274582,0.994,3/10,10.72%,ELOVL7;ELOVL5;ELOVL6
prerank,sodium channel activity (GO:0005272),-0.5204352720265958,-1.5801207855661021,0.012853470437017995,0.16231527356406872,0.995,14/37,15.47%,GRIK2;HCN1;GRIK1;SCN1A;SCN2A;GRIK4;CACNA1G;SCN7A;SCN3A;SCN9A;SCN8A;KCNK1;GRIK3;CACNA1H
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.6114427268945432,1.5712093806754304,0.03747870528109029,0.6013551596838773,1.0,3/27,1.24%,SLC22A6;SLC22A8;SLC5A5
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.7392526049982842,1.5705180944247958,0.053231939163498096,0.5772815222577448,1.0,4/10,12.26%,KDM7A;KDM2B;KDM2A;RIOX2
prerank,active ion transmembrane transporter activity (GO:0022853),0.581073403197001,1.556064077016696,0.032,0.6156746046690642,1.0,3/37,1.25%,SLC22A6;SLC22A8;ATP13A3
prerank,amino acid binding (GO:0016597),-0.5246993972064447,-1.554144508181087,0.02729528535980149,0.19668250191370562,0.999,10/31,15.74%,GRM7;NOS3;GRIN2B;GLRB;GRIN3A;GLRA3;GLRA1;NOS1;GLRA2;GRIN1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.6307351719043586,1.543154464401971,0.04745166959578207,0.6461286206114079,1.0,3/21,3.03%,FGF1;KL;FRS2
prerank,acid-thiol ligase activity (GO:0016878),0.6974662781100827,1.5427907107045262,0.0583804143126177,0.6213492549549704,1.0,2/13,3.80%,ACSL1;ACSS3
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),0.745623115120666,1.5335606856279518,0.046065259117082535,0.640098139372248,1.0,1/10,0.04%,PRKAG2
prerank,LRR domain binding (GO:0030275),0.6725649189956802,1.520362347448295,0.06433823529411764,0.6763219015287502,1.0,2/14,0.75%,ROBO1;PAWR
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.6347484065710667,1.5200217429024834,0.047285464098073555,0.6534485324796689,1.0,4/20,4.31%,LPGAT1;AGPAT4;MOGAT3;GPAT2
prerank,metal ion:proton antiporter activity (GO:0051139),-0.6379464089105269,-1.517462488785271,0.04158004158004158,0.25542486635675893,0.999,4/13,8.52%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,cyclic nucleotide binding (GO:0030551),-0.5582473977331112,-1.5167345674220236,0.040380047505938245,0.2498445812923611,0.999,6/21,2.16%,PDE4D;PDE4B;PDE10A;RAPGEF4;HCN1;PDE11A
prerank,phospholipid transfer activity (GO:0120014),-0.5516713237303678,-1.5154311045976254,0.045351473922902494,0.2458356212530897,0.999,13/21,25.62%,CERT1;PITPNC1;PLTP;GLTP;PITPNB;TNFAIP8L3;MTTP;PITPNA;PLEKHA3;PRELID3B;TRIAP1;ABCA3;PRELID1
prerank,retinoic acid binding (GO:0001972),0.6915738495041568,1.514617096833277,0.07524752475247524,0.6558287658906242,1.0,2/12,4.73%,NR2F2;CYP26B1
prerank,phospholipase C activity (GO:0004629),-0.5449407900074489,-1.508902507025907,0.04357798165137615,0.25209952375702005,1.0,8/25,9.55%,PLCB4;EDNRA;PLCL1;PLCE1;CHRM3;PLCG2;PLCH1;PDIA3
prerank,glycine binding (GO:0016594),-0.6541631752004387,-1.5066012941099378,0.037422037422037424,0.25048798444834486,1.0,7/11,15.74%,GRIN2B;GLRB;GRIN3A;GLRA3;GLRA1;GLRA2;GRIN1
prerank,R-SMAD binding (GO:0070412),0.6399781226462607,1.5046391433213102,0.04736842105263158,0.6797074963217443,1.0,5/18,6.06%,SMAD3;DDX5;PMEPA1;SMAD6;LDLRAD4
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.45212013325151745,-1.5026048325591737,0.01524390243902439,0.25212017805888176,1.0,19/60,9.79%,NRP1;TEK;ERBB4;NTRK3;EPHB1;ROR1;EPHA5;MERTK;EPHA6;NRP2;TIE1;NTRK2;KDR;MET;ROR2;EPHB2;EPHA7;FLT4;ERBB2
prerank,sodium:proton antiporter activity (GO:0015385),-0.6753835942390487,-1.5015346667322333,0.03177966101694915,0.24798291325184948,1.0,4/11,8.52%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,secondary active transmembrane transporter activity (GO:0015291),0.5212818952705376,1.497538827654838,0.03560371517027864,0.6915333255516636,1.0,7/51,7.28%,SLC22A6;SLC22A8;SLC5A5;MCU;TMEM241;SLC5A8;SLC20A2
prerank,ion channel activity (GO:0005216),-0.42257493504574506,-1.4927566433179882,0.0,0.2581193139178123,1.0,20/80,9.38%,GRID2;GRIK2;PIEZO2;GRIA4;GRIK1;GRIN2B;GRIA1;GRIA2;GABRB1;ABCC9;GRIA3;UNC80;GRIK4;GRIN3A;TRPC1;GRIN2A;TRPC6;PIEZO1;GRID1;TRPV4
prerank,calcium ion binding (GO:0005509),-0.34411104438608175,-1.4923305255358523,0.0,0.25328293875628305,1.0,92/323,18.17%,KCNIP4;ADGRL3;CDH11;SLC8A1;NRXN1;SLIT2;SYT1;ASTN2;CDH2;CDH8;CDH13;GSN;SPOCK2;LTBP4;MCTP1;ESYT2;PLA2G4A;RASGRP3;RYR2;THBS1;TPD52;ACER3;IQGAP1;STIM2;TPT1;CDH10;PCLO;DNER;CDH12;KCNIP1;S100A6;RYR3;SLC25A13;ANXA1;ASPN;CALM1;CDH6;MICU3;CALM2;GLCE;PPP3R1;TKT;CDH7;CDH20;CDH19;PPP3CA;PAM;DYSF;SPOCK1;ENPP1;HSPA5;CALR;CRACR2A;S100B;CAMKK2;TUBB4A;TPM4;EFHD2;AGRN;ESYT3;ENPP2;SPARCL1;CALM3;CDH1;ASAH2;S100A16;SNCA;RET;PITPNM3;CETN3;SDF4;CDK5R1;MAN1B1;SYT7;PCP4;TRPM2;CDH9;RASGRP2;GRIN1;AOC3;AMY1A;AMY1B;AMY1C;ITPR3;GCA;AOAH;CLEC3B;SYT6;CETN2;EFCAB11;EML1;CASQ2
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.4972869121161696,-1.4917237139322999,0.03608247422680412,0.2492225890440764,1.0,9/32,10.83%,KCNB2;KCNQ5;KCNC2;KCNQ3;KCNS3;KCNA6;KCNQ1;KCNC1;KCNB1
prerank,intracellular chloride channel activity (GO:0061778),-0.5856791367127783,-1.4877546248351052,0.047109207708779445,0.24642877043475994,1.0,7/16,15.24%,ANO4;ANO1;ANO3;TTYH2;ANO5;TTYH1;ANO2
prerank,intracellular calcium activated chloride channel activity (GO:0005229),-0.5856791367127783,-1.4877546248351052,0.047109207708779445,0.24642877043475994,1.0,7/16,15.24%,ANO4;ANO1;ANO3;TTYH2;ANO5;TTYH1;ANO2
prerank,NAD binding (GO:0051287),0.5932626781067929,1.485916683186919,0.05042016806722689,0.7268626735734102,1.0,10/26,9.64%,SORD;CRYL1;ALDH1A1;SIRT5;BDH2;ALDH2;SIRT3;PARP9;ZC3HAV1;SIRT1
prerank,monovalent cation:proton antiporter activity (GO:0005451),-0.6431638568814545,-1.4849655834912325,0.03375527426160337,0.2461009243734626,1.0,4/12,8.52%,SLC9A2;SLC9B2;SLC9A6;SLC9A7
prerank,peptidase inhibitor activity (GO:0030414),0.5593909588681115,1.484125542353239,0.06333333333333334,0.7138422417030463,1.0,6/33,8.66%,ITIH2;TFPI;SERPIND1;RENBP;KNG1;HRG
prerank,MAP kinase activity (GO:0004707),0.6534924869689819,1.469199337759802,0.08602150537634409,0.7626228650795279,1.0,1/14,0.09%,MAPK4
prerank,phosphatidate phosphatase activity (GO:0008195),-0.6103366652891727,-1.4678509034915879,0.06926406926406926,0.2711744600030588,1.0,5/13,13.75%,PLPP1;PLPPR1;PLPPR5;PLPPR4;LPIN3
prerank,outward rectifier potassium channel activity (GO:0015271),0.7092895398243766,1.46753573749982,0.08440366972477065,0.7478021964615547,1.0,4/11,1.75%,KCNK2;KCNT1;KCND3;KCNA5
prerank,alkali metal ion binding (GO:0031420),0.6707381274705775,1.4665136117091322,0.08221797323135756,0.7313283281402626,1.0,4/13,12.83%,ATP1A2;ATP4A;HDAC4;TDG
prerank,thyroid hormone receptor binding (GO:0046966),0.581813125761252,1.4611078100054067,0.06055363321799308,0.7350220260104824,1.0,15/28,21.22%,BRD8;NSD1;NCOA3;MED12;TRIP12;MED17;THRAP3;TRIP6;TAF11;HMGN3;NCOR1;TAF7;MED1;MED13;NCOA6
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.5416457742338997,-1.4597423220875354,0.0425531914893617,0.2703557182812089,1.0,9/22,15.95%,CHRM3;HTR2C;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.5416457742338997,-1.4597423220875354,0.0425531914893617,0.2703557182812089,1.0,9/22,15.95%,CHRM3;HTR2C;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,serotonin receptor activity (GO:0099589),-0.5416457742338997,-1.4597423220875354,0.0425531914893617,0.2703557182812089,1.0,9/22,15.95%,CHRM3;HTR2C;HTR2A;CHRM2;HTR1F;HTR7;HTR4;HTR1B;HRH1
prerank,mRNA 3'-UTR binding (GO:0003730),0.4831893765806827,1.4559087545318012,0.03225806451612903,0.7398966916438326,1.0,27/79,19.08%,CPEB2;CELF2;DDX5;CPEB4;RBMS2;LARP4B;IGF2BP1;TP53;HNRNPA2B1;IGF2BP2;PABPC4L;RBMS1;LARP1;CPEB3;CSDC2;RBMS3;RSL1D1;HNRNPC;ZFP36L1;PABPC5;RBM4;ILF3;DAZAP1;CRYZ;BOLL;RNF20;LARP4
prerank,sialyltransferase activity (GO:0008373),-0.5434351026169186,-1.4557547162933702,0.061465721040189124,0.2725781365572374,1.0,9/20,8.47%,ST6GALNAC3;ST3GAL4;ST8SIA4;ST3GAL1;ST6GAL2;ST8SIA1;ST6GALNAC5;ST3GAL6;ST8SIA6
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.5973554457950349,-1.4533058347013141,0.06290672451193059,0.27172298818947155,1.0,8/15,15.21%,SLC1A5;SLC1A2;SLC1A1;SLC25A13;SLC1A4;SLC17A6;SLC38A7;SLC1A6
prerank,acylglycerol lipase activity (GO:0047372),-0.6370633383183945,-1.4525473420891881,0.06512605042016807,0.268058414328852,1.0,3/11,13.20%,ABHD2;MGLL;LIPE
prerank,phosphoric diester hydrolase activity (GO:0008081),-0.4756563086205339,-1.4524963892477003,0.04076086956521739,0.26345709485854385,1.0,12/35,11.65%,PLCB4;PLCL1;PLCE1;PDE11A;PLCXD3;GPCPD1;ENPP6;GDPD1;ENPP1;PDIA3;ENPP2;SMPDL3A
prerank,ribosomal small subunit binding (GO:0043024),0.6358654894652507,1.4487565164099583,0.07930367504835589,0.7530875482105349,1.0,3/17,8.44%,CPEB2;DDX3X;LARP1
prerank,ligand-gated cation channel activity (GO:0099094),-0.40293250439770933,-1.448543748521805,0.016286644951140065,0.2661603552094894,1.0,13/75,4.69%,GRIK2;GRIA4;KCNJ3;GRIK1;GRIN2B;GRIA1;KCNJ2;GRIA2;KCNN2;PTK2B;GRIA3;GRIK4;GRIN3A
prerank,transcription coactivator binding (GO:0001223),0.5945705418533781,1.4482931937378762,0.08156028368794327,0.7364892726691571,1.0,7/20,9.36%,RORA;THRB;SMAD3;VGLL4;CCNT2;TERT;TEAD2
prerank,cyclin-dependent protein kinase activity (GO:0097472),-0.5327222619911134,-1.447747407505355,0.07021791767554479,0.2590393691825622,1.0,4/21,15.97%,CDK14;CDK19;CDK8;CDKL4
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),-0.5327222619911134,-1.447747407505355,0.07021791767554479,0.2590393691825622,1.0,4/21,15.97%,CDK14;CDK19;CDK8;CDKL4
prerank,potassium channel activity (GO:0005267),-0.3940320918973174,-1.4477442637066829,0.017985611510791366,0.25479282214678245,1.0,24/89,10.83%,GRIK2;KCND2;KCNT2;KCNB2;KCNQ5;KCNC2;KCNH7;HCN1;KCNMA1;GRIK1;KCNN2;ABCC9;KCNQ3;KCNK5;KCNMB2;GRIK4;KCNS3;KCNK13;KCNA6;KCNQ1;KCNK9;KCNH5;KCNC1;KCNB1
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.6175917243151594,1.4446406160067295,0.09090909090909091,0.7342728569157784,1.0,5/18,8.09%,ALDH1A2;ALDH1A1;AKR1B10;ALDH3B1;ALDH2
prerank,ubiquitin-specific protease binding (GO:1990381),0.6129785878540696,1.4417550511780366,0.10073260073260074,0.7294048179659915,1.0,10/19,23.41%,PRKN;LCOR;CLTC;PTEN;AMFR;SYVN1;SUMO1;SELENOS;BAG6;DERL1
prerank,metal ion transmembrane transporter activity (GO:0046873),0.5764738295814444,1.4380361621460778,0.09285714285714286,0.7283618723835217,1.0,5/27,6.62%,SLC41A1;ITPR2;ITPR1;CNNM2;MRS2
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6342217259606004,1.4365711884280887,0.09363295880149813,0.7185158945231753,1.0,2/15,1.56%,ACKR2;CCR9
prerank,protein tyrosine kinase activator activity (GO:0030296),-0.5564085922836821,-1.4345414782128252,0.061052631578947365,0.2728366649154668,1.0,6/19,12.73%,NRG3;GRM5;EFNA5;GAS6;ABI1;ERCC6
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.6603647108990424,1.4324576413147012,0.1100196463654224,0.7193781653535558,1.0,4/12,12.29%,KDM7A;HR;KDM3B;PHF2
prerank,vitamin D receptor binding (GO:0042809),0.6318705492494562,1.4217797802526932,0.10771992818671454,0.748429162825923,1.0,9/14,23.57%,MED12;MED17;THRAP3;TAF11;TAF7;RXRA;MED1;MED13;MED24
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.49772825968058887,1.4159934758542188,0.07120253164556962,0.7583646735446496,1.0,21/44,18.13%,KMT2A;CXXC1;SMYD3;KMT5C;NSD1;KMT5B;SETD7;NSD3;ASH2L;KMT2C;WDR82;KMT5A;KMT2D;DOT1L;SETD1B;SETDB2;EHMT2;EHMT1;ASH1L;KMT2E;SETD3
prerank,ribosomal large subunit binding (GO:0043023),0.6821961200330862,1.4134094222901157,0.10176125244618395,0.7538807732754897,1.0,1/11,0.33%,CPEB2
prerank,endopeptidase regulator activity (GO:0061135),0.523107757781,1.4132276367708396,0.0632279534109817,0.7390392162535505,1.0,7/40,9.69%,ITIH2;TFPI;SERPIND1;RENBP;KNG1;HRG;APH1B
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.4618080907909084,1.4132215718602783,0.056818181818181816,0.7242994234349419,1.0,12/74,8.47%,NADK2;FAM20A;HK2;PI4KA;SPHK1;GK5;TKFC;GALK2;GK;PANK1;PIK3CA;DCAKD
prerank,insulin-like growth factor I binding (GO:0031994),-0.5765135377994964,-1.410732262292617,0.0847457627118644,0.3106407000004573,1.0,5/13,10.36%,ITGA6;ITGB4;IGFBP4;IGFBP6;ITGB3
prerank,methylated histone binding (GO:0035064),0.48115172982150717,1.4084063435050898,0.07342143906020558,0.729267031389648,1.0,27/62,25.37%,KDM7A;ZMYND8;CXXC1;ZCWPW2;TDRD3;ATRX;CBX5;PHF1;PHF2;TAF7;MPHOSPH8;LRWD1;MORC4;NCAPD3;KMT2E;SGF29;CHD8;TAF1;FMR1;SPIN4;CBX8;BPTF;MSL3;PHF13;ING2;ING3;SUZ12
prerank,carbohydrate kinase activity (GO:0019200),0.640604193304301,1.4069620891157408,0.13163064833005894,0.7212534391855152,1.0,6/11,24.03%,HK2;GALK2;GALK1;GNE;HK1;NAGK
prerank,monocarboxylic acid binding (GO:0033293),0.592967459119136,1.404467697659758,0.12098298676748583,0.7174093699383558,1.0,3/18,4.73%,NAPEPLD;NR2F2;CYP26B1
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.6660539740807547,1.401348664538132,0.12546125461254612,0.7159280468929821,1.0,6/11,19.78%,SLC25A48;SLC25A20;SLC22A5;SLC25A47;SLC25A29;SLC22A4
prerank,organic anion transmembrane transporter activity (GO:0008514),0.42354663354682354,1.4007826740993052,0.03369272237196765,0.7051284411626593,1.0,20/134,8.79%,SLC22A6;SLC13A3;SLC6A13;SLC6A1;SLC16A12;SLC16A11;SLC38A3;SLC7A2;PDPN;SFXN2;SLC6A9;SLC26A3;SLC25A2;SLC25A23;SLC19A1;SLC1A3;SLC27A1;SLC26A1;SLC38A1;CTNS
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.5418200303721874,1.3977103546841403,0.1040268456375839,0.7033154320821977,1.0,12/32,18.82%,KDM7A;TET2;BBOX1;TMLHE;KDM2B;KDM2A;RIOX2;TET1;HIF1AN;ALKBH5;TET3;PHYH
prerank,death receptor activity (GO:0005035),-0.612345246397656,-1.3962026755807777,0.0860655737704918,0.3345674178134081,1.0,5/11,17.99%,TNFRSF11A;TNFRSF19;TNFRSF1B;FAS;TNFRSF25
prerank,carboxylic acid binding (GO:0031406),-0.4556415904073562,-1.3957357737152238,0.057291666666666664,0.3303692654607973,1.0,13/38,13.03%,GRM7;NOS3;SESN3;GRIN2B;GLRB;GRIN3A;GLRA3;PSAP;EPDR1;GLRA1;GLUD1;NOS1;GLRA2
prerank,transforming growth factor beta receptor binding (GO:0005160),0.5963660688739456,1.394649145915901,0.11231884057971014,0.7016559310099592,1.0,5/18,7.47%,TGFBR3;SMAD3;TGFBR1;SMAD6;TGFBR2
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.6238044320174314,1.3929353637071364,0.13840155945419103,0.6960428472303262,1.0,2/13,0.47%,BMP6;BMP7
prerank,phosphotyrosine residue binding (GO:0001784),-0.46376026506738977,-1.3912659494367634,0.047979797979797977,0.3345496191252507,1.0,16/37,22.88%,PIK3R1;NCK2;BCAR3;SHE;PLCG2;CRK;RASA1;SAMSN1;PTPN3;VAV1;SYK;LDLRAP1;SHC1;IRS1;YES1;SHC3
prerank,amino acid transmembrane transporter activity (GO:0015171),0.4909344915037671,1.3910943293469837,0.08422664624808576,0.6914190244674878,1.0,7/47,3.69%,SLC6A13;SLC6A1;SLC38A4;SLC38A3;SLC7A2;SLC7A11;PDPN
prerank,kinase activator activity (GO:0019209),0.5412413487918952,1.3899447734324668,0.08631921824104234,0.6839774449115633,1.0,2/30,2.39%,PRKAG2;GPRC5C
prerank,calcium-activated potassium channel activity (GO:0015269),-0.6073956584965918,-1.3893275804986145,0.1053763440860215,0.3334693552323105,1.0,3/11,4.50%,KCNMA1;KCNN2;KCNMB2
prerank,acetyltransferase activity (GO:0016407),0.5233572937541712,1.387691835909217,0.10684474123539232,0.681332596755535,1.0,9/31,15.67%,SPHK1;PAFAH2;NAA80;SAT1;KAT6B;SMARCE1;KAT2B;NAA16;CREBBP
prerank,sulfuric ester hydrolase activity (GO:0008484),0.6469158926125713,1.3865171331056942,0.1339622641509434,0.6743929254704677,1.0,4/12,10.98%,SULF2;ARSG;ARSB;SULF1
prerank,methylation-dependent protein binding (GO:0140034),0.47919993789737814,1.3829752238280726,0.08669656203288491,0.6760670601525958,1.0,16/57,17.82%,KDM7A;ZMYND8;CXXC1;ZCWPW2;TDRD3;ATRX;CBX5;PHF1;PHF2;MPHOSPH8;LRWD1;MORC4;NCAPD3;KMT2E;SGF29;CHD8
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),-0.4663450467478162,-1.3823568950822338,0.06701030927835051,0.3430234054291658,1.0,13/32,13.49%,SLC6A6;SLC1A5;SLC7A5;SLC38A6;SLC1A1;SLC1A4;SLC38A5;SLC43A2;SLC6A7;SLC43A1;SFXN1;SLC38A7;SFXN3
prerank,nucleotide diphosphatase activity (GO:0004551),0.6386477011484293,1.381446486031619,0.12921348314606743,0.6701470814291395,1.0,4/14,5.05%,NUDT4;FHIT;CILP2;NUDT13
prerank,glycerophospholipid flippase activity (GO:0140333),-0.5989594417422707,-1.3652564628919557,0.11440677966101695,0.37222045331923437,1.0,8/11,14.38%,ATP10A;ATP8A1;ATP8B1;ATP11A;ATP8A2;ATP11C;ABCB4;ATP8B2
prerank,MHC class II protein complex binding (GO:0023026),-0.6011477257415168,-1.362745193695862,0.12525252525252525,0.37191512885693045,1.0,8/11,20.88%,ATP1B1;HSP90AB1;YWHAE;HSPA8;HSP90AA1;PKM;CD74;CD81
prerank,nuclear receptor binding (GO:0016922),0.42335869140691823,1.3618539508900467,0.06456043956043957,0.7317299222794281,1.0,28/111,13.70%,PPARGC1B;SMAD3;DDX5;PPARGC1A;BRD8;NCOR2;PRKCB;NSD1;NCOA3;LCOR;HMGA1;WIPI1;BCAS3;SMARCD3;MED12;TRIP12;SMARCA4;TMF1;TCF7L2;SMARCE1;SIRT1;MED17;THRAP3;TRIP6;TAF11;CCDC62;HMGN3;NCOR1
prerank,BMP receptor binding (GO:0070700),0.6238047197033283,1.3578346501549046,0.154296875,0.7349901325369861,1.0,2/12,0.47%,BMP6;BMP7
prerank,actinin binding (GO:0042805),0.5736196483563918,1.3569552056734673,0.13451327433628318,0.7271709702346527,1.0,5/21,4.60%,CACNA1D;KCNA5;CSRP3;DAG1;CACNA1C
prerank,alpha-actinin binding (GO:0051393),0.5459618161800324,1.3568681120549448,0.13162393162393163,0.7167636172248721,1.0,4/24,4.60%,CACNA1D;KCNA5;DAG1;CACNA1C
prerank,anion transmembrane transporter activity (GO:0008509),0.6006385502456509,1.3522870555242077,0.14534883720930233,0.7219406295739503,1.0,2/12,6.19%,SLC22A6;SLC19A1
prerank,metal ion binding (GO:0046872),-0.30270613177759415,-1.3521665689367166,0.0,0.38926668179185264,1.0,130/477,18.99%,KCNIP4;ADGRL3;CDH11;SLC8A1;NRXN1;SLIT2;SYT1;CSGALNACT1;MARK1;ASTN2;CDH2;CDH8;CDH13;GSN;SPOCK2;LTBP4;MAP3K5;SNRK;HMGCLL1;MCTP1;ESYT2;PLA2G4A;RASGRP3;ADCY2;RYR2;THBS1;CDC42BPA;TPD52;ACER3;IQGAP1;STIM2;TPT1;CDH10;PCLO;DNER;CDH12;KCNIP1;S100A6;RYR3;SLC25A13;NLK;ANXA1;ASPN;CALM1;CDH6;MICU3;APOE;CALM2;GLCE;GNAI1;PPP3R1;TKT;CDH7;CDH20;CDH19;PPP3CA;PAM;DYSF;SPOCK1;ENPP1;HSPA5;CALR;CRACR2A;IRAK3;PDE2A;S100B;CAMKK2;TUBB4A;TPM4;EFHD2;AGRN;RAP2A;ESYT3;MT1F;MT1M;MT1G;MT1B;MT1E;MT1A;MT1X;MT1H;ENPP2;SPARCL1;CALM3;CDH1;MARK2;TRIM27;ASAH2;S100A16;SNCA;DUT;RET;PITPNM3;RPE;PINK1;CETN3;SDF4;CDK5R1;MAN1B1;SYT7;MT3;MAPK12;PCP4;TRPM2;CDH9;RASGRP2;GRIN1;AOC3;AMY1A;AMY1B;AMY1C;PDXK;TOP2A;ITPR3;GCA;AOAH;TPPP;CLEC3B;SYT6;ENDOV;CETN2;EFCAB11;EML1;CASQ2;PLA2G4E;HPRT1;RAN;IMPA1;RHEB;EXD2
prerank,pre-mRNA binding (GO:0036002),0.5292161431981912,1.351665452855658,0.12998266897746968,0.7136767673317214,1.0,2/28,1.30%,CELF2;DDX5
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.43534407404928843,-1.3496255398033299,0.0678391959798995,0.3894827600515485,1.0,18/42,22.88%,PIK3R1;NCK2;BCAR3;SHE;YWHAE;YWHAB;PLCG2;CRK;RASA1;SAMSN1;PTPN3;VAV1;SYK;LDLRAP1;SHC1;IRS1;YES1;SHC3
prerank,metalloexopeptidase activity (GO:0008235),0.47299207686251565,1.3496241359461367,0.1021021021021021,0.7108706636524208,1.0,13/51,15.47%,AEBP1;ACE;CPQ;CPA4;METAP2;PEPD;NPEPPS;MMP14;FOLH1;ERAP1;AGBL3;ANPEP;ZMPSTE24
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.6468386099654336,1.3459059831822011,0.14791666666666667,0.7137646062741404,1.0,1/10,0.09%,SLC22A6
prerank,nuclear receptor coactivator activity (GO:0030374),0.4700432885892429,1.3397424341788085,0.09472049689440994,0.7253390915748718,1.0,15/52,12.18%,PPARGC1B;PPARGC1A;BRD8;PRKCB;NCOA3;HMGA1;MED12;TMF1;CALCOCO1;CCAR1;MED17;THRAP3;ZMIZ1;ZMIZ2;CCDC62
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.36086897636006604,1.339093035625289,0.0030864197530864196,0.7180160902214088,1.0,136/831,12.40%,AEBP1;EPAS1;HLF;ZKSCAN2;RORA;MAF;THRB;SMAD3;TFDP2;GLIS3;OSR1;ZIC2;MXI1;NFYC;CUX1;PKNOX2;PPARA;CREBRF;FOXP4;ZFHX2;IKZF2;GLI2;ZNF423;DNMT3A;HOXB4;CREB5;ZBTB20;ZNF160;HOXB6;NPAS3;FOXD1;HOXC6;HOXA1;SOX5;ZNF568;NFAT5;NR2F2;KCNIP3;GLI3;MITF;ELF1;ZNF697;NR6A1;ARNT2;FOXC1;HOXB3;NFIB;ZBTB38;RFX8;MAFG;VEZF1;NACC2;ASCL3;ATOH1;NFYB;NHLH2;SALL4;FOXP2;MEIS1;RREB1;CUX2;NSD1;TEF;TEAD3;OTP;ESRRA;STAT2;HOXB5;HOXB9;HOXA3;TP53;BHLHE41;RORC;MGA;ZSCAN29;SOX12;ZIC5;NR1D2;ZSCAN25;MEF2A;RBL2;ZIC1;HOXC4;CALCOCO1;ZIC4;TCF4;TCF7L2;IRX1;CCAR1;NEUROD4;TCF7;HDAC1;TFDP1;KLF3;MYBL1;GLI1;NR2C2;ZBTB26;TEAD2;HDAC4;ZFP90;HIVEP2;HBP1;SOX13;FOXC2;PRDM5;ZBTB8B;ZNF219;THRAP3;RBL1;ZFP28;FOXL1;ZFP3;ZNF367;ZBTB6;ZKSCAN5;ATF2;ZNF569;TEAD1;RARG;NFATC3;MNT;ZSCAN22;ZBTB48;ZNF467;SNAI1;TFAP2D;SKOR1;IRF1;ZBTB1;MYBL2;ZNF148;HOXB2;HES6;ZNF235;DEAF1
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.39746771941321046,-1.338674556089215,0.07530120481927711,0.40767630776072833,1.0,18/60,9.79%,TEK;ERBB4;NTRK3;EPHB1;ROR1;EPHA5;MERTK;EPHA6;TIE1;ACVRL1;NTRK2;KDR;MET;ROR2;EPHB2;EPHA7;FLT4;ERBB2
prerank,potassium:proton antiporter activity (GO:0015386),-0.6099541486595682,-1.3385769206098823,0.11368421052631579,0.4022974208207475,1.0,3/10,8.52%,SLC9A2;SLC9A6;SLC9A7
prerank,protein tyrosine kinase activity (GO:0004713),-0.35929060447363104,-1.3385505234109256,0.0299625468164794,0.3969977130378184,1.0,26/108,10.46%,TEK;ERBB4;NTRK3;EPHB1;ROR1;EPHA5;MERTK;EPHA6;PEAK1;TIE1;PTK2B;NTRK2;KDR;LYN;BMX;MET;ROR2;EPHB2;EPHA7;PTK2;FLT4;CAMKK2;ERBB2;HIPK1;JAK1;TEC
prerank,tropomyosin binding (GO:0005523),0.5704309044973517,1.3340257790955095,0.15789473684210525,0.7260278986241004,1.0,3/16,5.26%,NEBL;TMOD2;TMOD3
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.5315350273557081,-1.331605628487673,0.1368421052631579,0.40710716037993866,1.0,4/15,22.91%,PLA2G4A;PLA2G12A;PLA2G4E;PLA2G4F
prerank,histone acetyltransferase activity (GO:0004402),0.5216435113561743,1.3293391088117579,0.13402061855670103,0.7325748534829747,1.0,11/30,18.55%,ARRB1;NCOA3;SRCAP;KAT6B;BAZ1A;ATF2;KAT14;KAT7;KAT2B;CREBBP;TAF1
prerank,rRNA binding (GO:0019843),-0.4144825236162568,-1.3281186520731283,0.09523809523809523,0.4089927301384164,1.0,20/42,26.43%,CAVIN1;RPLP0;RPS3;RPL5;RPL12;RPS9;RPL23;RPS5;EMG1;NOP53;RCC1L;MRPL16;UTP23;ERI1;RPS13;RPL11;FASTKD5;FASTKD2;RRS1;DDX28
prerank,voltage-gated ion channel activity (GO:0005244),-0.5460793147913622,-1.3276751366570492,0.1592356687898089,0.40467602919454004,1.0,7/14,17.01%,KCND2;CACNA1E;HCN1;VDAC1;CACNA1H;GPR89B;GPR89A
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),-0.49109615521449357,-1.3269751662027158,0.11926605504587157,0.40098104766252135,1.0,6/23,9.40%,PLCB4;EDNRA;PLCE1;CHRM3;PLCG2;PLCH1
prerank,lipid phosphatase activity (GO:0042577),-0.5498731594811258,-1.3250782639521996,0.13733905579399142,0.39984835093310195,1.0,4/14,10.07%,PLPP1;PLPPR1;PLPPR5;PLPPR4
prerank,Toll-like receptor binding (GO:0035325),-0.5624038472298081,-1.322244796284183,0.15492957746478872,0.40101644520022256,1.0,7/11,34.93%,DAB2IP;TIRAP;TOLLIP;CD36;TLR1;MYD88;TLR2
prerank,NAD+ binding (GO:0070403),0.6293923238574686,1.3221115833901593,0.16568047337278108,0.749292796696546,1.0,6/12,9.64%,CRYL1;SIRT5;SIRT3;PARP9;ZC3HAV1;SIRT1
prerank,muscle alpha-actinin binding (GO:0051371),-0.5339222812535411,-1.3214044814773747,0.14316702819956617,0.3979361907796465,1.0,8/15,30.02%,PDLIM1;SYNPO2;PDLIM3;LDB3;TTN;PDLIM2;PDLIM4;NRAP
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.5967488105740599,1.3197173378191078,0.15134099616858238,0.7478979183859856,1.0,5/15,4.40%,HS3ST3A1;HS3ST3B1;NDST1;HS2ST1;HS3ST6
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.46409829041645734,1.3127925229845796,0.12965964343598055,0.7621306923008951,1.0,3/48,1.14%,TRPM3;SLC41A1;TRPM6
prerank,adenylyltransferase activity (GO:0070566),0.5411435216513882,1.3090365193701485,0.16974789915966387,0.7662209247000666,1.0,13/21,23.72%,OAS2;NMNAT1;TENT2;FLAD1;ABL1;OAS3;TENT4B;PAPOLG;NMNAT2;SELENOO;KARS1;TUT1;NMNAT3
prerank,ADP binding (GO:0043531),0.5226829539468963,1.3062769427720131,0.16457960644007155,0.7667562497362346,1.0,2/25,4.22%,PRKAG2;MYO18A
prerank,G protein-coupled receptor binding (GO:0001664),0.4005703865108664,1.3008298590416596,0.08377659574468085,0.776701565586321,1.0,17/132,10.32%,WNT5B;ACE;RNF43;WNT4;TULP3;WNT6;PRKN;GNAT2;ARRB1;ARHGEF12;ARHGEF11;GNAT3;ADM;RYK;GPRC5B;PICK1;CCL25
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3764389962984113,1.300715856835694,0.047619047619047616,0.7676400395416348,1.0,43/232,15.84%,RNF220;RNF152;PDZRN3;SH3RF2;RNF43;ASB2;PRKN;TRIM63;KCMF1;DTX1;NEDD4;NHLRC4;RNF151;PIAS1;RNF135;TRIM56;RNF181;UBR4;MGRN1;UBR2;SMURF2;RNF8;TRIP12;RNF217;HUWE1;RNF19A;RNF34;UBR5;SH3RF1;CDC42;RNF41;RNF13;WWP2;NSMCE2;TRIM62;DTX3;ASB12;BIRC3;RNF115;AMFR;PIAS3;RNF19B;HECTD1
prerank,chloride channel inhibitor activity (GO:0019869),0.6283040991364233,1.2997342371001277,0.20233463035019456,0.7619174265141848,1.0,1/10,0.46%,WNK4
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.5612178704025652,1.297870433314759,0.18650088809946713,0.7594399951659876,1.0,8/16,29.75%,ALOX12;ADI1;BCO2;ETHE1;CDO1;ALOXE3;HAAO;PIR
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.4626264474772725,-1.297637461791167,0.14442013129102846,0.4449002980219956,1.0,9/23,5.53%,PDE4D;PDE4B;PDE3A;PDE10A;PDE8A;PDE3B;PDE11A;PDE1C;PDE7B
prerank,transcription cis-regulatory region binding (GO:0000976),0.36080595966069257,1.2969022045824132,0.030803080308030802,0.7543032995836219,1.0,87/406,17.21%,AEBP1;EPAS1;RORA;SMAD3;TFDP2;OSR1;FOXN3;MXI1;NFYC;CUX1;CREBRF;ZBTB20;NPAS3;GABPB1;GABPB2;SOX5;ZNF568;ARID4A;GLI3;FOXC1;VEZF1;ASCL3;CREB3L2;NFYB;SMAD6;BNC2;RREB1;CUX2;OTP;TIPARP;TBL1X;HMGA1;TP53;SOX12;BCOR;MEF2A;RBL2;TBL1XR1;CALCOCO1;TCF7L2;TCF7;HDAC1;TFDP1;GLI1;NR2C2;HDAC4;ZFP90;ASH2L;SOX13;FOXC2;PRDM5;ZBTB8B;RBL1;ZFP3;ATF2;TEAD1;MNT;HNRNPL;ZBTB48;SNAI1;TFAP2D;IRF1;DEAF1;BRD7;FOXA2;KMT2D;TAF4;TBP;NCOR1;ATF6B;PER2;NFKB1;TAF7;HSF2;PURB;STAT6;SATB2;MZF1;HOXB8;ZBTB8A;NKX2-1;RXRA;PER3;YAP1;SMAD4;RB1;KLF15
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.544739172304674,-1.2961696598397916,0.16204690831556504,0.44339048791067043,1.0,6/13,13.85%,PTPRJ;IL1R1;PDGFC;PDGFA;ITGB3;VEGFA
prerank,insulin-like growth factor binding (GO:0005520),-0.5191402030194083,-1.2951147596873531,0.140625,0.44066884490521685,1.0,5/15,10.36%,ITGA6;ITGB4;IGFBP4;IGFBP6;ITGB3
prerank,DNA binding (GO:0003677),0.3482659313749311,1.2928541093005628,0.00944386149003148,0.7594265530560252,1.0,190/694,21.68%,DENND4A;EPAS1;HLF;RORA;THRB;SMAD3;APLP2;ZIC2;PPARGC1A;NFYC;CUX1;PPARA;SSBP2;SPO11;GLI2;ZNF423;POLR2A;DNMT3A;SPHK1;FOXD1;HOXA1;ARID4A;NUPR1;NR2F2;TSHZ3;NR6A1;CXXC5;FOXC1;NFIB;PCBP2;ASCL3;NFYB;FOXP2;MEIS1;CHD4;TIGD3;CUX2;POLG;DDX3X;OTP;ARID3A;ESRRA;NHEJ1;COLEC11;HMGA1;TSHZ1;TP53;CAMTA2;BCLAF3;PARP4;DNASE1L1;SOX12;FBH1;SMARCA4;POLR2D;HUWE1;KDM2B;TERT;MEF2A;SAMHD1;RBMS1;C1D;TWNK;SLTM;SIRT3;CALCOCO1;ZIC4;TCF4;TCF7L2;IRX1;GLI1;XRCC4;NR2C2;HDAC4;SSBP1;DDX60;HIVEP2;WDR76;SOX13;FOXC2;PRDM5;ZNF219;THRAP3;ABL1;FOXL1;RTF1;SURF6;ZBTB6;RBBP8;TEAD1;ZDHHC1;PRKDC;RARG;MAU2;MSH3;IRF1;ZNF148;HOXB2;IGHMBP2;PHF1;RAD50;PNKP;TOP3A;FOXA2;KMT2D;MLXIPL;TDG;MTERF2;MCM7;MCM2;TAF4;ZMYM6;PBX4;PSIP1;DDB2;MBD6;ILF2;ZBTB32;SDE2;TDP2;ZKSCAN3;PURB;E2F4;HOXA7;ZMYM4;TET1;FUBP3;DEDD;CREBBP;DNASE1L2;ILF3;POLL;NKX2-1;RXRA;RFX2;CLSPN;CENPC;SMAD4;CHD2;TCF7L1;BCL6;MBD4;ZBP1;MSH4;CHD8;BARX2;FOXO3;MBD1;CRY1;TINF2;EZH1;CARF;OGG1;TAF1;ZGPAT;PDS5B;HES7;NBN;APTX;FEN1;RFC1;FOXD2;XPA;ZNF496;RAD51D;POU4F1;MCM9;HDGFL2;NR1H3;ZNF76;FOXE1;NR5A1;MAP1S;MLH1;LIG4;RTF2;SPDEF;IKZF3;GTF2A1;GTF3C3;YAF2;SAP30L;CEBPG;POLR2G;THAP11;TAF6L;SP1;MSX2;YY1;MCM5
prerank,5'-nucleotidase activity (GO:0008253),0.585479201284067,1.2924568439077813,0.1963302752293578,0.7522290795255189,1.0,7/13,19.17%,NT5C1B-RDH14;NT5C1B;NT5DC1;NT5C2;NT5C3A;NT5C3B;NT5C
prerank,GTPase activator activity (GO:0005096),0.3648238735730922,1.2923703231985393,0.044673539518900345,0.7441109869711325,1.0,70/313,13.00%,RANBP3L;DENND4A;DOCK11;RAPGEF5;ARHGAP28;ARHGAP29;ERRFI1;SIPA1L1;SMAP2;RIN2;ARHGEF10L;ARHGEF18;FNIP1;ARHGEF16;SRGAP2;FGD4;ARHGAP18;SYDE2;ALS2;ARHGAP9;RGL1;ALDH1A1;RGS16;DOCK5;NGEF;AKAP13;NPRL3;TBC1D16;ASAP3;LRRK2;GMIP;ARHGAP26;RAPGEF3;DENND2A;RAB3IP;IQSEC2;ARRB1;ASAP1;NPRL2;ARFGEF2;WDR41;RIN3;RAB3IL1;ARHGAP17;ARFGAP3;ARHGEF11;ELMOD3;DENND5A;SH3BP5;OPHN1;NUCB1;DNM1L;EPS8L2;GRTP1;RALGAPB;MTSS2;HPS1;RANBP3;FGD1;OCRL;RGPD1;RGP1;ANKRD27;RALBP1;EPS8L1;GNB5;RIC8B;RAP1GAP;DENND4C;MON1A
prerank,androgen receptor binding (GO:0050681),0.5172223669666861,1.2904199504910188,0.15300546448087432,0.7425839126230254,1.0,6/25,8.59%,DDX5;PRKCB;NSD1;WIPI1;SMARCA4;TMF1
prerank,C-C chemokine receptor activity (GO:0016493),0.5370908601243256,1.2850140624415318,0.19856887298747763,0.7532752382584391,1.0,2/21,1.56%,ACKR2;CCR9
prerank,actin binding (GO:0003779),-0.3185440948637688,-1.283616013505268,0.02358490566037736,0.46281327035261105,1.0,46/170,13.20%,UTRN;SYNE1;ACTN4;MYRIP;MAP1B;GSN;ABLIM1;TMSB4X;FMN2;NOS3;KCNMA1;PARVB;MICAL2;FXYD5;MOBP;KLHL2;CCDC88A;MYH9;CAP2;KLHL1;SMTN;LIMA1;CORO2B;ITGB1;MRTFA;RDX;ANLN;CEACAM1;PTK2;PDLIM1;MYO6;TRPV4;TLNRD1;ADD2;PACRG;EPS8;SYNPO2;CALD1;SPEF1;MAPT;PDLIM3;MTSS1;PFN2;DMTN;SNCA;SPTB
prerank,ubiquitin protein ligase activity (GO:0061630),0.3737904118392579,1.282211067789024,0.048628428927680795,0.7541991629203393,1.0,27/228,9.18%,RNF220;RNF152;PDZRN3;SH3RF2;RNF43;ASB2;PRKN;TRIM63;KCMF1;DTX1;NEDD4;NHLRC4;RNF151;RNF135;TRIM56;RNF181;UBR4;MGRN1;UBR2;SMURF2;RNF8;TRIP12;RNF217;HUWE1;RNF19A;RNF34;UBR5
prerank,voltage-gated cation channel activity (GO:0022843),-0.3420362297233696,-1.274928183128398,0.05514705882352941,0.4784881610532234,1.0,22/97,10.83%,KCND2;CACNB2;KCNB2;CACNA1E;KCNQ5;KCNC2;KCNH7;HCN1;KCNMA1;GRIN2B;CACNA2D1;KCNQ3;PTK2B;GRIN3A;KCNS3;CACNA1B;GRIN2A;KCNA6;KCNQ1;KCNH5;KCNC1;KCNB1
prerank,calcium activated cation channel activity (GO:0005227),-0.4927713934561945,-1.2739447691181731,0.17286652078774617,0.4753618867874502,1.0,4/17,4.50%,KCNMA1;ANO1;KCNN2;KCNMB2
prerank,FAD binding (GO:0071949),0.5101473754492252,1.2699941499381615,0.17758620689655172,0.7872903661852815,1.0,4/24,7.00%,DDO;MICAL3;PRODH;MTHFR
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.34278624160350807,1.2673003946528143,0.014537902388369679,0.7879308877801962,1.0,118/732,12.04%,HLF;ZKSCAN2;RORA;MAF;THRB;SMAD3;GLIS3;ZIC2;FOXN3;MXI1;NFYC;PKNOX2;PPARA;FOXP4;ZFHX2;IKZF2;GLI2;ZNF423;DNMT3A;HOXB4;CREB5;ZBTB20;ZNF160;HOXB6;FOXD1;HOXC6;HOXA1;SOX5;ZNF568;NFAT5;NR2F2;KCNIP3;GLI3;MITF;ELF1;ZNF697;NR6A1;ARNT2;FOXC1;HOXB3;NFIB;ZBTB38;RFX8;MAFG;NACC2;ATOH1;NFYB;NHLH2;SALL4;FOXP2;MEIS1;RREB1;NSD1;TEF;TEAD3;TIPARP;ESRRA;STAT2;HOXB5;HMGA1;HOXB9;HOXA3;TP53;BHLHE41;RORC;MGA;ZSCAN29;SOX12;ZIC5;NR1D2;ZSCAN25;MEF2A;ZIC1;HOXC4;CALCOCO1;ZIC4;TCF4;TCF7L2;IRX1;CCAR1;NEUROD4;TCF7;HDAC1;KLF3;MYBL1;GLI1;NR2C2;ZBTB26;TEAD2;HDAC4;HIVEP2;HBP1;SOX13;FOXC2;PRDM5;ZNF219;THRAP3;ZFP28;FOXL1;ZNF367;ZBTB6;ZKSCAN5;ATF2;ZNF569;TEAD1;RARG;NFATC3;MNT;ZSCAN22;ZBTB48;ZNF467;SNAI1;SKOR1;IRF1;ZBTB1;MYBL2;ZNF148;HOXB2
prerank,bHLH transcription factor binding (GO:0043425),0.5403585945858426,1.2662855831266022,0.20677361853832443,0.7829593479062933,1.0,4/19,9.64%,SMAD3;FHL2;BHLHE41;SIRT1
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.4381260302670623,1.2660554868384972,0.14485981308411214,0.7754973880114483,1.0,13/60,12.11%,LRRK1;CTDSPL;MTMR3;PPEF2;PPP1CB;PPM1E;LRRK2;CDC14A;PTEN;PP2D1;CDC14B;PHLPP2;CTDSP2
prerank,sequence-specific DNA binding (GO:0043565),0.34716661454177994,1.265024919765715,0.022058823529411766,0.7710734791619088,1.0,85/590,12.04%,EPAS1;HLF;RORA;MAF;THRB;SMAD3;OSR1;PPARGC1A;KMT2A;CUX1;PKNOX2;PPARA;CXXC1;GLI2;ZNF423;HOXB4;CREB5;ZBTB20;HOXB6;FOXD1;HOXA1;NFAT5;NR2F2;GLI3;ELF1;NR6A1;CXXC5;ARNT2;FOXC1;CXXC4;NFIB;ZBTB38;MAFG;MBNL2;ATOH1;SMG1;NHLH2;FOXP2;CUX2;FBXL19;TEF;ESRRA;ACD;HOXB5;HOXB9;BHLHE41;RORC;ZSCAN29;SOX12;ZIC5;ELF2;NR1D2;KDM2B;TERT;MEF2A;ZIC1;HOXC4;KDM2A;SLTM;SIRT3;CALCOCO1;ZIC4;TCF4;TCF7L2;IRX1;TCF7;KLF3;NR2C2;ZBTB26;TEAD2;HDAC4;SOX13;FOXC2;PRDM5;ABL1;FOXL1;ATF2;TEAD1;RARG;NFATC3;SNAI1;SKOR1;MYBL2;ZNF148;HOXB2
prerank,poly(U) RNA binding (GO:0008266),0.5374692603831682,1.2637348030497826,0.20898100172711573,0.7676077865736782,1.0,8/20,16.37%,RBMS2;HNRNPH1;PABPC4L;RBMS1;RBMS3;HNRNPC;PABPC5;DAZAP1
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.4643187898903026,-1.260692234250337,0.17333333333333334,0.5013518481345535,1.0,9/21,5.53%,PDE4D;PDE4B;PDE3A;PDE10A;PDE8A;PDE3B;PDE11A;PDE1C;PDE7B
prerank,flavin adenine dinucleotide binding (GO:0050660),0.44312275841452997,1.2595785182530022,0.1834862385321101,0.7738699553330105,1.0,19/53,19.38%,DDO;MICAL3;PRODH;DPYD;POR;MTHFR;LDHD;DLD;NOX4;ACOXL;MTRR;ACOX3;GCDH;SQOR;MICAL1;KDM1A;CRY1;MMACHC;ETFDH
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.5242466269784797,-1.2585411959633122,0.19294605809128632,0.5007398344392714,1.0,6/12,18.86%,VEGFC;CCDC88A;DAB2IP;ITGB3;VEGFA;ITGA5
prerank,low-density lipoprotein particle binding (GO:0030169),-0.4966079856758053,-1.2585204937779166,0.16143497757847533,0.4952901586443461,1.0,8/16,8.86%,CDH13;THBS1;SCARB1;PLTP;LDLR;SORL1;STAB1;SCARF1
prerank,P-type ion transporter activity (GO:0015662),-0.5442876556424979,-1.2555267894543156,0.1702127659574468,0.49720891335353024,1.0,5/12,12.21%,ATP2C1;ATP2B2;ATP2A3;ATP2B4;ATP2B1
prerank,sodium channel regulator activity (GO:0017080),-0.40616613895930476,-1.251084423869934,0.1650485436893204,0.5029107817040118,1.0,14/37,21.34%,FGF14;FGF12;CAMK2D;FXYD5;NEDD4L;FGF13;ATP2B4;NOS1;PTPN3;SCN2B;FXYD6;COMMD1;SCN1B;PKP2
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",-0.5379492780858246,-1.2506138965545723,0.2135523613963039,0.498627073512504,1.0,7/12,27.51%,B3GALT1;B3GALNT1;B3GALT5;B3GNT3;B3GNT2;B3GNT6;B4GAT1
prerank,semaphorin receptor activity (GO:0017154),-0.5426831495950446,-1.248733090312954,0.2025862068965517,0.4979643472011809,1.0,4/11,8.41%,NRP1;NRP2;PLXNA4;PLXNC1
prerank,acetylglucosaminyltransferase activity (GO:0008375),-0.384137841030872,-1.247769337674987,0.15263157894736842,0.49506640370751076,1.0,12/46,12.15%,MGAT4C;GCNT2;EXT1;MGAT4A;B3GALT1;HEXB;B3GALNT1;EXT2;LFNG;MGAT5;MFNG;B3GALT5
prerank,C-C chemokine binding (GO:0019957),0.514254964816546,1.245688823997307,0.20646319569120286,0.8133944627306687,1.0,2/22,1.56%,ACKR2;CCR9
prerank,myosin II binding (GO:0045159),-0.566071653131399,-1.2451057216780053,0.19427402862985685,0.495964439976602,1.0,4/10,9.74%,GSN;STXBP5L;SHROOM4;SHROOM1
prerank,phosphoric ester hydrolase activity (GO:0042578),0.4465017028574207,1.242266004171477,0.17834394904458598,0.8169181088604248,1.0,9/49,11.37%,ATP1A2;MPPED2;PPP1CB;LHPP;PXYLP1;PTPN22;SAMHD1;PRUNE1;DUSP10
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.33601065196850405,1.2414901453957459,0.032191069574247146,0.8112098565627388,1.0,118/731,12.36%,HLF;ZKSCAN2;RORA;MAF;THRB;SMAD3;GLIS3;ZIC2;MXI1;NFYC;PKNOX2;PPARA;FOXP4;ZFHX2;IKZF2;GLI2;ZNF423;DNMT3A;HOXB4;CREB5;ZBTB20;ZNF160;HOXB6;FOXD1;HOXC6;HOXA1;SOX5;ZNF568;NFAT5;NR2F2;KCNIP3;GLI3;MITF;ELF1;ZNF697;NR6A1;ARNT2;FOXC1;HOXB3;NFIB;ZBTB38;RFX8;MAFG;NACC2;ATOH1;CREB3L2;NFYB;NHLH2;SALL4;FOXP2;MEIS1;RREB1;NSD1;TEF;TEAD3;ESRRA;STAT2;HOXB5;HOXB9;HOXA3;TP53;BHLHE41;RORC;MGA;ZSCAN29;SOX12;ZIC5;NR1D2;ZSCAN25;MEF2A;ZIC1;HOXC4;CALCOCO1;ZIC4;TCF4;TCF7L2;IRX1;CCAR1;NEUROD4;TCF7;HDAC1;KLF3;MYBL1;GLI1;NR2C2;ZBTB26;TEAD2;HDAC4;HIVEP2;HBP1;SOX13;FOXC2;PRDM5;ZNF219;THRAP3;ZFP28;FOXL1;ZNF367;ZBTB6;ZKSCAN5;ATF2;ZNF569;TEAD1;RARG;NFATC3;MNT;ZSCAN22;ZBTB48;ZNF467;SNAI1;SKOR1;IRF1;ZBTB1;MYBL2;ZNF148;HOXB2;HES6;ZNF235
prerank,N-acyltransferase activity (GO:0016410),0.48294473238127866,1.2389358584363295,0.19935691318327975,0.8123382349816314,1.0,7/32,9.64%,NMT2;NAA80;CERS6;CERS5;SAT1;SMARCE1;SIRT1
prerank,MAP-kinase scaffold activity (GO:0005078),0.5931081936012952,1.237890009914776,0.24151696606786427,0.8083702441453373,1.0,5/11,13.76%,KSR1;AKAP13;SH3RF1;MAP2K1;MAP2K2
prerank,tRNA methyltransferase activity (GO:0008175),0.5397317132494258,1.2364295143098283,0.23467600700525393,0.8056295002208174,1.0,2/16,7.70%,TRMT9B;TRMT44
prerank,lipoprotein particle binding (GO:0071813),-0.4627537922773784,-1.2357647104381244,0.19437939110070257,0.5127381260265906,1.0,8/20,8.86%,CDH13;THBS1;SCARB1;PLTP;LDLR;SORL1;STAB1;SCARF1
prerank,potassium ion leak channel activity (GO:0022841),0.5474294562686903,1.2350632840670905,0.24080882352941177,0.8024570780394219,1.0,1/15,0.26%,KCNK2
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),0.49998659699141135,1.2349707740589462,0.21252059308072488,0.7951777606392012,1.0,1/29,0.04%,PRKAG2
prerank,protein kinase regulator activity (GO:0019887),0.39902733873754254,1.2346553273754912,0.15948275862068967,0.788792347384582,1.0,20/95,15.41%,PRKAG2;GPRC5C;CCNA2;PRKAG3;CCNA1;CCNT2;CCND3;SH3BP5;GPRC5B;CCNB2;TRIB1;SOCS3;GPRC5A;WNK1;PRKAR1A;PARVA;CCNL1;FAF1;RPTOR;CCNG1
prerank,filamin binding (GO:0031005),0.570752278908144,1.2331848404140564,0.23483365949119372,0.7862471794555189,1.0,1/11,0.51%,NEBL
prerank,chemokine receptor activity (GO:0004950),0.49742133027305846,1.2331399759109978,0.22395833333333334,0.7792392215961356,1.0,2/24,1.56%,ACKR2;CCR9
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.4532591490736104,-1.232984329897667,0.18357487922705315,0.5141697204942557,1.0,10/23,19.72%,HIP1;CLVS1;PLEKHA5;JPH2;PHLDA3;CLVS2;SESTD1;HIP1R;PLA2G4E;COMMD1
prerank,actin monomer binding (GO:0003785),-0.45237401818228884,-1.2324289037985772,0.20568927789934355,0.5102232188903787,1.0,7/22,14.82%,TMSB4X;NOS3;LIMA1;MRTFA;MTSS1;PFN2;COBL
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.4320280768082989,1.2320059688076377,0.1869009584664537,0.7756904012281097,1.0,11/54,9.64%,UPB1;ASPA;HDAC8;NGLY1;ASPG;PM20D1;NAAA;SIRT5;HDAC1;HDAC4;SIRT1
prerank,MAP kinase phosphatase activity (GO:0033549),0.5728289193226564,1.2301688610525365,0.23251417769376181,0.7751146176200039,1.0,3/12,11.65%,DUSP29;DUSP10;DUSP2
prerank,transcription coregulator binding (GO:0001221),0.4353136129436878,1.229227043209589,0.1907790143084261,0.7711753876147048,1.0,9/50,9.36%,RORA;THRB;SMAD3;VGLL4;LCOR;USP11;CCNT2;TERT;TEAD2
prerank,protein kinase activator activity (GO:0030295),0.4284968904468906,1.2277624089978503,0.18210361067503925,0.7694177677890233,1.0,16/60,15.35%,PRKAG2;FAM20A;GPRC5C;ALS2;DDX3X;RICTOR;AFAP1L2;GPRC5B;NRG1;IRGM;GPRC5A;MAP2K1;WNK1;MAP2K2;STK4;RPTOR
prerank,MAP kinase kinase kinase activity (GO:0004709),-0.5394100406849929,-1.2261606812916794,0.23481781376518218,0.5198967259250333,1.0,2/11,6.89%,MAP3K5;MAP3K7
prerank,mechanosensitive ion channel activity (GO:0008381),-0.5253419911127211,-1.2260934357963418,0.21193415637860083,0.5149697934509041,1.0,2/12,7.72%,PIEZO2;PIEZO1
prerank,GDP binding (GO:0019003),-0.36053959432866495,-1.2253582231142044,0.13134328358208955,0.5116170834752419,1.0,18/63,18.89%,RIT2;RAB31;KRAS;RAP1B;RAP1A;RASL12;RAB27A;GNAI1;RERG;RALB;RAB18;RAP2A;RAB27B;RRAS;ARF6;ARL8B;RAN;RHEB
prerank,metallocarboxypeptidase activity (GO:0004181),0.4863374905782084,1.2250163743720706,0.23743500866551126,0.7712908388756912,1.0,3/26,5.91%,AEBP1;CPA4;PEPD
prerank,potassium channel regulator activity (GO:0015459),-0.37899410650405885,-1.2220064741107672,0.14327485380116958,0.5142696084640855,1.0,12/49,7.28%,KCNIP4;DPP10;DPP6;ABCC9;KCNIP1;KCNAB1;KCNMB2;NEDD4L;YWHAE;KCNS3;FLNA;WNK2
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.47757422833486585,1.221061566291094,0.22797927461139897,0.777001072493294,1.0,9/28,14.76%,PRKAA2;LRRK2;MAP2K5;MAPKAPK3;AURKB;MAPK10;MAP2K1;MAP2K2;MAP2K6
prerank,calcium channel regulator activity (GO:0005246),-0.39609877156943213,-1.2202308878615804,0.17530864197530865,0.5137413349741605,1.0,11/37,14.33%,PRKG1;NRXN1;STIM2;YWHAE;CALM1;CALM2;FKBP1A;NRXN2;SLC30A1;MCUB;CACNG8
prerank,GDP-dissociation inhibitor activity (GO:0005092),-0.5162364535060393,-1.216165609962917,0.22098214285714285,0.5179514351209452,1.0,6/13,17.28%,CCDC88A;ARHGDIB;SH3BP4;RANBP1;ARHGDIA;GDI1
prerank,chloride channel regulator activity (GO:0017081),0.5501757126762455,1.2156733794016505,0.266173752310536,0.7872208603223801,1.0,1/14,0.46%,WNK4
prerank,I-SMAD binding (GO:0070411),0.5443632871043743,1.2132158492007556,0.2613430127041742,0.7882527738433825,1.0,3/13,4.75%,SMAD3;TGFBR1;SMAD6
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),-0.3919789940678524,-1.2081259710239767,0.18689320388349515,0.5312530944591733,1.0,14/35,22.31%,PEAK1;PTK2B;LYN;BMX;PTK2;TEC;FES;SYK;BTK;PKDCC;TXK;SLA;YES1;FYN
prerank,poly-pyrimidine tract binding (GO:0008187),0.5042774019560762,1.2072018694165474,0.24825174825174826,0.800531396896099,1.0,10/23,21.77%,RBMS2;HNRNPH1;PABPC4L;RBMS1;RBMS3;HNRNPC;PABPC5;DAZAP1;FMR1;U2AF2
prerank,platelet-derived growth factor binding (GO:0048407),0.5771596809627031,1.2065742968496729,0.27435387673956263,0.7960721352914911,1.0,3/11,6.54%,COL5A1;PDGFRB;COL1A2
prerank,GTPase regulator activity (GO:0030695),0.34913559180935916,1.2027274082570893,0.12795031055900621,0.8018158866325927,1.0,49/212,14.46%,RANBP3L;CPEB2;ARHGAP28;ARHGAP29;ERRFI1;SIPA1L1;SMAP2;RIN2;ARHGEF10L;SRGAP2;ARHGAP18;SYDE2;ALS2;ARHGAP9;ALDH1A1;RGS16;NPRL3;TBC1D16;ASAP3;LRRK2;GMIP;ARHGAP26;ARRB1;GPS2;ASAP1;NPRL2;ARHGAP17;ARFGAP3;ELMOD3;OPHN1;DNM1L;WASL;GRTP1;RALGAPB;MTSS2;RANBP3;PDE6D;OCRL;RGPD1;RALBP1;GNB5;RIC8B;RAP1GAP;KRIT1;FLCN;HACD3;SGSM2;DEPDC5;VAV3
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.5434519452785855,-1.1986942755895365,0.22736842105263158,0.5482352940401589,1.0,2/10,5.51%,MECOM;PRDM16
prerank,calcium-release channel activity (GO:0015278),0.5184343951388565,1.198508654883076,0.2670157068062827,0.8091538577875522,1.0,3/17,3.71%,ITPR2;ITPR1;TPCN1
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.5201087568146199,-1.1970046475376228,0.2582781456953642,0.547326366735385,1.0,6/11,31.55%,RPS3;HMCES;HMGA2;APEX1;APEX2;NEIL2
prerank,carboxypeptidase activity (GO:0004180),0.45935799923060894,1.1969305560766437,0.25493421052631576,0.8076993094466557,1.0,5/35,7.48%,AEBP1;CPA4;NAALADL1;PEPD;SCPEP1
prerank,dipeptidyl-peptidase activity (GO:0008239),-0.5417163616537415,-1.1958358189388136,0.25684210526315787,0.5453561863571859,1.0,4/10,8.24%,DPP10;DPP6;FAP;NAALAD2
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3940476221650894,1.1942022372105285,0.20206489675516223,0.8097144832956856,1.0,11/75,9.16%,ME2;SORD;CRYL1;AKR1B10;LDHB;BDH1;DHDH;DHRS11;DHRS3;BDH2;LDHD
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.4939520460139956,-1.1917560341725704,0.2425531914893617,0.5496996681913402,1.0,5/13,12.14%,RYR2;GSK3B;KCNQ1;PRKAR2B;PRKAR1B
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.5049733160732769,1.1903503549131635,0.2645985401459854,0.8153702533421497,1.0,7/17,15.36%,DPYD;BDH2;PTGR2;MECR;TM7SF2;LBR;DECR1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.3670886387682932,1.190133425255869,0.18239795918367346,0.8096310520421334,1.0,34/147,13.00%,DENND4A;DOCK11;RAPGEF5;RIN2;ARHGEF18;FNIP1;ARHGEF16;FGD4;ALS2;RGL1;DOCK5;NGEF;AKAP13;RAPGEF3;DENND2A;RAB3IP;IQSEC2;ARFGEF2;WDR41;RIN3;RAB3IL1;ARHGEF11;DENND5A;SH3BP5;NUCB1;EPS8L2;HPS1;FGD1;RGP1;ANKRD27;EPS8L1;RIC8B;DENND4C;MON1A
prerank,ubiquitin-protein transferase activity (GO:0004842),0.33225807443786026,1.1880474177823361,0.1285878300803674,0.8096871521540897,1.0,78/346,18.89%,RNF220;RNF152;PDZRN3;SH3RF2;UBE2E2;RNF43;ASB2;PRKN;RNF213;TRIM63;KCMF1;DTX1;NEDD4;NHLRC4;RNF151;RNF135;TRIM56;RNF181;UBR4;MGRN1;UBR2;SMURF2;TTC3;RNF8;FBXW11;RNF141;TRIP12;BCOR;RNF217;HUWE1;BTRC;RNF19A;RNF34;UBR5;FBXO22;SH3RF1;CDC42;UBE2M;FBXW8;RNF41;FBXO4;RNF13;CUL4A;WWP2;FBXO10;TRIM62;DTX3;ASB12;PML;DDB2;FBXO11;DZIP3;BIRC3;RMND5A;UBE2H;RNF115;AMFR;RNF19B;HECTD1;RNF31;BIRC6;MAEA;RNF146;UBE2E1;UBR1;SYVN1;RNF7;KCTD13;CDC34;RNF25;ARIH1;RNF2;TAF1;MIB1;RNF20;RNF214;NHLRC3;FBXL22
prerank,sterol binding (GO:0032934),0.41331584810223293,1.1874476941203722,0.2277526395173454,0.8050988066103683,1.0,10/56,9.40%,RORA;OSBPL8;GRAMD1B;INSIG2;OSBPL11;VDAC2;OSBPL9;RORC;SIDT1;SULT2B1
prerank,leucine zipper domain binding (GO:0043522),0.5581727452847001,1.1851462234232077,0.2859848484848485,0.8058008655994386,1.0,1/10,0.75%,PAWR
prerank,hormone receptor binding (GO:0051427),-0.4956697818518754,-1.1834139789121072,0.2606924643584521,0.5646283711860041,1.0,3/14,12.38%,SOCS2;JAK1;PTHLH
prerank,cytokine activity (GO:0005125),0.363678357705609,1.1831708845215507,0.19137466307277629,0.8059560809041705,1.0,9/131,6.56%,WNT5B;BMP6;BMP7;WNT4;WNT6;IL18;IFNK;IL17D;IL12B
prerank,translation elongation factor activity (GO:0003746),-0.4773861152586826,-1.1814124875503937,0.2577962577962578,0.5642804010340635,1.0,10/14,37.25%,EEF1A1;EIF5A2;EEFSEC;EEF2;TUFM;GTPBP2;EEF1A2;GFM1;EEF1B2;GTPBP1
prerank,cholesterol transfer activity (GO:0120020),-0.4720329252303505,-1.1740629394409066,0.27429805615550756,0.5769845657040035,1.0,6/16,11.76%,PLTP;ABCG1;NPC2;STARD5;MTTP;STARD4
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.47868765504882893,-1.1722855682005848,0.25,0.5765352020371577,1.0,3/13,3.20%,PIP5K1B;PIP4K2A;PIK3C2B
prerank,leak channel activity (GO:0022840),0.5073141889929864,1.1709880386262768,0.29080675422138835,0.8374862036890083,1.0,1/18,0.26%,KCNK2
prerank,GABA receptor binding (GO:0050811),0.5514974422851119,1.1702637133081821,0.31499051233396586,0.8332921126175096,1.0,3/11,10.44%,TRAK1;ARFGEF2;SHISA7
prerank,MAP kinase kinase activity (GO:0004708),0.5189158750395856,1.1701036230750315,0.2977941176470588,0.8276431720183142,1.0,7/15,14.76%,LRRK2;MAP2K5;MAPKAPK3;MAPK10;MAP2K1;MAP2K2;MAP2K6
prerank,nucleotidase activity (GO:0008252),0.5103379326047213,1.17005701294313,0.28597122302158273,0.8215890931419455,1.0,7/15,19.17%,NT5C1B-RDH14;NT5C1B;NT5DC1;NT5C2;NT5C3A;NT5C3B;NT5C
prerank,myosin binding (GO:0017022),-0.3538745190170758,-1.1696662666200135,0.1956521739130435,0.5778966828316926,1.0,11/55,11.80%,MYRIP;GSN;STXBP5L;SHROOM4;MOBP;RAB3C;NKD2;MYOC;SHROOM1;CALD1;RAB27B
prerank,phospholipase activity (GO:0004620),-0.33625956195698514,-1.1693610185234895,0.20569620253164558,0.5736823550551726,1.0,13/67,14.27%,PLCB4;PLCL1;PLA2G4A;PLCE1;MGLL;GDPD1;PDIA3;ENPP2;PLA2G12A;SMPDL3A;PITPNM3;PNPLA3;ABHD4
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.5504926409540498,1.1675571191752114,0.2985685071574642,0.8233979085114036,1.0,3/10,6.81%,RENBP;DSE;GALM
prerank,high voltage-gated calcium channel activity (GO:0008331),0.5642087435535031,1.1616207603128847,0.31736526946107785,0.8354355354737999,1.0,3/10,6.93%,CACNA1D;CACNA1C;CACNB3
prerank,RNA methyltransferase activity (GO:0008173),0.5005360004892256,1.157979041428495,0.302536231884058,0.8406400509565601,1.0,1/19,0.82%,TRMT9B
prerank,nucleoside monophosphate kinase activity (GO:0050145),-0.4322916208919533,-1.1568085641767563,0.27571115973741794,0.5993785047498005,1.0,5/20,11.44%,DLG2;MAGI3;CASK;MPP1;CMPK1
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.5470339490364375,1.156097651002623,0.33081285444234404,0.8406971823537505,1.0,1/11,1.46%,NUDT4
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),0.5303096416186392,1.1557975839852794,0.3110687022900763,0.8357032791397133,1.0,2/11,2.99%,SASH1;PPEF2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.485327138709358,1.1507903639018735,0.3041958041958042,0.8450838251907448,1.0,5/22,16.22%,CPEB2;CPEB3;RBMS3;ZFP36L1;ILF3
prerank,hexosyltransferase activity (GO:0016758),-0.31001380741552265,-1.150568513260675,0.1701388888888889,0.6091561098491446,1.0,17/101,12.15%,TMTC2;CSGALNACT1;MGAT4C;GCNT2;CHSY3;FUT9;EXT1;MGAT4A;DPY19L1;B4GALT5;B3GALT1;HEXB;B3GALNT1;EXT2;LFNG;MFNG;B3GALT5
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),-0.4824108704737662,-1.1498934332142807,0.27645788336933047,0.6056942868625937,1.0,2/12,13.47%,CDK19;CDK8
prerank,endopeptidase inhibitor activity (GO:0004866),0.3702021495164689,1.1481447448008983,0.24339360222531292,0.8472232121984826,1.0,10/82,8.66%,ITIH2;TIMP3;TFPI;SERPIND1;RENBP;COL4A3;KNG1;SERPINE1;SERPINA9;HRG
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.4713793439747752,-1.147734632435787,0.3117154811715481,0.6055636469808457,1.0,4/14,9.06%,MAL;APAF1;NOD1;ATP2A3
prerank,transaminase activity (GO:0008483),0.5348278033989812,1.1464223019811404,0.3135755258126195,0.8469148341313125,1.0,5/11,20.29%,BCAT2;GOT2;ABAT;GOT1;GOT1L1
prerank,cardiolipin binding (GO:1901612),0.5480274899360328,1.1429868844970972,0.30648330058939094,0.8518493689084236,1.0,2/10,7.15%,GSDME;OPA1
prerank,copper ion binding (GO:0005507),0.4175467112364464,1.1388913728048948,0.2764976958525346,0.8586937779935796,1.0,5/42,6.65%,MOXD1;LACC1;LOXL3;SOD3;TP53
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.4265155412848477,1.1387098183144992,0.30906148867313915,0.8533018145220153,1.0,11/35,20.54%,TRMT9B;PTRH1;TARS2;DUS4L;PUS10;LCMT2;NT5C3A;DUS3L;DTWD2;DUS2;DUS1L
prerank,pyridoxal phosphate binding (GO:0030170),0.4942166738203985,1.1358674593927536,0.32379248658318427,0.8558310601775971,1.0,6/20,18.06%,PYGM;SRR;CTH;ABAT;ACCS;THNSL2
prerank,cAMP response element binding (GO:0035497),0.5308778655637811,1.131899707945578,0.31902985074626866,0.8618952227815178,1.0,3/10,11.05%,CREB5;CREB3L2;ATF2
prerank,ATPase binding (GO:0051117),-0.3225188882122739,-1.1311869186907446,0.2084592145015106,0.6420779118098918,1.0,15/71,8.84%,PDE4D;CAV1;ESR1;SLC2A13;ATP6V0A1;ATP1B1;AR;NKD2;TRPC1;ATP6V0A4;PSEN1;PPP3CA;RDX;RALB;DNAJC10
prerank,voltage-gated calcium channel activity (GO:0005245),0.4152256090869463,1.1291665093692116,0.28253968253968254,0.8646715136792995,1.0,5/37,6.93%,CACNA1D;CACNA2D3;CACNG4;CACNA1C;CACNB3
prerank,epidermal growth factor receptor binding (GO:0005154),-0.3980510702989505,-1.1259500375737475,0.2535885167464115,0.6505399817601689,1.0,3/25,4.34%,HIP1;ERBB4;CCDC88A
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.30786553551161083,1.1255247163154605,0.1724137931034483,0.8699415581184053,1.0,124/597,17.99%,HLF;MAF;THRB;SMAD3;OSR1;NFYC;CUX1;PKNOX2;GLI2;HOXB4;CREB5;ZBTB20;HOXB6;GABPB1;GABPB2;HOXA1;SOX5;ZNF568;ARID4A;NFAT5;GLI3;ELF1;NR6A1;ARNT2;FOXC1;NFIB;MAFG;MBNL2;ATOH1;CREB3L2;NFYB;SMAD6;NHLH2;BNC2;CUX2;TEF;ESRRA;HOXB5;TBL1X;HOXB9;TP53;BHLHE41;RORC;ZSCAN29;SOX12;ZIC5;ELF2;NR1D2;BCOR;ZIC1;HOXC4;TBL1XR1;CALCOCO1;ZIC4;TCF4;TCF7L2;IRX1;TCF7;KLF3;GLI1;NR2C2;ZBTB26;TEAD2;HDAC4;ASH2L;SOX13;FOXC2;PRDM5;ABL1;ATF2;TEAD1;RARG;NFATC3;HNRNPL;ZBTB48;SNAI1;SKOR1;IRF1;MYBL2;HOXB2;HES6;BRD7;FOXA2;KMT2D;KAT7;MCM7;MCM2;FOXJ2;TBP;DHX33;NCOR1;ORC3;ATF6B;NR3C2;BEND3;ZBTB32;PER2;NFKB1;TAF7;HSF2;E2F4;HOXA7;TGIF2;MZF1;HOXB8;NKX2-1;RXRA;HIVEP1;PER3;RFX2;ELF4;HSF4;YAP1;CENPC;SMAD4;KLF15;TCF7L1;BCL6;MBD4;ZNF23;POU1F1;BARX2;FOXO3;MEF2D
prerank,N-acetyltransferase activity (GO:0008080),0.4765536556921016,1.1247518935111513,0.31095406360424027,0.8663349933266803,1.0,9/19,25.84%,NAA80;SAT1;SMARCE1;KAT2B;NAT1;EP300;ESCO1;NAA50;AANAT
prerank,ribosome binding (GO:0043022),0.40550063264828623,1.1247134978225786,0.2930232558139535,0.8607334089551866,1.0,6/46,12.19%,CPEB2;CPEB4;CPEB3;YTHDF3;IGHMBP2;ETF1
prerank,phospholipase binding (GO:0043274),0.5185305981633381,1.124564222387608,0.35551330798479086,0.8554954366770476,1.0,3/13,8.69%,PRKN;ARHGAP6;PDPK1
prerank,transcription corepressor binding (GO:0001222),0.4434326973864247,1.1239219304932921,0.3159722222222222,0.8518262773449541,1.0,9/27,17.65%,RORA;LCOR;USP11;PHF1;PER2;EHMT2;EHMT1;PER3;CTBP2
prerank,sterol transfer activity (GO:0120015),-0.4442858324516139,-1.1235600029363986,0.3289760348583878,0.6516132416865719,1.0,6/17,11.76%,PLTP;ABCG1;NPC2;STARD5;MTTP;STARD4
prerank,nucleotidyltransferase activity (GO:0016779),0.46228181674919083,1.1228510376338847,0.3220640569395018,0.8493892642623493,1.0,7/19,16.29%,DNTT;REV1;TUT4;TERT;TENT2;TENT4B;TUT7
prerank,ATP hydrolysis activity (GO:0140603),0.41171294329269714,1.1224250899259065,0.31239935587761675,0.845218417118645,1.0,6/41,7.77%,ABCA4;RNF213;MYO18A;DDX3X;CLPX;MYO19
prerank,titin binding (GO:0031432),0.5116463724818964,1.1209852383599126,0.3436293436293436,0.8441819745105653,1.0,2/13,2.88%,ACTN2;TRIM63
prerank,symporter activity (GO:0015293),0.5342685993280618,1.1176634760686175,0.3320610687022901,0.8493205155822663,1.0,2/10,7.03%,SLC5A5;SLC5A8
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.5027639876156431,1.1171371225469255,0.35687732342007433,0.8454757647755895,1.0,7/14,19.38%,RSAD2;NDUFS1;ACO2;NFU1;CIAO3;SDHB;ETFDH
prerank,ephrin receptor activity (GO:0005003),-0.4404813525413228,-1.1152547677852895,0.31627906976744186,0.6619168264785158,1.0,5/17,8.56%,EPHB1;EPHA5;EPHA6;EPHB2;EPHA7
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.4404813525413228,-1.1152547677852895,0.31627906976744186,0.6619168264785158,1.0,5/17,8.56%,EPHB1;EPHA5;EPHA6;EPHB2;EPHA7
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.4525654568133206,-1.1140369041246452,0.3415730337078652,0.6597330963540036,1.0,6/15,19.48%,PIK3R1;SOCS2;PIK3R6;SOCS5;PIK3R5;CCKBR
prerank,mitogen-activated protein kinase binding (GO:0051019),0.43225742576474946,1.113158001550168,0.3181818181818182,0.851824128943148,1.0,7/29,11.65%,ACE;CDK5RAP3;MAPKAPK3;SIRT1;ABL1;DUSP10;DUSP2
prerank,gated channel activity (GO:0022836),-0.4551838363276258,-1.113152206686065,0.32426778242677823,0.6566422102351338,1.0,4/14,19.28%,PIEZO2;PIEZO1;TMEM266;TMEM63A
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),-0.4847241344139898,-1.112791818044946,0.3300395256916996,0.6523813348352008,1.0,1/11,2.08%,HCN1
prerank,peptide hormone receptor binding (GO:0051428),-0.48640088962218886,-1.1104422518810064,0.34408602150537637,0.6534946965404465,1.0,8/11,50.47%,PTHLH;GNRH1;VIP;UCN2;CCK;GPHB5;ADCYAP1;GHRH
prerank,L-amino acid transmembrane transporter activity (GO:0015179),-0.3330320346550393,-1.1069222475124483,0.27371273712737126,0.6565114374309242,1.0,16/53,13.25%,SLC47A1;SLC1A5;SLC7A5;SLC1A2;SLC38A6;SLC1A1;SLC7A1;SLC25A13;SLC1A4;SLC38A5;SLC17A6;SLC43A2;SLC6A7;SLC43A1;SFXN1;SLC38A7
prerank,protein phosphatase binding (GO:0019903),-0.29084709058558156,-1.1034966301796985,0.22357723577235772,0.6597745511625203,1.0,31/117,17.20%,PIK3R1;MAP3K5;PTPRT;IQGAP1;PPP1R16B;STAT3;GRIN3A;DAB2IP;MET;FOXO1;KCNQ1;CEACAM1;PTK2;PPP1R16A;FBXL2;MFHAS1;FLT4;ERBB2;ATP2B4;JAK1;AKAP11;MTMR9;CTNNB1;MAPT;SMG5;KIF3A;STRN4;MYO16;SKAP1;EIF2AK3;SHOC2
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3688938937768261,1.1034634967535892,0.3056379821958457,0.8753736205016092,1.0,15/71,9.45%,EYA1;PTPN13;EYA2;PTPN14;PTPN9;MTMR3;EYA4;TNS2;PTPN23;CDC14A;PTPN22;PTPRU;PTEN;CDC25A;PTPN21
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3276264973086198,1.1030576748532848,0.2848180677540778,0.8711458940121317,1.0,57/181,18.10%,SMAD3;PPARGC1A;PPARA;NCOR2;RERE;ARNT2;IFI27;NHLH2;PIAS1;CHD4;TEAD3;NCOA3;TP53;BCAS3;SMARCD3;BHLHE41;LDB2;LDB1;SMARCA4;SPEN;MEF2A;RBL2;CDK5RAP3;TCF7L2;HDAC1;SMARCE1;PARP9;HDAC4;SIRT1;ATN1;MKKS;RBL1;ATF2;RBBP8;BBS10;WWP2;HES6;TAF4;TBP;NCOR1;SIN3A;MTA2;MIER3;CTDP1;FAF1;CREBBP;PIAS3;HIF1AN;BBS2;RXRA;GTF2I;RB1;MED1;KDM1A;POU1F1;RNF25;CRY1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.3664528139517808,-1.1030440948705855,0.29562982005141386,0.6559951213755457,1.0,6/34,5.21%,CYTH3;ARAP2;MYO10;MYO1B;IQGAP1;ARAP3
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),0.530220907940537,1.101044880030726,0.3698630136986301,0.8718539176936458,1.0,2/10,3.63%,CFLAR;CASP3
prerank,SH2 domain binding (GO:0042169),0.4290183589293172,1.1007393382286115,0.3385146804835924,0.8673538711698205,1.0,5/31,7.13%,AFAP1;INPPL1;DAG1;SH3PXD2B;AFAP1L2
prerank,SUMO transferase activity (GO:0019789),0.4735752116638822,1.0989058131921594,0.38632162661737524,0.8674390145708499,1.0,6/16,21.42%,PIAS1;HDAC4;NSMCE2;PIAS3;PIAS4;UBE2I
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.38530132714014115,1.0982053122369537,0.335423197492163,0.864206540407799,1.0,5/55,3.26%,CACNA1D;SLC24A3;ITPR2;ITPR1;MCU
prerank,vinculin binding (GO:0017166),-0.48114471966276695,-1.097992076426713,0.35232067510548526,0.6636011396961182,1.0,3/11,6.57%,UTRN;ACTN1;CORO2B
prerank,ankyrin binding (GO:0030506),-0.4150787752853208,-1.0963486073562236,0.31956521739130433,0.6628480550019609,1.0,6/19,13.20%,SLC8A1;SPTBN1;PTPRC;NRCAM;CDH1;SPTB
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.49701131184615743,1.0961221843547682,0.36312849162011174,0.8650133876484514,1.0,5/12,23.00%,GNAT2;RHO;OPN1SW;OPN1MW;OPN1MW3
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),-0.4323241489130785,-1.0941418100159677,0.3512304250559284,0.6635234971712678,1.0,6/15,18.49%,PLA2G4A;PLEKHA5;JPH2;PHLDA3;SESTD1;PLA2G4E
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.4872302514956419,1.0927614925531577,0.3742911153119093,0.8700815433798944,1.0,5/14,16.90%,ALDH4A1;MTHFR;ALDH1L1;AASS;MTHFD1
prerank,metallopeptidase activity (GO:0008237),0.3429645595487463,1.0922300794319444,0.314404432132964,0.8663847687273846,1.0,24/113,15.47%,ADAM12;ACE;ADAMTS10;TRABD2B;ADAMTS2;ADAMTS15;ADAMTSL5;METAP2;ADAMTS9;ADAM30;MMP19;RCE1;MMP14;BMP1;CHMP1A;ADAM28;ADAM18;ADAM17;ADAMTS7;ERAP1;ANPEP;PITRM1;NRDC;ZMPSTE24
prerank,syntaxin binding (GO:0019905),0.37524429428390565,1.090707249034627,0.3106646058732612,0.865745467548831,1.0,9/61,10.49%,SYT9;UNC13C;SYT12;STXBP4;LRRK2;STXBP2;VPS54;BLOC1S6;ABL1
prerank,protein heterodimerization activity (GO:0046982),0.3243555038592584,1.0888464243689624,0.3106060606060606,0.8656984193439723,1.0,20/178,8.89%,ATP1A2;EPAS1;BMP6;TOP2B;NPAS3;ZHX2;ARNT2;ADRA2A;KRT1;BDKRB2;MIGA2;TPM1;TLR4;IL12B;TP53;MICU1;BHLHE41;MEF2A;SLC51A;TCF4
prerank,phosphatase activity (GO:0016791),0.3673624563089512,1.0888388384506975,0.32526475037821484,0.860653834219064,1.0,11/73,12.02%,ATP1A2;PPP1CB;CILP2;LHPP;HDDC2;PXYLP1;PTPN22;PRUNE1;DUSP10;OCRL;NOCT
prerank,enoyl-CoA hydratase activity (GO:0004300),0.5318793439870875,1.0859414930104567,0.3857404021937843,0.8638662083531771,1.0,5/10,21.73%,ECHDC3;ECHDC1;EHHADH;HADHA;ECHS1
prerank,peptidoglycan binding (GO:0042834),-0.4835514271904705,-1.0826102177302133,0.35546875,0.6877088510298988,1.0,3/10,16.98%,NOD1;PGLYRP1;NOD2
prerank,chloride transmembrane transporter activity (GO:0015108),-0.4306555142634213,-1.0804101007071207,0.37067209775967414,0.6882711834981609,1.0,3/16,4.65%,SLC26A7;SLC26A2;SLC1A1
prerank,Tat protein binding (GO:0030957),-0.4958083100138418,-1.077294646398243,0.40501043841336115,0.6909889258237633,1.0,2/10,2.69%,ACTB;MDFIC
prerank,histone deacetylase activity (GO:0004407),0.45457848967010606,1.0767246913474098,0.37568058076225047,0.8859437424858954,1.0,6/19,14.80%,HDAC8;SIRT3;HDAC1;HDAC4;SIRT1;MIER3
prerank,DNA-binding transcription factor binding (GO:0140297),0.3193655848833046,1.0763747706306326,0.31870967741935485,0.8819004577805571,1.0,55/189,18.82%,SMAD3;FHL2;ZMYND8;PPARA;CXXC5;RERE;IFI27;NFYB;NHLH2;PIAS1;CHD4;TEAD3;SIK1;TP53;BHLHE41;LDB2;LDB1;SPEN;MEF2A;RBL2;TCF7L2;TLE1;HDAC1;HDAC4;SIRT1;PRDM5;ATN1;MKKS;RBL1;ATF2;RBBP8;BBS10;CBX5;WWP2;HES6;TBP;NCOR1;SIN3A;TLE2;MTA2;MIER3;PURB;CREBBP;PIAS3;BBS2;GTF2I;YAP1;RB1;KDM1A;POU1F1;CRTC1;MEF2D;RUNX1T1;TAF1;NBN
prerank,general transcription initiation factor binding (GO:0140296),-0.37955562581285174,-1.0746002398427443,0.3557692307692308,0.6926695520023495,1.0,11/25,27.84%,ESR1;AR;GTF2A2;YEATS2;TAF1B;HHEX;DR1;RUVBL2;RELA;THRA;DRAP1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.4651696560645537,1.070695562934283,0.4101633393829401,0.8936851120312511,1.0,1/16,0.20%,SLC13A3
prerank,clathrin adaptor activity (GO:0035615),0.4768658640587261,1.0701004113686245,0.3736059479553903,0.8903017489487608,1.0,3/15,7.85%,DAB2;STON1;AP1G2
prerank,small GTPase binding (GO:0031267),0.31904841977905835,1.0684025656277707,0.3257287705956908,0.8900425584638673,1.0,57/169,19.92%,RNF152;AFDN;PICALM;ARHGEF16;SRGAP2;FGD4;ALS2;AKAP13;GCC1;LRRK2;RAB34;NOX1;BRAF;RIN3;EXOC2;TRIOBP;RABGGTA;DNM1L;DOCK7;CYRIB;MTSS2;RNF41;PDE6D;FGD1;OCRL;MAPKAP1;RGP1;ANKRD27;RALBP1;MYO1C;RAP1GAP;GOLGA4;SGSM2;EXOC4;RUSC2;SPHK2;RAB29;MICALL1;ARFIP2;GOLGA5;UNC13D;TMEM127;SGSM3;PEX5;OPTN;TBC1D7;RABGEF1;RANBP9;KCTD13;RTKN;PAK2;ARHGAP1;EVI5;USP33;TSC2;EVI5L;ANKFY1
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.4896695000928333,1.0681698157082369,0.39186691312384475,0.8858022742664606,1.0,2/13,4.31%,AGPAT4;GPAT2
prerank,bicarbonate transmembrane transporter activity (GO:0015106),-0.4321026028607055,-1.0670883700189755,0.39227642276422764,0.7067404050089626,1.0,2/15,2.75%,SLC26A7;SLC26A2
prerank,histone methyltransferase activity (GO:0042054),0.4007705252558742,1.0667012900300596,0.3825503355704698,0.8849585339260673,1.0,10/32,17.48%,SMYD3;KMT5B;SETD7;NSD3;KMT2C;KMT5A;DOT1L;EHMT2;EHMT1;KMT2E
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.40616237905955793,-1.0660279347478652,0.36650485436893204,0.7044784793968267,1.0,2/21,3.95%,GRIK2;GLRB
prerank,mRNA binding (GO:0003729),0.3071246415649605,1.064609044012476,0.33175355450236965,0.8859232401508552,1.0,57/249,16.67%,CPEB2;CELF2;SRRM2;DDX5;RBM47;CPEB4;RBMS2;LARP4B;SNRNP70;PCBP2;HNRNPR;IGF2BP1;DDX3X;SRSF5;ZC3H12B;TP53;CLUH;ZCCHC13;HNRNPA2B1;SNIP1;IGF2BP2;SAMD4A;PABPC4L;RBM15;RBMS1;LARP1;CPEB3;NOVA1;CSDC2;YTHDF3;LSM14A;LUC7L3;SCAF8;NUP98;HNRNPL;MRPS7;NOCT;DDX6;ETF1;DCP1A;RBPMS2;DHX33;RBMS3;RSL1D1;HNRNPC;ZC3H12C;PURB;NYNRIN;ZFP36L1;PABPC5;SLC4A1AP;FUBP3;RBM4;HNRNPM;DAZAP1;MARF1;GRSF1
prerank,Notch binding (GO:0005112),0.4367851673538278,1.060894497821419,0.3890845070422535,0.8916162218467663,1.0,4/22,3.79%,SNED1;NCOR2;AAK1;DTX1
prerank,aspartic-type peptidase activity (GO:0070001),0.5031858734388522,1.060657059899889,0.4163424124513619,0.8875167912209105,1.0,1/10,1.50%,BACE2
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.49508427601055893,1.0554820303152208,0.4187380497131931,0.8970419996143246,1.0,4/12,17.12%,SLC25A23;SLC19A1;SLC25A42;SLC25A17
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4728815975786843,1.0543231859364601,0.38939670932358317,0.895179869860454,1.0,9/15,23.08%,PI4KA;ATM;PIK3CA;PIKFYVE;PIK3R3;PI4K2B;PI4KB;PI4K2A;PIK3C3
prerank,aspartic-type endopeptidase activity (GO:0004190),0.48538988479757816,1.0533227673703873,0.42344045368620037,0.893132913706746,1.0,1/12,1.50%,BACE2
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.3515644854409078,1.0524785242492067,0.36588921282798836,0.8906616893364863,1.0,7/72,2.81%,ACTN2;TULP3;GSDME;PICALM;SNX21;AVIL;FRMPD4
prerank,cation channel activity (GO:0005261),0.33422815805510614,1.0516109693227276,0.36464088397790057,0.8883374584276957,1.0,5/94,3.26%,TRPM3;CACNA1D;SLC24A3;TRPM6;MCU
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),0.49359178976881324,1.0494741216518333,0.3968871595330739,0.8895156902310896,1.0,2/11,3.63%,CFLAR;CASP3
prerank,GTPase inhibitor activity (GO:0005095),0.4784810544605529,1.048228800821486,0.3934740882917466,0.8886264564930193,1.0,2/13,5.78%,CPEB2;GPS2
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.31106802956480145,1.047453586656088,0.376720901126408,0.8861069228515962,1.0,46/188,17.21%,SMAD3;NFYC;ZBTB20;GABPB1;GABPB2;SOX5;ZNF568;ARID4A;FOXC1;CREB3L2;NFYB;SMAD6;BNC2;TBL1X;TP53;SOX12;BCOR;TBL1XR1;CALCOCO1;TCF7L2;TCF7;GLI1;HDAC4;ASH2L;SOX13;FOXC2;PRDM5;HNRNPL;ZBTB48;IRF1;BRD7;FOXA2;KMT2D;TBP;NCOR1;ATF6B;PER2;NFKB1;TAF7;MZF1;NKX2-1;RXRA;PER3;YAP1;SMAD4;KLF15
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.35653620807152264,1.0465851228224068,0.3872832369942196,0.884005444532563,1.0,13/69,15.67%,LPGAT1;SPHK1;MOGAT3;ASPG;CERS6;CERS5;KAT6B;ZDHHC18;ZDHHC1;PORCN;KAT2B;NAA16;CREBBP
prerank,voltage-gated potassium channel activity (GO:0005249),0.34701467400112423,1.0463401596738986,0.403899721448468,0.8799937048757933,1.0,6/80,1.95%,KCNK2;KCNT1;KCNJ13;KCND3;KCNA5;LRRC38
prerank,acyl-CoA hydrolase activity (GO:0047617),0.44951021036117694,1.0456695499165372,0.4151291512915129,0.8772394774149304,1.0,6/17,17.33%,ACSBG2;ACOT11;PLA2G6;ACOT8;THEM4;ACOT12
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.3909867728946938,1.0446789968330426,0.41098169717138106,0.8755120196600256,1.0,14/34,25.07%,SMYD3;KMT5B;SETD7;NSD3;KMT5A;DOT1L;EHMT2;EHMT1;KMT2E;SETD3;N6AMT1;CAMKMT;EEF1AKMT1;SETDB1
prerank,kinase activity (GO:0016301),0.33234239282068695,1.0446655262107354,0.38114209827357237,0.8710327250736823,1.0,15/109,10.49%,NADK2;EPHA4;PI4KA;SPHK1;LRRK2;GK5;TKFC;GK;PANK1;COQ8B;PIK3CA;DCAKD;ITPKB;PPIP5K2;ABL1
prerank,cholesterol binding (GO:0015485),-0.32294851081909653,-1.0416073153134098,0.3898305084745763,0.7618596818657994,1.0,13/47,11.76%,CAV1;OSBPL6;PROM1;ABCG1;PTCH1;NPC2;VDAC1;STARD5;APOD;STARD3NL;OSBP2;ERLIN1;STARD4
prerank,triglyceride lipase activity (GO:0004806),0.4437402290600567,1.0415341940810945,0.4154676258992806,0.8751006923590926,1.0,3/20,8.71%,CEL;PNLIP;DDHD2
prerank,ubiquitin-dependent protein binding (GO:0140036),-0.46785039711183335,-1.04145321903001,0.43141153081510936,0.7570308427694729,1.0,4/10,14.08%,ANKRD13A;DNAJC2;FAAP20;LAPTM5
prerank,protein kinase C binding (GO:0005080),0.3812240325215129,1.0413243521954265,0.4163934426229508,0.8712463792291271,1.0,10/43,13.78%,PARD6G;TOP2B;GRK5;DACT2;PRKCB;PICK1;ABL1;ITGAV;PRKCSH;ADCY6
prerank,protein kinase binding (GO:0019901),0.2858528762067979,1.0362995131604855,0.3624309392265193,0.8803598853154657,1.0,69/479,12.05%,PRKAG2;MAPK4;PARD6G;SMAD3;ACE;ANK2;OXSR1;ERRFI1;KIF13B;SASH1;DLG1;KCNA5;TOP2B;RHOBTB2;PRKN;RHOD;EPHA4;GRK5;CCNA2;PRKAG3;TOM1L2;CEP250;PPEF2;PPP1CB;SUFU;NISCH;ADRA2A;TPRKB;NBEAL1;DACT2;PRKCB;EZR;GYS1;FZD5;PTPN23;PDGFRB;EXOC2;TRIB2;CACUL1;SIK1;TP53;RICTOR;CLTC;CCND3;CDK5RAP3;MAPKAPK3;GPRC5B;MVP;TCF7L2;CDC25A;CDH5;PICK1;SIRT1;JTB;MAVS;BECN1;NOX4;IRGM;ABL1;CDC42;ATF2;CASS4;TRIB1;DUSP10;RNF13;DUSP2;MAPKAP1;ITGAV;TNNI3
prerank,beta-tubulin binding (GO:0048487),0.40142321521797064,1.0345521641166653,0.41946308724832215,0.8805140378069648,1.0,4/31,8.57%,GJB6;EML4;BCAS3;HTT
prerank,chemokine binding (GO:0019956),0.3985167254395231,1.0325055194122683,0.41652613827993257,0.8816504449286431,1.0,3/30,3.69%,ACKR2;CCR9;PDPN
prerank,TBP-class protein binding (GO:0017025),-0.3787168455072164,-1.0307639897051057,0.41244239631336405,0.7801011110292114,1.0,11/21,33.24%,ESR1;GTF2A2;YEATS2;TAF1B;HHEX;DR1;RUVBL2;THRA;DRAP1;AHR;GTF2B
prerank,phospholipase A2 activity (GO:0004623),-0.35605038874376654,-1.0302458817844788,0.3916083916083916,0.776157541043295,1.0,6/26,22.91%,PLA2G4A;PLA2G12A;PNPLA3;PLA2G4E;PLA2G15;PLA2G4F
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.4794515662547816,1.0300439767688554,0.42213883677298314,0.8842744876635268,1.0,2/13,2.36%,SLC38A3;SLC7A2
prerank,hydro-lyase activity (GO:0016836),0.3839633432055794,1.0295933913906308,0.413312693498452,0.8810789482451067,1.0,14/41,22.51%,ECHDC3;GMDS;HACD4;HACD1;UROC1;ACO2;HACD3;ECHDC1;EHHADH;L3HYPDH;HADHA;PCBD1;ECHS1;CBS
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.3834733343950871,-1.0270845014730707,0.431980906921241,0.7793425430735891,1.0,5/21,16.74%,GRM5;GRIA1;GRM1;CHRFAM7A;CHRNA7
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",0.48190373870747216,1.0265311209951913,0.4418604651162791,0.8848864770012997,1.0,2/11,1.43%,ITPR2;ITPR1
prerank,ATP binding (GO:0005524),0.2933340721893072,1.025820030331578,0.4075425790754258,0.8824828337302113,1.0,43/266,14.95%,PRKAG2;ATP1A2;WNK4;KSR1;OXSR1;SPHK1;BMPR1A;OAS2;TGFBR1;DMPK;MYO18A;P2RX3;NUAK2;CLPX;SIK1;CDC42BPG;MOV10L1;GCK;SRR;PPIP5K2;MKNK1;BRSK1;ABCC6;ABL1;KIFC1;SRPK2;TRIB1;GALK1;IGHMBP2;PNKP;TDG;PRKCI;WNK1;HSPA4;OAS3;CAD;STK36;ATP5F1D;STK17B;ACVR1B;CARS2;SYN3;STK4
prerank,calcium:sodium antiporter activity (GO:0005432),0.49147208708075335,1.0255955093623983,0.43137254901960786,0.8788329037298879,1.0,2/10,2.03%,SLC24A3;SLC8A3
prerank,fibroblast growth factor binding (GO:0017134),0.42454847012273295,1.0243257113792923,0.43636363636363634,0.877949518808182,1.0,6/21,11.89%,FGFR2;KL;FGFR1;FIBP;KLB;ITGAV
prerank,gap junction channel activity (GO:0005243),0.4212179340950854,1.0242411906188014,0.4238178633975482,0.8738715887309991,1.0,1/22,0.56%,GJB6
prerank,PDZ domain binding (GO:0030165),0.3510832545439768,1.0239383557118817,0.42201834862385323,0.870493069263446,1.0,11/61,7.90%,TGFBR3;ARHGAP29;PRKN;ARHGEF16;CXXC4;FZD8;SYNJ2;PLEKHA2;SLC22A5;SRR;PTEN
prerank,receptor ligand activity (GO:0048018),0.2953934855095747,1.023821936581351,0.4167664670658683,0.8665830017473576,1.0,25/245,10.32%,FGF1;WNT5B;BMP6;BMP7;WNT4;IGF1;WNT6;IL18;EDA;METRNL;TNFSF13;DPP4;SEMA3B;F2;IFNK;IL17D;IL12B;APLN;OSGIN2;NRG1;GDNF;NBL1;SLURP1;HBEGF;CCL25
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.4657042601875876,1.0222544004086316,0.45585585585585586,0.8664042884923665,1.0,2/14,1.75%,KCND3;KCNA5
prerank,wide pore channel activity (GO:0022829),0.41668656898272677,1.0217967580782548,0.42077464788732394,0.8635414513021585,1.0,1/23,0.56%,GJB6
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.4979614650216644,1.0214073493149072,0.44288577154308617,0.8604832624230299,1.0,4/11,17.12%,SLC25A23;SLC19A1;SLC25A42;SLC25A17
prerank,transition metal ion binding (GO:0046914),0.2828838763714611,1.0211271787825063,0.4108527131782946,0.8571987948194681,1.0,57/397,12.29%,KDM7A;SMAD3;ACE;UPB1;MOXD1;SORD;KMT2A;ZMYND8;LACC1;PRKN;GLI2;NAPEPLD;MPPED2;LARGE1;CXXC5;CXXC4;LOXL3;SOD3;NAALADL1;CHD4;KNG1;NSD1;TET2;FBXL19;BBOX1;SOD2;B4GALT1;BAZ1B;TP53;ENPP3;SCD5;SIRT5;RNF8;PLSCR1;KDM2B;SAMHD1;KDM2A;ADAM30;SIRT3;CYP2R1;HRG;JMJD6;TAB2;HDAC4;NPEPPS;PTGR2;CHMP1A;DHH;ABL1;ZKSCAN5;DHX58;FNTB;ACO2;PHF5A;NFU1;ZMYM2;PHF2
prerank,metalloendopeptidase inhibitor activity (GO:0008191),-0.411695427517711,-1.0194404919931974,0.44567627494456763,0.7939336864598014,1.0,5/14,8.33%,SPOCK2;SPOCK3;NGF;TIMP2;SPOCK1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.42190920504145596,1.0167493489183475,0.46017699115044247,0.8643461390668783,1.0,4/22,11.65%,DUSP29;MTMR3;DUSP10;DUSP2
prerank,acetylgalactosaminyltransferase activity (GO:0008376),-0.36369215572988467,-1.0135608189532153,0.46116504854368934,0.8042923764434231,1.0,5/26,12.15%,CSGALNACT1;CHSY3;B3GALT1;B3GALNT1;B3GALT5
prerank,RNA polymerase II complex binding (GO:0000993),0.3852099590525835,1.0116188629631475,0.45757071547420963,0.8733764761751339,1.0,6/32,13.29%,CTR9;ELOF1;NCOA3;RPRD2;SCAF8;WDR43
prerank,UDP-glycosyltransferase activity (GO:0008194),-0.2896741713989588,-1.00932002962173,0.42857142857142855,0.8098735353779651,1.0,13/70,12.15%,CSGALNACT1;MGAT4C;GCNT2;CHSY3;EXT1;MGAT4A;B3GALT1;HEXB;B3GALNT1;EXT2;LFNG;MFNG;B3GALT5
prerank,iron ion binding (GO:0005506),0.36329407335097397,1.0091006779858085,0.4428794992175274,0.8759182761661772,1.0,10/48,15.98%,KDM7A;TET2;SCD5;CYP2R1;JMJD6;ACO2;NFU1;PHF2;TET1;HIF1AN
prerank,poly(A) binding (GO:0008143),0.41376605236715835,1.008800143039217,0.451114922813036,0.8727129506005908,1.0,8/21,15.52%,RBMS2;DDX3X;TIA1;PABPC4L;RBMS1;RBMS3;PABPC5;HNRNPDL
prerank,alpha-tubulin binding (GO:0043014),-0.3290827707490183,-1.0082418545845178,0.4765432098765432,0.8072613057271993,1.0,12/31,18.70%,TTLL7;DIP2B;TRPV4;PACRG;SETD2;TRIM36;SNCA;CDK5R1;ARL8B;EFHC2;SPAST;TBCE
prerank,disordered domain specific binding (GO:0097718),-0.3691302259337851,-1.0081643673033664,0.47240618101545256,0.8021152481429782,1.0,6/23,10.88%,FN1;HSP90AB1;CALM1;CALM2;HSP90AA1;CALM3
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.39075827835591076,1.0072538006591818,0.4663299663299663,0.8728934463262089,1.0,9/34,14.95%,FAM20A;ALS2;DDX3X;RICTOR;CCNT2;IRGM;MAP2K1;MAP2K2;STK4
prerank,cation:chloride symporter activity (GO:0015377),0.4826449471334218,1.0060401614392314,0.4470588235294118,0.871991353278901,1.0,1/10,0.37%,SLC6A1
prerank,5'-3' RNA polymerase activity (GO:0034062),0.4032010253193895,1.0010370897748544,0.4514003294892916,0.8810146107659046,1.0,5/27,13.04%,POLR2A;POLR2D;TERT;TENT2;POLR3A
prerank,ligand-gated calcium channel activity (GO:0099604),-0.3796615246537455,-1.000749230907728,0.4551148225469729,0.8167484929967871,1.0,8/19,18.49%,RYR2;GRIN2B;RYR3;GRIN2A;TRPM2;GRIN1;ITPR3;TRPA1
prerank,zinc ion binding (GO:0008270),0.28198172373836505,1.0005735814793018,0.4642857142857143,0.8782012925197864,1.0,40/293,11.12%,KDM7A;SMAD3;ACE;UPB1;SORD;KMT2A;ZMYND8;PRKN;GLI2;NAPEPLD;CXXC5;CXXC4;NAALADL1;CHD4;KNG1;NSD1;TET2;FBXL19;BBOX1;BAZ1B;TP53;ENPP3;SIRT5;RNF8;PLSCR1;KDM2B;SAMHD1;KDM2A;ADAM30;SIRT3;HRG;TAB2;HDAC4;NPEPPS;PTGR2;CHMP1A;DHH;ZKSCAN5;DHX58;FNTB
prerank,protein serine/threonine kinase activity (GO:0004674),0.28129697123062486,0.9998839917408253,0.4592074592074592,0.8759811072415229,1.0,63/334,15.20%,MAPK4;WNK4;ROCK2;OXSR1;PRKCZ;FAM20A;PRKAA2;GRK5;STK32B;BMPR1A;TGFBR1;DMPK;AAK1;LRRK2;TP53RK;IKBKE;SMG1;PRKCB;ATM;CAMK1;BRAF;CLK4;NUAK2;EIF2AK2;SIK1;CDC42BPG;CPNE3;TGFBR2;MAPKAPK3;PDPK1;CSNK1A1;PIKFYVE;RIPK1;RIPK2;MKNK1;BRSK1;ARAF;DYRK1A;SRPK2;AURKB;MYLK3;MYLK;PRKDC;PRKCA;MAPK6;CSNK2A2;CSNK2A1;HIPK3;RPS6KC1;MAP3K1;PRKCI;MAPK10;MAP2K1;WNK1;GRK3;BMP2K;STK36;ACVR2B;STK17B;ACVR1B;STK4;MAPK9;CLK1
prerank,adrenergic receptor binding (GO:0031690),-0.38690515498863454,-0.9983575150642218,0.4639830508474576,0.817860282689792,1.0,2/16,1.59%,PDE4D;GNAS
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.3677677193650511,0.9981797585647858,0.4375,0.8764462009509693,1.0,5/38,8.66%,TFPI;SERPIND1;SERPINE1;SERPINA9;HRG
prerank,GTP binding (GO:0005525),-0.2461549144534239,-0.996389132310366,0.46153846153846156,0.8179441112932425,1.0,61/172,26.10%,RHOBTB1;RHOJ;RIT2;RND3;RAB31;KRAS;RAP1B;RAP1A;RASL12;GCH1;RAB27A;RHOB;GNAI1;EEF1A1;RERG;RALB;GLUD1;MFHAS1;TUBA1A;RHOH;GBP4;TUBB4A;RAP2A;ARL1;ARL5A;RAB27B;ARL5B;ATL2;MTG2;RAB38;RRAS;TUBB2B;RAB6A;ARF5;RAB32;ARF6;RAB39A;TUBB3;ARL8B;ATL3;RHOBTB3;MMAA;RAN;TUBA4A;RHEB;PIP4K2B;RND2;RAB14;GNL2;RAC3;GEM;TUBA1B;RHOC;RND1;TUBA1C;TUBG2;RNF112;RAB1B;RHOG;ARF3;RAP2C
prerank,cation transmembrane transporter activity (GO:0008324),0.35381137316475886,0.9942426583893917,0.46634615384615385,0.8829414943844076,1.0,7/48,8.07%,SLC41A1;SLC38A3;SLC7A2;SFXN2;SLC6A9;SLC25A2;SLC38A1
prerank,double-stranded RNA binding (GO:0003725),-0.2847952603485949,-0.9929640342105727,0.45110410094637227,0.8215177952506297,1.0,14/70,12.24%,MBNL1;ACTN1;LRRFIP1;RFTN1;ADARB2;ADARB1;TFRC;HSP90AB1;DROSHA;FXR1;MSN;STRBP;STAU2;VIM
prerank,G protein-coupled receptor activity (GO:0004930),-0.23510739710291745,-0.989870120601563,0.5542857142857143,0.8244995583907312,1.0,38/239,16.34%,ADGRL3;ADGRB3;ADGRL4;ADGRL2;CALCRL;GRM5;ADGRG6;GRM3;ADRA1B;ADGRE5;GRM8;RORB;XPR1;GRM1;AGTR1;PDGFRL;S1PR1;GPR156;GABBR2;P2RY12;LGR5;CYSLTR1;PTH1R;HCRTR2;CYSLTR2;GPR63;CMKLR1;ADGRA1;ADGRB1;GPR26;P2RY1;ADGRG1;GPR34;APLNR;HRH1;VIPR2;CX3CR1;ADGRD1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2851288509962027,0.9889801529793298,0.5082938388625592,0.8924670786963725,1.0,43/254,15.60%,HLF;SMAD3;TFDP2;NFYC;PPARA;CREBRF;HOXA1;NFAT5;MITF;ELF1;FOXC1;HOXB3;NFIB;VEZF1;NFYB;MEIS1;RREB1;TP53;SMARCD3;SOX12;PLSCR1;MEF2A;HOXC4;TCF4;TFDP1;MYBL1;NR2C2;FOXC2;ATF2;NFATC3;IRF1;MYBL2;HOXB2;FOXJ2;NFIA;ATF6B;NFKB1;HSF2;E2F4;HOXA7;STAT6;SATB2;MZF1
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.4262784309015663,-0.9885351339985414,0.4927835051546392,0.8227584499801702,1.0,4/12,7.90%,PIK3R1;GNAS;SOCS2;YWHAG
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.4331140632858102,0.9849896873832964,0.4786476868327402,0.8986979690569835,1.0,2/15,4.31%,AGPAT4;GPAT2
prerank,lipase activator activity (GO:0060229),0.47056833954844907,0.9839497092802677,0.4897959183673469,0.8974792384028332,1.0,2/10,8.69%,ARHGAP6;PDPK1
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.37834132893204847,-0.983522135802357,0.489749430523918,0.8306536682694884,1.0,6/18,19.48%,PIK3R1;SOCS2;PIK3R6;SOCS5;PIK3R5;CCKBR
prerank,serine-type endopeptidase activity (GO:0004252),0.3312212362618777,0.9834990846481765,0.4905109489051095,0.8947205328279427,1.0,6/80,5.45%,CORIN;KLK2;F11;CTSH;DPP4;F2
prerank,chemokine receptor binding (GO:0042379),-0.32668655020309445,-0.9810214374897093,0.49222797927461137,0.8319621637578737,1.0,22/35,46.93%,CXCL12;CXCL16;CX3CR1;CCL13;CCL19;CXCL10;CCL2;CCL28;CCRL2;CCL4;PF4;PPBP;CCL8;CXCL5;CCL14;CKLF;CXCL1;CCL1;CCL3;CCL11;CXCL13;CXCL2
prerank,phosphatidylinositol binding (GO:0035091),0.314944046555633,0.9798855075879442,0.5007032348804501,0.9000007447770592,1.0,6/91,1.84%,APPL2;TULP3;ITPR2;PICALM;ITPR1;PARD3B
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.4115168104848809,0.9786736279864372,0.5034722222222222,0.8991486942497212,1.0,3/20,8.32%,SLC30A10;SLC30A2;SLC39A13
prerank,calcium channel activity (GO:0005262),0.3169851233325011,0.976421340001477,0.4780058651026393,0.9009524979864696,1.0,9/84,8.41%,CACNA1D;SLC24A3;CACNA2D3;CACNG4;MCU;CACNA1C;CACNB3;TRPM5;ANXA9
prerank,GTPase activity (GO:0003924),-0.23815272030272744,-0.9718905599679997,0.5628415300546448,0.8513104551989867,1.0,50/192,18.89%,DNM3;RHOBTB1;RHOJ;GNAS;RIT2;RND3;RAB31;KRAS;RAB3C;RAP1B;RAP1A;RASL12;SRPRA;GCH1;RAB27A;RHOB;GNAI1;DNM1;ARHGDIB;EEF1A1;RERG;RALB;GNA12;RAB18;RHOH;GBP4;RAP2A;ARL1;GNA14;RAB27B;GNB2;HBS1L;ATL2;MTG2;GNAO1;RAB38;GNB1;RRAS;GNAL;RAB6A;RAB32;SEPTIN9;TPPP;ARL8B;ATL3;RHOBTB3;MMAA;EEF2;RAN;RHEB
prerank,hormone activity (GO:0005179),0.33946121791285977,0.9715832495547951,0.5061349693251533,0.9090882511291806,1.0,9/54,17.81%,IGF1;METRNL;APLN;AGRP;SPX;CCL25;NPFF;INHA;NMB
prerank,protein homodimerization activity (GO:0042803),0.26440995634929904,0.9712228153147215,0.5764331210191083,0.906057434416129,1.0,64/589,9.99%,NADK2;MAPK4;SMAD3;APPL2;UPB1;DUSP29;TPD52L1;PAXX;KIT;CPQ;MTUS2;KMT2A;ST6GAL1;FGFR2;SRGAP2;ZHX2;SNX6;ALS2;CRYL1;NR2F2;FGFR1;NPR3;BMPR1A;NR6A1;LRRK2;PGRMC1;ADRA2A;DPYD;PEX11A;ZBTB38;NACC2;MIGA2;DPP4;FOXP2;LHPP;TPM1;NAALADL1;IL17D;GBP3;ZNF318;GALM;BHLHE41;RNF8;PANK1;PON3;CLN6;LDB1;GBP2;SRR;TERT;PEX11B;IDH1;SLC39A13;CYP2R1;GDNF;SLC51A;KLHL7;DNM1L;SSBP1;RIPK1;RIPK2;CBY1;BLOC1S6;CHMP1A
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.3980577677444557,0.9710785692463442,0.4899665551839465,0.902570784329808,1.0,7/24,18.33%,ITPKB;AK4;AK3;PPIP5K2;NME6;AK8;IP6K3
prerank,RNA stem-loop binding (GO:0035613),0.4442019540108677,0.9701015377776921,0.4893203883495146,0.9013378151267484,1.0,2/12,8.71%,DDX3X;CPEB3
prerank,protein phosphatase 1 binding (GO:0008157),0.39908352512198264,0.9688113838801358,0.4911660777385159,0.9008274353936102,1.0,3/21,10.21%,SH3RF2;PPP1R3B;PHACTR4
prerank,endopeptidase activator activity (GO:0061133),-0.44287012697567907,-0.967736131677333,0.533066132264529,0.8562177088935969,1.0,3/10,17.82%,VSIR;PSMD14;APH1A
prerank,cGMP binding (GO:0030553),0.45141431745625543,0.9670488335479137,0.4931237721021611,0.9014153343011471,1.0,1/11,0.71%,PDE5A
prerank,ferrous iron binding (GO:0008198),-0.3552635196948902,-0.9663708283927437,0.4709976798143852,0.854424118291951,1.0,7/21,19.93%,FTH1;FTL;SNCA;EGLN2;ISCU;EGLN3;ALKBH3
prerank,methyl-CpG binding (GO:0008327),0.4026535089280454,0.9654513871340477,0.5119047619047619,0.9014815932204411,1.0,8/22,20.40%,CXXC5;CXXC4;ZBTB38;TET1;LRWD1;TET3;MBD1;MBD2
prerank,adenyl ribonucleotide binding (GO:0032559),0.2719042530385599,0.9641336162231882,0.5559481743227326,0.9010670624496394,1.0,49/291,14.95%,PRKAG2;ATP1A2;WNK4;KSR1;OXSR1;MPPED2;SPHK1;PRKAG3;BMPR1A;OAS2;TGFBR1;DMPK;MYO18A;P2RX3;SLC19A1;NUAK2;CLPX;SIK1;CDC42BPG;MOV10L1;GCK;SRR;PPIP5K2;MKNK1;BRSK1;ABCC6;ABL1;KIFC1;CNBD2;SRPK2;TRIB1;GALK1;IGHMBP2;PNKP;TDG;PRKCI;WNK1;HSPA4;OAS3;CAD;COQ8A;STK36;POPDC2;ATP5F1D;STK17B;ACVR1B;CARS2;SYN3;STK4
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.39815409746791963,-0.9639519539510191,0.5322245322245323,0.8554734761226591,1.0,2/14,2.75%,SLC26A7;SLC26A2
prerank,phospholipase activator activity (GO:0016004),0.46264266709437496,0.961769171302366,0.5161943319838057,0.9033887531994115,1.0,2/10,8.69%,ARHGAP6;PDPK1
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.36965527685620425,0.9611684374661639,0.5052447552447552,0.9010009660562525,1.0,6/29,12.46%,SLC13A3;SLC26A3;SLC19A1;SLC26A1;SLC25A12;SLC25A11
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.3121245865486643,0.9605399036478307,0.5340909090909091,0.8987514831643743,1.0,10/91,6.54%,ACTN2;TULP3;GSDME;PICALM;SNX21;AVIL;FRMPD4;TTPAL;SH3PXD2B;WIPI1
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.41059924074124204,-0.9596261252451992,0.5203252032520326,0.86059924897451,1.0,5/12,21.37%,APAF1;NOD1;ATP2A3;RPS27L;PYCARD
prerank,cytokine receptor binding (GO:0005126),0.31043919905705,0.9588001032446921,0.5228571428571429,0.8992743677983401,1.0,4/83,2.05%,TGFBR3;SMAD3;IL13RA1;IL18
prerank,histone deacetylase binding (GO:0042826),0.3110772634806818,0.9571136030628702,0.5229485396383866,0.8996165686165138,1.0,24/88,18.15%,TOP2B;PRKN;NCOR2;GLI3;NACC2;CHD4;LCOR;TP53;CAMTA2;NIPBL;BHLHE41;BCOR;MEF2A;HDAC1;HDAC4;NCOR1;KAT2B;MTA2;MIER3;SATB2;KCTD21;NACC1;MEF2D;PKN2
prerank,ion gated channel activity (GO:0022839),-0.3470615601413505,-0.9551623882158077,0.5416666666666666,0.8670277766338705,1.0,8/24,15.24%,KCNT2;ANO4;ANO1;ANO3;TTYH2;ANO5;TTYH1;ANO2
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),-0.32977512365741934,-0.9550974160473334,0.5328083989501312,0.8619976000538235,1.0,9/30,14.23%,CST3;GAS6;SPOCK1;RPS6KA3;SERPINB9;SNCA;RPS6KA1;MT3;CARD16
prerank,double-stranded DNA binding (GO:0003690),0.2627320112581188,0.9545564584332968,0.6089266737513284,0.9019177123393147,1.0,68/531,12.83%,HLF;MAF;THRB;OSR1;CUX1;PKNOX2;GLI2;HOXB4;CREB5;ZBTB20;HOXB6;HOXA1;NFAT5;GLI3;ELF1;NR6A1;ARNT2;NFIB;MAFG;MBNL2;ATOH1;NHLH2;CUX2;TEF;ESRRA;HOXB5;HOXB9;CAMTA2;BHLHE41;RORC;ZSCAN29;SOX12;ZIC5;FBH1;ELF2;NR1D2;RBMS1;ZIC1;HOXC4;ZIC4;TCF4;IRX1;TCF7;KLF3;NR2C2;ZBTB26;TEAD2;DDX60;FOXC2;ABL1;ATF2;RBBP8;TEAD1;PRKDC;RARG;MAU2;NFATC3;ZBTB48;MSH3;SNAI1;SKOR1;MYBL2;HOXB2;HES6;RAD50;PNKP;FOXA2;TDG
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),-0.4337941922911907,-0.9528053647560879,0.5390946502057613,0.8624203742366418,1.0,2/10,9.33%,CD200;CD47
prerank,phosphatidylinositol phosphate binding (GO:1901981),-0.26021331246505364,-0.9509027909472079,0.5521235521235521,0.862045378479961,1.0,13/100,6.61%,HIP1;CYTH3;ARAP2;MYO10;MYO1B;CERT1;PLA2G4A;IQGAP1;CLVS1;ARAP3;DAB2IP;LAPTM4B;PLEKHA5
prerank,phosphatase binding (GO:0019902),0.3054299327824298,0.9508799132477181,0.5490463215258855,0.9069704069055691,1.0,14/105,10.19%,SH3RF2;SMAD3;DLG1;CHCHD3;MTMR3;MAGI2;IKBKE;TP53;SH2D4A;DLG3;MVP;CDH5;ELL;GTF2F1
prerank,inward rectifier potassium channel activity (GO:0005242),-0.34881368403925117,-0.9506120824159628,0.5088161209068011,0.8578079851404992,1.0,8/24,15.05%,KCNJ3;KCNJ2;KCNN2;ABCC9;KCNK1;KCNJ8;KCNJ6;KCNJ12
prerank,translation initiation factor activity (GO:0003743),-0.316298819064594,-0.9498841732448287,0.5623409669211196,0.8544036465267025,1.0,10/36,20.40%,EIF3M;EIF3F;EIF2B3;EIF3B;EIF1;EIF4E;EIF4A1;COPS5;EIF3L;EIF3D
prerank,protein kinase C activity (GO:0004697),0.42306655817955435,0.9485707581712023,0.5239043824701195,0.9088414429741277,1.0,5/14,12.93%,PRKCZ;SMG1;PRKCB;PRKCA;PRKCI
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.44734251857000995,0.9476041033175332,0.5424710424710425,0.9073503013088239,1.0,4/12,7.47%,TGFBR3;BMPR1A;TGFBR1;TGFBR2
prerank,ion channel inhibitor activity (GO:0008200),0.36415913980575165,0.9468910362725275,0.5226890756302521,0.9053525694345821,1.0,3/35,3.85%,WNK4;ITPR1;NEDD4
prerank,alanine transmembrane transporter activity (GO:0022858),-0.40515228352596994,-0.9463760654146721,0.5441478439425051,0.8579933087600767,1.0,4/12,13.25%,SLC6A6;SLC1A4;SLC38A5;SLC38A7
prerank,aminopeptidase activity (GO:0004177),0.37949187536204465,0.9434144713850313,0.5304777594728172,0.909872072340249,1.0,8/26,16.87%,CTSH;NAALADL1;METAP2;NPEPPS;MMP14;ERAP1;ANPEP;XPNPEP1
prerank,GTPase binding (GO:0051020),0.27725135702210213,0.9428686646492063,0.5851581508515815,0.9075250064666512,1.0,58/194,18.96%,RNF152;AFDN;PICALM;ARHGEF16;SRGAP2;FGD4;ALS2;AKAP13;GCC1;LRRK2;RAB34;NOX1;BRAF;RIN3;EXOC2;TRIOBP;AMBRA1;RABGGTA;DNM1L;DOCK7;CYRIB;BECN1;MTSS2;RNF41;PDE6D;FGD1;OCRL;MAPKAP1;RGP1;ANKRD27;RALBP1;MYO1C;RAP1GAP;GOLGA4;SGSM2;EXOC4;RADIL;RUSC2;SPHK2;RAB29;MICALL1;ARFIP2;GOLGA5;UNC13D;TMEM127;SGSM3;PEX5;OPTN;TBC1D7;RABGEF1;RANBP9;KCTD13;RRAGD;RTKN;PAK2;ARHGAP1;EVI5;USP33
prerank,protein phosphatase activator activity (GO:0072542),-0.3871119176256847,-0.9419967855265828,0.537117903930131,0.8639204973747499,1.0,4/13,10.88%,PPP2R5A;CALM1;CALM2;CALM3
prerank,N-methyltransferase activity (GO:0008170),0.3960484992878066,0.9416840795478634,0.5569395017793595,0.9066402173851161,1.0,9/20,27.66%,HNMT;ZCCHC4;SETD3;FDXACB1;GNMT;N6AMT1;TRMT1L;METTL5;PEMT
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),-0.3549463471437535,-0.9410527163841871,0.573394495412844,0.8613817239993422,1.0,3/18,8.90%,STXBP6;ANXA1;PDLIM1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",-0.418484255908411,-0.9408702484295479,0.5444191343963554,0.8569332147087082,1.0,5/10,29.57%,EXD2;POLD1;TATDN1;MGME1;APEX1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.35068947430133673,0.9401718533894231,0.5544715447154471,0.906434813007065,1.0,7/33,13.29%,CTR9;ELOF1;NCOA3;RPRD2;SCAF8;TBP;WDR43
prerank,signal sequence binding (GO:0005048),-0.3035575024088981,-0.9396765219488571,0.5563725490196079,0.8550654086380757,1.0,11/35,21.21%,PEX5L;NFKBIA;CEMIP;AP2B1;KDELR3;CABP1;AP2M1;CAT;RANBP6;TOMM20;POM121
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.38922658161763624,-0.938494815374602,0.5625,0.8530662315187159,1.0,6/14,15.21%,SLC1A2;SLC1A1;SLC25A13;SLC17A6;SLC38A7;SLC1A6
prerank,chemokine activity (GO:0008009),-0.32050833504742654,-0.9381315980416367,0.5239294710327456,0.8491671972086968,1.0,20/31,46.93%,CXCL12;CXCL16;CCL13;CCL19;CXCL10;CCL2;CCL28;CCL4;PF4;PPBP;CCL8;CXCL5;CCL14;CKLF;CXCL1;CCL1;CCL3;CCL11;CXCL13;CXCL2
prerank,CoA hydrolase activity (GO:0016289),0.40107955322702254,0.9375274652489469,0.5327433628318584,0.9089947249948496,1.0,4/16,17.33%,ACSBG2;ACOT11;ACOT8;ACOT12
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.3816247783393428,0.9374584719836212,0.5355871886120996,0.9056309785559594,1.0,4/25,5.07%,MICAL3;CYP27A1;CYP26B1;POR
prerank,calmodulin-dependent protein kinase activity (GO:0004683),-0.33871015933133636,-0.9373305893863608,0.5623409669211196,0.846458675910553,1.0,5/24,12.51%,CAMK2D;PTK2B;EEF2K;CAMK4;DAPK1
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.40141814681091237,0.9372009920452491,0.5277777777777778,0.9027538652184628,1.0,4/18,7.47%,TGFBR3;BMPR1A;TGFBR1;TGFBR2
prerank,transforming growth factor beta binding (GO:0050431),-0.3425821999463736,-0.9357678283215383,0.5467289719626168,0.8453277919848438,1.0,7/23,7.17%,LTBP1;LTBP4;ENG;THBS1;ACVRL1;TGFB3;CD109
prerank,SH3 domain binding (GO:0017124),0.31746902764847373,0.934703714295835,0.5814307458143074,0.9048835176538091,1.0,9/62,7.96%,ADAM12;AFAP1;PRKN;SYNJ2;REPS1;AFAP1L2;PTPN22;PLSCR1;CNTNAP1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.33958014222141963,0.934563201439304,0.5451761102603369,0.9016741205877742,1.0,13/42,21.79%,CCNA2;CCNA1;CCNT2;CCND3;CCNB2;KAT2B;CCNL1;CCNG1;CCNE1;CNPPD1;HEXIM2;CCNG2;CCNL2
prerank,lipase activity (GO:0016298),0.3424032869278767,0.9327388824102724,0.5427215189873418,0.9025965705751281,1.0,9/43,14.92%,LIPA;CEL;PLA1A;PNLIP;LYPLA1;DDHD2;ABHD12;SEC23IP;SMPD3
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.27739711395260314,0.9287986873154737,0.6080206985769728,0.9082022990904727,1.0,25/173,12.40%,AEBP1;MXI1;PPARA;FOXP4;ZBTB20;KCNIP3;MITF;NACC2;FOXP2;OTP;BHLHE41;RORC;IRX1;ZBTB26;ZFP90;SOX13;PRDM5;ZNF219;ZBTB6;NFATC3;MNT;SNAI1;ZBTB1;ZNF148;DEAF1
prerank,nucleoside-triphosphatase activity (GO:0017111),-0.2205684025513395,-0.9281555903970863,0.7435897435897436,0.8593117686755921,1.0,89/248,26.58%,DNM3;RHOBTB1;RHOJ;GNAS;RIT2;RND3;MYL6;RAB31;KRAS;MYH9;RAB3C;RAP1B;RAP1A;RASL12;SRPRA;GCH1;RAB27A;RHOB;DYNC1I1;GNAI1;DNM1;ARHGDIB;EEF1A1;RERG;RALB;MYO6;GNA12;ABCD2;RAB18;RHOH;GBP4;KIF26A;RAP2A;HSP90AA1;ARL1;GNA14;RAB27B;ATP2B1;GNB2;HBS1L;ATL2;MTG2;GNAO1;RAB38;CLU;GNB1;RRAS;GNAL;RAB6A;RAB32;DHX9;SEPTIN9;KIF15;TPPP;ARL8B;ATL3;RHOBTB3;ATAD1;MMAA;EEF2;RAN;RHEB;DNA2;CFTR;GPN3;MYO1E;RND2;RAB14;GNL2;RAC3;GEM;GPN2;KIF5A;SAR1B;RHOC;RND1;RUVBL2;KIF14;MMUT;RNF112;RAB1B;RHOG;EEF1A2;ABCA3;GNG3;RAP2C;KIF1A;RAB5B;GNG8
prerank,cytochrome-c oxidase activity (GO:0004129),-0.3815125473322818,-0.9278822578831434,0.5799086757990868,0.8551463527989266,1.0,7/15,26.13%,COX4I1;COX6A1;CYB5A;COX5B;COX5A;NDUFA4L2;COX4I2
prerank,RNA polymerase core enzyme binding (GO:0043175),0.34618992383535346,0.9263826416986232,0.5823817292006526,0.9105611379933238,1.0,6/33,13.29%,CTR9;ELOF1;NCOA3;RPRD2;SCAF8;WDR43
prerank,lysophospholipase activity (GO:0004622),-0.3419641098655529,-0.9263302296935788,0.5560640732265446,0.8541550794324282,1.0,5/20,14.27%,PLA2G4A;MGLL;GDPD1;ENPP2;ABHD4
prerank,estrogen receptor binding (GO:0030331),0.3513397200469701,0.9223989573678819,0.5481727574750831,0.9161054097855226,1.0,4/32,6.54%,PPARGC1B;NSD1;LCOR;WIPI1
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.4050850174497943,-0.920500492284812,0.5738396624472574,0.862991360914921,1.0,2/11,2.38%,SGMS1;SGMS2
prerank,guanyl ribonucleotide binding (GO:0032561),-0.22402093756562075,-0.9204346781730396,0.7397959183673469,0.8585036859493662,1.0,49/196,18.89%,RHOBTB1;RHOJ;PDE10A;PDE11A;RIT2;RND3;RAB31;KRAS;RAP1B;RAP1A;RASL12;GCH1;RAB27A;RHOB;GNAI1;EEF1A1;RERG;RALB;GLUD1;MFHAS1;TUBA1A;PDE2A;RAB18;RHOH;GBP4;TUBB4A;RAP2A;ARL1;ARL5A;RAB27B;ARL5B;ATL2;MTG2;RAB38;RRAS;TUBB2B;RAB6A;ARF5;RAB32;ARF6;RAB39A;TUBB3;ARL8B;ATL3;RHOBTB3;MMAA;RAN;TUBA4A;RHEB
prerank,carbohydrate:cation symporter activity (GO:0005402),0.43669633349977516,0.9197543535902561,0.5583657587548638,0.9186344666372195,1.0,2/11,12.58%,SLC5A3;SLC5A11
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.40185998912256915,-0.9195741724998269,0.5764966740576497,0.8558520841553436,1.0,1/12,1.47%,ENTPD1
prerank,hyaluronic acid binding (GO:0005540),-0.4102221674128903,-0.9178592945453677,0.5805785123966942,0.8551720396929189,1.0,3/10,9.82%,LAYN;CEMIP;CD44
prerank,peptide N-acetyltransferase activity (GO:0034212),0.4448360235146136,0.9164161732310773,0.5619223659889094,0.9226272006594133,1.0,3/10,15.44%,NAA80;NAA20;NAA16
prerank,poly-purine tract binding (GO:0070717),0.36359830293690903,0.9158030171657605,0.5707070707070707,0.920425606377586,1.0,11/27,20.48%,RBMS2;DDX3X;TIA1;PABPC4L;RBMS1;RBMS3;PABPC5;HNRNPDL;DAZAP1;LARP4;FMR1
prerank,protein phosphatase 2A binding (GO:0051721),-0.32583907453050825,-0.914436638624712,0.5738916256157636,0.8584828732859797,1.0,7/23,13.89%,GRIN3A;DAB2IP;FOXO1;MFHAS1;MAPT;SMG5;STRN4
prerank,receptor tyrosine kinase binding (GO:0030971),0.3235835930571036,0.9136073412825766,0.5835913312693498,0.9219428998074864,1.0,11/56,11.08%,LRP4;PTPN14;ARHGEF16;FRS2;GAB2;TP53;CPNE3;NRG1;ALKAL2;FLT3LG;RNF41
prerank,potassium ion antiporter activity (GO:0022821),0.40083377605785186,0.9126910871810218,0.5686274509803921,0.9204972857520055,1.0,1/15,0.62%,SLC24A3
prerank,magnesium ion binding (GO:0000287),0.27993359284927793,0.9123118141409272,0.6213720316622692,0.9178923664863554,1.0,29/135,17.54%,EYA2;OXSR1;SPHK1;CLYBL;LRRK2;NUAK2;ATP4A;SIK1;CDC42BPG;MOV10L1;OPA1;PLSCR1;SRR;IDH1;BRSK1;ABL1;SRPK2;TDG;PGM1;TDP2;THTPA;STK4;CERK;XXYLT1;RP2;NT5C3A;EPHX2;PRKACB;IDH2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.4333642586298695,0.9069140277051329,0.5746268656716418,0.9264385230036032,1.0,3/11,15.44%,NAA80;NAA20;NAA16
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.4187400201025374,0.9063957635554548,0.553763440860215,0.9241155580931248,1.0,5/13,19.01%,DNASE1L1;DICER1;DNASE1L2;FEN1;SLX4
prerank,syntaxin-1 binding (GO:0017075),-0.3358688179727009,-0.9059975039175087,0.6145124716553289,0.8729221942634994,1.0,7/22,12.51%,SYT1;SNAP25;UNC13B;SYPL1;NSF;SYNPR;DAPK1
prerank,phosphatidic acid binding (GO:0070300),-0.34380046232023714,-0.9039965999178509,0.6116071428571429,0.8729392115830319,1.0,5/19,11.07%,MARK1;PITPNC1;PLTP;RAPGEF6;JPH2
prerank,kinase binding (GO:0019900),0.24932196886869215,0.9016166421024099,0.7339246119733924,0.9313429091405989,1.0,54/434,11.05%,PRKAG2;MAPK4;SMAD3;ANK2;OXSR1;ERRFI1;KIF13B;SASH1;DLG1;KCNA5;RHOBTB2;PRKN;POLR2A;RHOD;CCNA2;PRKAG3;TOM1L2;CEP250;PPP1CB;SUFU;NISCH;ADRA2A;TPRKB;NBEAL1;TNS2;GYS1;FZD5;WWC2;PTPN23;PDGFRB;EXOC2;CACUL1;SIK1;TP53;RICTOR;CLTC;DLG3;PTPN22;CCND3;CDK5RAP3;HTT;GPRC5B;MVP;TCF7L2;CDC25A;MIDN;JTB;MAVS;BECN1;IRGM;TRIP6;AURKB;CDC42;ATF2
prerank,serine-type peptidase activity (GO:0008236),0.2941221321459418,0.9010955418300559,0.6315049226441631,0.9290830432519239,1.0,7/96,6.18%,CORIN;KLK2;F11;CTSH;DPP4;F2;TPP1
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.4189264730262705,0.9003357319457066,0.5899419729206963,0.9273127120780235,1.0,5/14,20.12%,TSEN2;RPP21;PRORP;POP7;POP1
prerank,O-methyltransferase activity (GO:0008171),0.43251674302243037,0.8987700690821071,0.5797979797979798,0.9274777149201371,1.0,3/10,13.66%,LRTOMT;ASMT;CMTR2
prerank,phosphatase activator activity (GO:0019211),-0.36266803421134636,-0.8975552377035557,0.5831533477321814,0.8828268605219356,1.0,5/14,10.88%,PPP2R5A;CALM1;CALM2;BMP2;CALM3
prerank,cytokine receptor activity (GO:0004896),-0.25073044731588556,-0.8973800801171998,0.6734006734006734,0.8785751938108568,1.0,21/83,17.94%,GHR;IL1R1;OSMR;LIFR;IL1RAP;IL1RAPL2;F3;IL6ST;FZD4;IL17RD;IFNGR2;CD44;IL4R;CNTFR;CMKLR1;IL31RA;GFRA1;CX3CR1;GFRA2;CD74;CRLF1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.42692160299151133,0.8958753819886178,0.5966029723991507,0.930484837689827,1.0,4/10,18.13%,NSD1;NSD3;ASH1L;SETD3
prerank,ATPase regulator activity (GO:0060590),0.333370454539913,0.894613360764435,0.5774410774410774,0.9298499959103971,1.0,2/38,2.19%,ATP1B3;FNIP1
prerank,protease binding (GO:0002020),0.2862633630609186,0.8939643765167383,0.6595135908440629,0.9279840732811441,1.0,18/99,9.92%,TIMP3;PRKN;CFLAR;BDKRB2;DPP4;POLG;LCOR;CD28;COL1A2;TP53;CLTC;SERPINE1;COMP;PTEN;TWNK;ANXA9;RIPK2;STIM1
prerank,exopeptidase activity (GO:0008238),0.3180365469754676,0.8937829610760004,0.6072507552870091,0.9250625514555135,1.0,14/50,16.87%,ACE;CTSH;DPP4;DPP8;NAALADL1;METAP2;RCE1;NPEPPS;FOLH1;ERAP1;ANPEP;ZMPSTE24;DPP7;XPNPEP1
prerank,neurexin family protein binding (GO:0042043),0.43302398045928414,0.8926078248393533,0.5882352941176471,0.9241564516509458,1.0,3/10,3.83%,SYTL3;NLGN2;CEL
prerank,solute:sodium symporter activity (GO:0015370),-0.30844777280304,-0.8925409998008775,0.6326963906581741,0.884345860980659,1.0,2/27,5.33%,SLC4A10;SLC5A6
prerank,steroid hydroxylase activity (GO:0008395),0.3888325709949487,0.8917975473810776,0.5684410646387833,0.9225541124484861,1.0,3/16,8.63%,CYP27A1;CYP21A2;CYP2R1
prerank,nuclear import signal receptor activity (GO:0061608),0.384440391895232,0.8902506090683737,0.594392523364486,0.9226444130694518,1.0,7/15,28.60%,TNPO1;KPNA6;TNPO2;HIKESHI;KPNA4;KPNA1;IPO4
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.41238096442664385,0.8902192413364887,0.5852713178294574,0.9194453043466208,1.0,7/12,28.10%,TENT2;TENT4B;PAPOLG;TENT5C;TUT1;TENT5D;TENT4A
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.3554917620077819,0.8877225818332295,0.6027397260273972,0.9216824350989584,1.0,2/27,2.03%,SLC41A1;SLC8A3
prerank,miRNA binding (GO:0035198),0.34135993461582614,0.8873401137323523,0.6135593220338983,0.9193247425977048,1.0,13/30,26.22%,ZC3H7B;HNRNPA2B1;TUT4;ZNF346;RBM4;TUT7;FMR1;ZC3H10;AGO1;SPOUT1;AGO2;PUM2;AGO4
prerank,anion:anion antiporter activity (GO:0015301),-0.3534739851967249,-0.8845609747176396,0.6109936575052854,0.8978822490396251,1.0,2/17,2.75%,SLC26A7;SLC26A2
prerank,nuclear export signal receptor activity (GO:0005049),-0.3953494508945228,-0.8845111916018921,0.6247464503042597,0.8933716399726735,1.0,4/11,21.06%,XPO1;EIF4ENIF1;RAN;XPO6
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2439679717494618,0.8836665250325795,0.7606263982102909,0.9237220236499932,1.0,66/431,14.95%,PRKAG2;ATP1A2;WNK4;KSR1;OXSR1;RHOQ;RHOBTB2;RHOD;SPHK1;BMPR1A;OAS2;TGFBR1;DMPK;LRRK2;MYO18A;GNAT2;P2RX3;ATL1;GBP3;NUAK2;CLPX;GBP7;SIK1;CDC42BPG;MOV10L1;GCK;GBP2;SRR;RRAS2;ARL4A;GTPBP4;PPIP5K2;MKNK1;BRSK1;RAB11B;ABCC6;RAB13;ABL1;KIFC1;SRPK2;CDC42;TRIB1;RAB22A;RABL6;GALK1;IGHMBP2;PNKP;TDG;PRKCI;TUBB2A;WNK1;HSPA4;OAS3;DNM2;CAD;GBP6;STK36;ATP5F1D;STK17B;ACVR1B;REM1;RAB21;CARS2;RAB29;SYN3;STK4
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.36972039389305983,0.8833695920805117,0.6003401360544217,0.9211300312727451,1.0,7/22,17.24%,PARP10;IKBKE;TAB2;ZBTB1;UIMC1;OPTN;SQSTM1
prerank,protein kinase A regulatory subunit binding (GO:0034237),-0.3252776536537728,-0.8831128053786077,0.6009501187648456,0.8918675074623692,1.0,6/21,18.92%,AKAP6;RYR2;KCNQ1;WASF1;WASF2;ACBD3
prerank,nuclease activity (GO:0004518),0.3092788671727403,0.8824622180797996,0.6450617283950617,0.9198629736302852,1.0,16/52,24.14%,DNASE1L1;PLSCR1;SAMHD1;SND1;PNKP;REXO5;DFFB;DIS3;DNASE1L2;OGG1;FEN1;RNASE12;MAP1S;REXO1;REXO4;N4BP2
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3109386563614034,0.8814686420637445,0.6565008025682183,0.9187612797808581,1.0,7/49,8.41%,SYT9;SYT11;SYT12;CPNE3;FER1L5;ANXA5;ANXA9
prerank,heme binding (GO:0020037),0.3003824110295085,0.8806488243631548,0.6494082840236687,0.9172877904570791,1.0,11/65,11.62%,CYP27A1;FLVCR2;PGRMC1;CYP21A2;CYP26B1;CYP2R1;SLC48A1;HRG;CYB561D2;NOX4;CYB5B
prerank,CXCR chemokine receptor binding (GO:0045236),-0.3823427573558766,-0.8805706276066516,0.6169772256728778,0.8929913620963033,1.0,8/11,46.93%,CXCL12;CXCL10;PF4;PPBP;CXCL5;CXCL1;CXCL13;CXCL2
prerank,ribonuclease P activity (GO:0004526),0.424369402827111,0.8757428392198404,0.6269230769230769,0.9244786182429536,1.0,4/11,20.12%,RPP21;PRORP;POP7;POP1
prerank,solute:proton symporter activity (GO:0015295),-0.34431428424915783,-0.8746839401362464,0.6506550218340611,0.9010261852265843,1.0,1/16,1.59%,SLC2A13
prerank,lipoprotein particle receptor binding (GO:0070325),-0.3054342002432174,-0.8741132929857939,0.6976190476190476,0.8978255494874491,1.0,9/27,18.91%,SYT1;APOE;RELN;HSPG2;AP2M1;SNX17;CLU;DNAJA1;LDLRAP1
prerank,myosin V binding (GO:0031489),-0.3556511874671289,-0.8720856490230342,0.6434782608695652,0.8975292450179436,1.0,9/15,38.42%,RAB3C;RAB27B;RAB6A;RAB14;RAB3A;RAB3B;RAB6B;RAB25;RAB11A
prerank,tau-protein kinase activity (GO:0050321),0.36554809901102026,0.8715493439248042,0.621342512908778,0.9300493877723817,1.0,3/20,10.71%,ROCK2;BRSK1;DYRK1A
prerank,CARD domain binding (GO:0050700),-0.3524076948546667,-0.8679187465538905,0.6687116564417178,0.9016715971287222,1.0,9/14,31.11%,NOD1;CARD14;CARD16;NOD2;CARD19;CASP4;CARD11;CARD10;BCL10
prerank,adenylate cyclase binding (GO:0008179),0.42547336110373796,0.8678102570108952,0.6314779270633397,0.9342904881288243,1.0,2/10,3.98%,ADCY5;AKAP12
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.27712657953365455,-0.8649656600306722,0.6923076923076923,0.9031294578780147,1.0,9/38,15.78%,HIP1;PLA2G4A;DAB2IP;PLEKHA5;JPH2;PHLDA3;ZFYVE28;SESTD1;SNX27
prerank,Wnt-activated receptor activity (GO:0042813),-0.3506437618758517,-0.8648991792778674,0.665938864628821,0.8987944990613012,1.0,4/15,10.52%,ROR1;FZD4;TSPAN12;PKD1
prerank,endopeptidase activity (GO:0004175),0.24897870502253558,0.8636825511907945,0.7647058823529411,0.9394085093167698,1.0,52/257,20.27%,ACE;CORIN;ADAMTS10;BACE2;KLK2;F11;TRABD2B;ADAMTS2;ADAMTS15;CASP3;ADAMTSL5;CTSH;DPP4;F2;ADAMTS9;USP9X;USP24;TPP1;USP11;MMP19;RCE1;MMP14;USP34;ADAM28;ADAM17;USP49;USP12;USP7;MBTPS1;PCSK7;ADAMTS7;USP18;PLAT;PITRM1;PREP;NRDC;ZMPSTE24;CELA3A;USP37;PIDD1;TYSND1;PRSS36;USP1;USP48;USP33;CLPP;ADAMTSL4;PCSK4;AFG3L2;USP35;USP16;ECEL1
prerank,single-stranded DNA helicase activity (GO:0017116),-0.3207273507136929,-0.862243276966735,0.6495535714285714,0.8998836329370256,1.0,12/19,30.41%,WRNIP1;DHX9;DNA2;RFC4;RFC2;POLQ;MCM6;RFC5;HELB;CHTF18;RAD51;PIF1
prerank,protein tyrosine kinase binding (GO:1990782),0.2902947668612497,0.8588334672757437,0.6917510853835022,0.9460532952326112,1.0,15/71,12.73%,LRP4;PTPN14;EPHA4;ARHGEF16;TP53;CPNE3;NRG1;CDH5;ALKAL2;NOX4;FLT3LG;CASS4;RNF41;PTPN11;PITPNM2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),-0.31484631941207386,-0.858484555436791,0.6877828054298643,0.9029980171795857,1.0,8/22,18.91%,SYT1;APOE;HSPG2;AP2M1;SNX17;CLU;DNAJA1;LDLRAP1
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.31002624139032015,0.8566262124355483,0.6687402799377916,0.9473415051947182,1.0,11/49,17.24%,PARP10;BABAM2;ZFAND6;IKBKE;TAB2;ZBTB1;UIMC1;DZIP3;UFD1;OPTN;SQSTM1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.3252060101785072,-0.8551122131086984,0.6937901498929336,0.9052539873354319,1.0,6/18,14.22%,GAS6;RPS6KA3;SERPINB9;SNCA;RPS6KA1;MT3
prerank,palmitoyltransferase activity (GO:0016409),-0.29954329871570196,-0.8547929633309912,0.6897374701670644,0.901509388854241,1.0,5/28,12.19%,ZDHHC9;HHAT;ZDHHC2;GOLGA7;ZDHHC14
prerank,retinoid X receptor binding (GO:0046965),0.4028836399586227,0.8543841414987594,0.6454033771106942,0.9484513671320262,1.0,3/11,11.32%,NSD1;HMGA1;RARG
prerank,ATPase activator activity (GO:0001671),0.36536156727922564,0.8524362127213858,0.655045871559633,0.9490948436051536,1.0,1/20,0.74%,ATP1B3
prerank,endonuclease activity (GO:0004519),0.30462090331915004,0.8513884131839035,0.6666666666666666,0.9479664146722868,1.0,16/49,24.14%,ZC3H12B;SND1;DICER1;PNKP;ZC3H12C;NYNRIN;DIS3;CPSF3;MBD4;OGG1;FEN1;SMG6;AGO1;REXO4;LACTB2;N4BP2
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),0.3979682392148556,0.8449023786165207,0.6358595194085028,0.9576589286493752,1.0,1/11,1.35%,KCND3
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.34196705591415,-0.8432410662383523,0.6741071428571429,0.9206787454238184,1.0,5/14,11.71%,MTMR6;MTMR2;MTMR11;MTMR7;MTMR9
prerank,mRNA 5'-UTR binding (GO:0048027),-0.3094601318487601,-0.8417622075265503,0.682983682983683,0.9191513508055881,1.0,5/24,8.36%,RPL41;RPL26;RPL5;RPS7;SYNCRIP
prerank,ubiquitin conjugating enzyme binding (GO:0031624),0.33494053453208467,0.8409355737061375,0.6794019933554817,0.9622653663249894,1.0,6/27,12.07%,PPARA;PRKN;RNF217;RNF19A;DCUN1D5;ZMYM2
prerank,chemoattractant activity (GO:0042056),-0.2967616968322071,-0.8403451835694027,0.6984126984126984,0.9175237566813151,1.0,6/26,14.48%,VEGFC;FGF2;BMP4;VEGFA;FGF7;SCG2
prerank,Hsp70 protein binding (GO:0030544),0.3212959992492888,0.8358874898683438,0.674061433447099,0.9692448512222239,1.0,3/31,3.05%,PRKN;PPEF2;HDAC8
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.32753202828293454,0.8357339607547187,0.6815834767641996,0.9663645848379483,1.0,4/28,9.65%,BABAM2;BID;EDA;RIPK1
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.3515821540917774,0.8313807575999059,0.6812386156648452,0.9716306065179927,1.0,4/20,13.25%,SENP3;USP9X;USP7;DESI2
prerank,galactosyltransferase activity (GO:0008378),0.3910720299090009,0.8308759532454248,0.681912681912682,0.969307545326628,1.0,4/11,13.12%,B4GALT1;A3GALT2;A4GALT;B4GALT2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",0.4004992607216198,0.8269421458986996,0.6579439252336449,0.9739077941501585,1.0,1/10,1.94%,LACC1
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.38863765583846693,0.8229294516363118,0.6711798839458414,0.978266990292888,1.0,3/11,19.41%,UBR5;AMFR;UBE4B
prerank,growth factor activity (GO:0008083),0.27429437574749893,0.8223395355645192,0.742816091954023,0.9762087207141036,1.0,16/74,18.81%,FGF1;F2;IL12B;OSGIN2;NRG1;GDNF;HBEGF;OSGIN1;VEGFD;TGFA;INHA;AMELX;NRTN;BTC;VEGFB;ARTN
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),-0.298996279770993,-0.8218612194777287,0.7188208616780045,0.9481212069559939,1.0,4/22,9.06%,ATP6V0A1;ATP2C1;ATP6V0A4;ATP2A3
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",-0.3400575545553165,-0.8215360159994413,0.720558882235529,0.9441626966330138,1.0,2/13,11.89%,SREBF2;IDI1
prerank,microtubule plus-end binding (GO:0051010),-0.3092586492013013,-0.8211034741110952,0.7254464285714286,0.9405264429678714,1.0,6/20,16.28%,CLASP2;DST;CLIP4;CLIP2;CLIP1;APC
prerank,single-stranded DNA binding (GO:0003697),0.26366753186734265,0.8178070949121979,0.776685393258427,0.9814903828557905,1.0,25/93,21.68%,SSBP2;PCBP2;FBH1;POLR2D;SAMHD1;RBMS1;TWNK;SSBP1;RTF1;RBBP8;MSH3;IGHMBP2;TOP3A;MCM7;MCM2;TDP2;PURB;FUBP3;APTX;RAD51D;POU4F1;MCM9;MLH1;POLR2G;MCM5
prerank,regulatory RNA binding (GO:0061980),0.29872321703316285,0.8162976146762116,0.7427652733118971,0.9812590594273322,1.0,14/38,26.22%,ZC3H7B;HNRNPA2B1;TUT4;ZNF346;DICER1;RBM4;TUT7;FMR1;ZC3H10;AGO1;SPOUT1;AGO2;PUM2;AGO4
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.3190833069990562,-0.8161641321805453,0.7015945330296127,0.9450404771464499,1.0,5/16,11.71%,MTMR6;MTMR2;MTMR11;MTMR7;MTMR9
prerank,growth factor receptor binding (GO:0070851),0.26148063865717147,0.8127447675978594,0.7695652173913043,0.9845763160237356,1.0,18/95,14.25%,FGF1;KL;FRS2;PDGFRB;IL12B;PLSCR1;ATXN2;HBEGF;TRIP6;FER;KLB;ADAM17;GLMN;VEGFD;TGFA;PDGFRA;ERAP1;TLR5
prerank,receptor antagonist activity (GO:0048019),0.35309874247351736,0.8110314411646407,0.7142857142857143,0.9846891372688322,1.0,1/17,2.76%,DKK3
prerank,DNA polymerase activity (GO:0034061),0.33256003800652906,0.8092608542182294,0.6859205776173285,0.9846238682055498,1.0,4/22,8.10%,POLM;POLG;REV1;TERT
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.28993723662803306,-0.8085842627583071,0.7616822429906542,0.9543228912019244,1.0,9/24,20.05%,CERT1;PLA2G4A;DAB2IP;PLEKHA5;JPH2;PLEKHA3;SESTD1;PLA2G4E;OSBP
prerank,microtubule binding (GO:0008017),0.23433999207019485,0.8083203137735591,0.8694581280788177,0.9831806276809616,1.0,21/222,9.00%,FMN1;GJB6;EML4;MTUS2;KIF13B;HOOK2;KIF2A;EML2;CLASP1;LRRK2;EZR;CCDC69;KIF3C;MAP2;APC2;OPA1;FBXW11;KIF1B;CEP57L1;KIF1C;DNM1L
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.38852639652368076,0.8066330518132611,0.6797020484171322,0.9832282791289715,1.0,3/11,22.41%,PADI6;PADI4;ARG1
prerank,RNA binding (GO:0003723),0.2119867019311574,0.8034718897927041,0.9817813765182186,0.9860083951255895,1.0,218/1321,16.38%,NSA2;CPEB2;PPARGC1B;CELF2;ROCK2;TRMT9B;BICC1;SRRM2;DDX5;PPARGC1A;NUDT4;POLR2A;HOXB6;MSI2;SON;SNTB2;RBM47;CPEB4;TNRC6A;IFIT1;IFIT2;FNDC3B;MRPS23;ZC3H7B;OAS2;RBMS2;TDRD3;TNPO1;NXF2;LARP4B;IFIT3;SNRNP70;KNOP1;PCBP2;PABPN1;MBNL2;PRRC2B;MYO18A;TLR3;SMG1;EZR;KYAT3;RBM28;HNRNPR;FAM120A;METAP2;IGF2BP1;HNRNPH1;TRIM56;DDX3X;ERI3;SRSF5;SIDT2;CCDC86;ZC3H12B;ANKRD17;EIF2AK2;PNO1;POLDIP3;LGALS1;CLTC;MOV10L1;ZC3H4;ANXA11;CLUH;ZCCHC13;CPNE3;HNRNPA2B1;SNIP1;TIA1;TNS1;IGF2BP2;GOT2;TNRC6B;SIDT1;ATXN2;MEX3A;MRPL37;MRPL2;SAMD4A;TUT4;PABPC4L;POLR2D;TEP1;HUWE1;RBM39;RBM15;SPEN;TERT;PARP12;SAMHD1;RBMS1;C1D;LRP1;SLTM;EXOSC7;LARP1;SND1;ARHGEF1;CPEB3;JMJD6;DIAPH1;KIF1C;NOVA1;CCAR1;FLYWCH2;RBM27;ZC3H18;DQX1;SCAF4;CSDC2;SSBP1;ZC3HAV1;DDX60;GPKOW;MOV10;GTPBP4;KHDC4;LARP7;YTHDF3;PPAN;TBRG4;NUP42;GTF2F1;LSM14A;THRAP3;PTRH1;RRP36;TRIP6;SAP18;LRRC47;LUC7L3;KMT2C;CRKL;SCAF8;SRPK2;RTF1;ZNF346;NOM1;SURF6;DDX18;DHX58;ANKHD1;NUP98;PRKDC;SUGP2;EIF4A2;DICER1;NOP2;NXF1;PNLDC1;HNRNPL;RPP21;SRSF11;PHF5A;NELFCD;CWC15;MRPS7;NOCT;IGHMBP2;DDX6;ETF1;DCP1A;SLC25A11;NOC4L;AKAP1;POLR1G;CAST;ALDH6A1;RBPMS2;WDR43;MRPS26;DHX33;RAMAC;GSPT2;OAS3;PSIP1;RBMS3;RSL1D1;HNRNPC;ZC3H12C;ILF2;SCAF11;PNISR;LBR;UBAP2L;DZIP3;SEC23IP;PUS10;SNRNP40;IMMT;PURB;ANXA7;NYNRIN;PRPF3;FCF1;RBM34;ZFP36L1;LGALS3;PABPC5;ATP5F1C;TENT4B;SARNP;HNRNPDL;SLC4A1AP;FUBP3;VIRMA;DIDO1;CPSF3;RBM4;HNRNPM;NEMF;DUSP14;FARSA;ILF3;TUT7;DAZAP1;SEPSECS
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.3759296408200881,0.8033471717696876,0.6819085487077535,0.9830826953299179,1.0,1/11,3.05%,AKR1B10
prerank,metalloendopeptidase activity (GO:0004222),0.26611042770124554,0.80303636264365,0.7758369723435226,0.9805181276847711,1.0,14/76,15.47%,ADAMTS10;TRABD2B;ADAMTS2;ADAMTS15;ADAMTSL5;ADAMTS9;MMP19;RCE1;MMP14;ADAM17;ADAMTS7;PITRM1;NRDC;ZMPSTE24
prerank,nucleosomal DNA binding (GO:0031492),0.3351261715022743,0.8026411040301683,0.7088607594936709,0.9781404873394759,1.0,10/21,22.32%,CHD4;SMARCA4;SMARCC2;HDAC1;SMARCE1;HNRNPC;MTA2;MBD2;SMARCD2;SMARCB1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.3694627592383563,0.8017855862413105,0.68,0.9766290664644097,1.0,3/12,12.02%,PAN3;PNLDC1;NOCT
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.22914141287415976,0.8012589402912222,0.882494004796163,0.9745858759860532,1.0,37/269,13.81%,SMAD3;SNCAIP;SYT11;PPARGC1A;FHIT;PRKN;POLR2A;DTX1;FZD8;PCBP2;SLC22A18;IKBKE;SMAD6;FZD5;ARRB1;STAT2;TRIB2;TP53;RNF8;TRIOBP;AMBRA1;PTPN22;CDK5RAP3;RNF34;DNM1L;PARP9;RIPK1;BECN1;TRIB1;AXIN2;MAGEC2;CUL4A;GLMN;USP7;PRKAR1A;PML;MFN2
prerank,tRNA binding (GO:0000049),0.28490189973816876,0.798719546251974,0.7692307692307693,0.9759330647191718,1.0,8/43,22.05%,TRMT9B;TERT;IGHMBP2;NEMF;SEPSECS;RPUSD4;XPOT;KARS1
prerank,peptidase activator activity (GO:0016504),-0.2993208504294057,-0.7985960491094516,0.7467532467532467,0.9669018176481925,1.0,4/22,9.07%,CAV1;MAL;VSIR;PSMD14
prerank,neuropeptide receptor binding (GO:0071855),0.356630049112706,0.7984316193854666,0.7137404580152672,0.9734241582340044,1.0,2/14,9.26%,APLN;AGRP
prerank,solute:anion antiporter activity (GO:0140323),0.35500789467671245,0.7973135541943969,0.7053941908713693,0.9723648549562485,1.0,3/14,8.06%,SLC7A11;SLC26A3;SLC26A1
prerank,1-phosphatidylinositol binding (GO:0005545),-0.32471080679321773,-0.7972066791698482,0.7472527472527473,0.964706917644694,1.0,6/15,16.18%,EPB41;SCARB1;SNAP91;ZFYVE9;SESTD1;WDFY3
prerank,motor activity (GO:0003774),-0.2392855624156425,-0.793676675314846,0.8571428571428571,0.9662063462017688,1.0,24/60,26.40%,STARD9;KIF21A;MYL6;MYH9;DYNC1I1;KIF5C;KIF26B;MYO6;KIF26A;KIF3A;KIF21B;CENPE;DNAH3;KIF15;KIF11;MYO1E;KIF4A;KIF22;KIF5A;KIF3B;KIF14;KIF23;KIF1A;KIF17
prerank,voltage-gated chloride channel activity (GO:0005247),0.3811454723857001,0.793522069368847,0.6779026217228464,0.9761482027311946,1.0,2/10,7.35%,CLCN2;ANO6
prerank,voltage-gated anion channel activity (GO:0008308),0.35066482835567836,0.7903324076532626,0.7222222222222222,0.9787258210641913,1.0,3/15,7.35%,CLCN2;VDAC2;ANO6
prerank,C2H2 zinc finger domain binding (GO:0070742),0.37340136430781184,0.7899795191109282,0.7125748502994012,0.9763491551856194,1.0,1/11,1.10%,SRRM2
prerank,"DNA binding, bending (GO:0008301)",-0.32340066040030374,-0.7898854682588442,0.7358490566037735,0.9679869631608536,1.0,5/14,16.56%,LEF1;TFAM;TERF1;HHEX;TOP2A
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.26162836246983245,0.787301077506383,0.7800289435600579,0.9780799083215735,1.0,10/73,13.84%,LGR4;NPR1;NPR3;BDKRB2;MC2R;NMUR1;NLRP6;KISS1R;SORCS2;VIPR1
prerank,neuropeptide receptor activity (GO:0008188),-0.2727569595114438,-0.7871946610967677,0.8106060606060606,0.9679857628278273,1.0,2/29,3.27%,SORCS1;SORCS3
prerank,telomeric DNA binding (GO:0042162),0.30090360157921403,0.7862356443232364,0.7431781701444623,0.976897584494546,1.0,10/32,19.97%,SMG1;ACD;HNRNPA2B1;TERT;ZBTB48;RAD50;TELO2;KDM1A;TINF2;UPF2
prerank,glucuronosyltransferase activity (GO:0015020),-0.3048963697727312,-0.7850341409093946,0.7785087719298246,0.9671820774058717,1.0,4/19,15.08%,CSGALNACT1;EXT1;EXT2;B3GAT2
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.3010415430080584,0.7846397542895707,0.752442996742671,0.9765821483339129,1.0,9/34,17.78%,ERI3;EXOSC7;ERI2;PAN3;PNLDC1;NOCT;DIS3;EXOSC3;DIS3L
prerank,ubiquitin binding (GO:0043130),0.26381213166598316,0.7833271037432895,0.776255707762557,0.9758214438370889,1.0,4/73,5.59%,SMAD3;PRKN;NEDD4;ASCC2
prerank,ephrin receptor binding (GO:0046875),0.32527006231135025,0.7807942540869159,0.7429577464788732,0.9771458714174845,1.0,1/21,0.54%,EFNB2
prerank,pyrophosphatase activity (GO:0016462),0.27776882000941616,0.7798210868221089,0.78419452887538,0.9758633108467013,1.0,5/50,6.74%,NUDT4;CILP2;LHPP;DDX3X;ENPP3
prerank,deoxyribonuclease activity (GO:0004536),0.35501538807700067,0.7771016588929175,0.724950884086444,0.9772658265122416,1.0,5/14,20.42%,DNASE1L1;DFFB;DNASE1L2;MBD4;MAP1S
prerank,ubiquitin protein ligase binding (GO:0031625),0.22372413571880972,0.7770837883313768,0.9133089133089133,0.9743644267361345,1.0,34/254,13.81%,SMAD3;SNCAIP;SYT11;PPARGC1A;FHIT;PRKN;POLR2A;DTX1;FZD8;PCBP2;SLC22A18;IKBKE;SMAD6;FZD5;ARRB1;TRIB2;TP53;RNF8;TRIOBP;AMBRA1;PTPN22;RNF34;DNM1L;RIPK1;BECN1;TRIB1;AXIN2;MAGEC2;CUL4A;GLMN;USP7;PRKAR1A;PML;MFN2
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.33939174589973076,0.7767531625972489,0.7137546468401487,0.9719728586408118,1.0,4/17,13.69%,AK4;AK3;NME6;AK8
prerank,UDP-galactosyltransferase activity (GO:0035250),-0.3458973536155826,-0.77651069953966,0.7545638945233266,0.9763803296964247,1.0,5/10,24.11%,B4GALT5;B3GALT1;B3GALT5;B3GALT6;B4GALT6
prerank,SUMO binding (GO:0032183),0.35557787682842606,0.7739837275237014,0.7252336448598131,0.9735452285154486,1.0,13/13,64.47%,TDG;PML;USPL1;SIMC1;USP25;UBA2;CASP8AP2;HERC2;RNF111;HABP4;RNF4;CBX4;SERBP1
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.26736310830622456,-0.7728590188944078,0.8082788671023965,0.9777159906821951,1.0,2/29,3.26%,ACER3;ACER2
prerank,cysteine-type peptidase activity (GO:0008234),-0.2229212708846565,-0.771975945103022,0.887459807073955,0.9748400180782303,1.0,22/73,20.62%,USP29;OTUD7B;CTSC;USP13;CTSB;PDIA3;UCHL1;CAPN2;CTSL;CTSS;USP46;CASP6;USP50;CTSO;ATG4A;USP8;USP14;CASP2;USP2;CTSZ;ATG4B;OTULINL
prerank,hexose transmembrane transporter activity (GO:0015149),-0.33418763329734213,-0.7719580951286056,0.7649667405764967,0.9705330989068661,1.0,1/12,1.32%,SLC2A1
prerank,dynactin binding (GO:0034452),0.3531418122385769,0.7717467716209656,0.7403100775193798,0.9741321337636495,1.0,2/12,8.57%,SNX6;HTT
prerank,death receptor binding (GO:0005123),0.3422999546520079,0.7666566874172546,0.7367424242424242,0.9790148233124149,1.0,3/15,9.65%,BID;EDA;RIPK1
prerank,mannosyltransferase activity (GO:0000030),-0.2845710468829957,-0.7643184196308436,0.8058690744920993,0.9779757097100632,1.0,2/21,5.76%,TMTC2;DPY19L1
prerank,signaling receptor complex adaptor activity (GO:0030159),0.2832552827702336,0.7642332582948939,0.7886178861788617,0.9799116354922273,1.0,5/38,6.32%,SORBS1;FRS2;MAGI2;LRRK2;GAB2
prerank,carboxylic ester hydrolase activity (GO:0052689),0.2519827132954168,0.7593872975662369,0.8601997146932953,0.9846792809320458,1.0,11/85,10.56%,PAFAH2;ASPG;LIPA;CEL;PON3;PNLIP;LYPLA1;DDHD2;PLA2G6;PTRH1;ABHD12
prerank,single-stranded telomeric DNA binding (GO:0043047),-0.3274887941853938,-0.7587786742944171,0.7621951219512195,0.9816968444321557,1.0,4/11,15.90%,TERF2IP;STN1;TERF1;RPA1
prerank,protein kinase inhibitor activity (GO:0004860),-0.24041068861691983,-0.7585991314704217,0.8856382978723404,0.9776955357033101,1.0,9/42,18.58%,CIT;YWHAB;INKA2;CDKN1A;SNCA;SPRED1;MBIP;NCK1;SPRY4
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.28753866888275703,0.7576508055242905,0.7984375,0.9845444604541975,1.0,6/33,12.07%,PPARA;PRKN;RNF217;RNF19A;DCUN1D5;ZMYM2
prerank,tubulin binding (GO:0015631),0.2132116418482116,0.7574092512516274,0.9642445213379469,0.9819982820038425,1.0,27/295,9.00%,FMN1;GJB6;EML4;MTUS2;KIF13B;HOOK2;KIF2A;PRKN;EML2;TTLL6;CLASP1;LRRK2;DAG1;EZR;CCDC69;KIF3C;MAP2;DDX3X;APC2;BCAS3;OPA1;TTLL9;KIF1B;HTT;CEP57L1;KIF1C;DNM1L
prerank,intracellular ligand-gated ion channel activity (GO:0005217),0.3620425084453316,0.7571143145613454,0.7450980392156863,0.9795625570872208,1.0,1/11,1.43%,ITPR1
prerank,tau protein binding (GO:0048156),0.2792118615033244,0.7564356555966285,0.814935064935065,0.97772786304025,1.0,5/40,10.71%,ROCK2;PICALM;MAP2;BRSK1;DYRK1A
prerank,aminoacyl-tRNA ligase activity (GO:0004812),-0.24369068355906526,-0.7548147797652791,0.8419689119170984,0.9786958259845542,1.0,4/37,11.74%,LARS2;WARS2;GARS1;DARS2
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.36496991279187246,0.7503741312519946,0.765625,0.9805588923368322,1.0,3/10,18.47%,DUSP10;DUSP2;DUSP4
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.36496991279187246,0.7503741312519946,0.765625,0.9805588923368322,1.0,3/10,18.47%,DUSP10;DUSP2;DUSP4
prerank,phosphate ion binding (GO:0042301),-0.3316029969369121,-0.7502862532091561,0.8041237113402062,0.9808231053541265,1.0,4/10,35.06%,PDE2A;RELA;RPH3A;MTHFD2
prerank,histone methyltransferase binding (GO:1990226),-0.3259608012956494,-0.74909214464135,0.7799145299145299,0.9782753604825813,1.0,4/11,21.42%,HSP90AB1;CTNNB1;LCORL;NOP56
prerank,cysteine-type endopeptidase activity (GO:0004197),0.2481167878929048,0.7486207549485536,0.8721804511278195,0.9803467257320505,1.0,24/78,22.00%,CFLAR;CASP3;CAPNS2;CTSH;USP9X;USP24;USP11;USP34;USP49;USP12;USP7;CAPN15;USP18;USP37;USP1;USP48;USP33;CASP12;USP35;USP16;CAPN8;GPAA1;USP5;CASP9
prerank,snoRNA binding (GO:0030515),0.29745966891372116,0.747289643286868,0.7814113597246127,0.9794025252349755,1.0,1/30,1.46%,NUDT4
prerank,WW domain binding (GO:0050699),0.2995979556770937,0.7468616449982359,0.8071672354948806,0.9772568939989159,1.0,7/26,19.60%,PMEPA1;TCEAL8;TCEAL6;SCNN1A;PRRG4;NDFIP1;WBP1
prerank,gamma-tubulin binding (GO:0043015),-0.27372941455369587,-0.7465918800287803,0.8468468468468469,0.9775111297313547,1.0,5/21,12.74%,ARHGEF7;PAK1;TUBGCP2;CDK5RAP2;RAB11FIP5
prerank,manganese ion binding (GO:0030145),0.27011636424041036,0.7449959090935676,0.8172920065252854,0.976979853162568,1.0,9/48,16.87%,MPPED2;LARGE1;SOD2;B4GALT1;ABL1;LARGE2;TDP2;XXYLT1;XPNPEP1
prerank,phosphatidylglycerol binding (GO:1901611),0.33924460402718,0.7444884956361653,0.7364341085271318,0.9749555367490127,1.0,2/13,7.15%,GSDME;OPA1
prerank,water transmembrane transporter activity (GO:0005372),-0.32032485002946376,-0.7384058925077772,0.8079331941544885,0.9841996449796472,1.0,2/11,7.46%,AQP4;AQP11
prerank,calcium channel inhibitor activity (GO:0019855),0.3520585129494543,0.7375877589292555,0.7541899441340782,0.9819591067578092,1.0,1/11,1.43%,ITPR1
prerank,omega peptidase activity (GO:0008242),-0.20471228514389048,-0.7337829784309674,0.9750889679715302,0.9857851062952092,1.0,19/89,17.65%,USP29;OTUD7A;OTUD7B;ASRGL1;USP13;PSMD14;UCHL3;UCHL1;USP31;USP53;YOD1;USP46;USP50;APEH;USP8;USP22;VCPIP1;USP14;USP2
prerank,3'-5' DNA helicase activity (GO:0043138),0.32850775817734623,0.7331090619024202,0.7897623400365631,0.9852012463922909,1.0,4/16,13.17%,FBH1;FANCM;MCM7;MCM2
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.35403107970778425,0.7330458463188729,0.7678916827852998,0.9825079333163473,1.0,3/10,10.99%,ATM;PIK3CA;PIK3R3
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3026870522812173,0.7324448824989752,0.8039927404718693,0.980551475286998,1.0,3/21,7.05%,POLM;POLG;REV1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.29058442153495345,0.7289674807687829,0.8175675675675675,0.9825007774322128,1.0,4/25,6.32%,FCHSD2;DAPP1;PLEKHA2;GAB2
prerank,O-acyltransferase activity (GO:0008374),0.28704876935679174,0.7275406830239769,0.8291873963515755,0.9816174048558574,1.0,3/30,5.30%,MOGAT3;GPAT2;PIGW
prerank,RNA polymerase binding (GO:0070063),0.30882827019011144,0.7263751719933146,0.8,0.9803840129362608,1.0,4/18,10.69%,NEDD4;PABPN1;CCNT2;SCAF8
prerank,ribonuclease P RNA binding (GO:0033204),0.357550810932409,0.7262676211328453,0.8099808061420346,0.9777987208967152,1.0,3/10,20.12%,RPP21;POP7;POP1
prerank,hexosaminidase activity (GO:0015929),-0.31109603257688867,-0.7251403218162189,0.8236514522821576,0.9921518020431084,1.0,2/12,8.46%,CEMIP;HEXB
prerank,deubiquitinase activity (GO:0101005),-0.20098951924112118,-0.7249209795845271,0.9693877551020408,0.9882418302304486,1.0,20/88,19.43%,USP29;OTUD7A;OTUD7B;USP13;PSMD14;EIF3F;UCHL3;UCHL1;USP31;USP53;YOD1;USP46;USP50;USP8;USP22;VCPIP1;USP14;USP2;COPS5;MINDY1
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.21454446492844376,-0.7233097233614919,0.9320113314447592,0.985950964905168,1.0,20/57,28.94%,COX4I1;COX6A1;CYB5A;NDUFB7;NDUFS6;UQCR11;COX5B;COX5A;NDUFA4L2;CYBRD1;NDUFB5;NDUFS7;NDUFA6;NDUFB8;NDUFA13;COX4I2;NDUFA7;NDUFA8;UQCR10;NDUFB10
prerank,proton transmembrane transporter activity (GO:0015078),-0.22974157497237074,-0.7186426019350048,0.921832884097035,0.9873728257054585,1.0,10/39,21.52%,COX4I1;COX6A1;CLCN3;CYB5A;UQCR11;COX5B;COX5A;ATP6V1B2;NDUFA4L2;ATP6V1F
prerank,glucose transmembrane transporter activity (GO:0005355),-0.2813509047866968,-0.7172865819547332,0.8509174311926605,0.9848708575550864,1.0,1/17,1.32%,SLC2A1
prerank,phospholipase inhibitor activity (GO:0004859),0.34054474999965256,0.7153369597995386,0.7771317829457365,0.9891506706259258,1.0,4/10,21.16%,ANXA5;ANXA9;ANXA2;ANXA4
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),-0.318640937764369,-0.7140076529860079,0.8369781312127237,0.9842652644944675,1.0,3/10,14.08%,ANKRD13A;FAAP20;LAPTM5
prerank,DNA secondary structure binding (GO:0000217),0.27803109685004773,0.7123078305760329,0.8564273789649416,0.9901407546055915,1.0,5/31,11.07%,KMT2A;HMGA1;FANCM;ABL1;RBBP8
prerank,endoribonuclease activity (GO:0004521),0.2746664968647975,0.7109634848255395,0.8683788121990369,0.9890220059872025,1.0,9/32,24.00%,ZC3H12B;SND1;DICER1;ZC3H12C;NYNRIN;CPSF3;SMG6;AGO1;LACTB2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.2756482493545368,0.7108413404268481,0.8564273789649416,0.9864272903575728,1.0,8/33,17.78%,ERI3;EXOSC7;ERI2;PNLDC1;NOCT;DIS3;EXOSC3;DIS3L
prerank,kinase inhibitor activity (GO:0019210),-0.23521916964518902,-0.7090716114451505,0.9191919191919192,0.9857844055368975,1.0,9/33,22.91%,YWHAB;RHOH;CDKN1A;SNCA;MBIP;NCK1;SPRY4;NPM1;LRP6
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.27408026443601624,0.7085859794590978,0.8502581755593803,0.9864707382769266,1.0,1/31,0.75%,UBE2E2
prerank,lysine N-methyltransferase activity (GO:0016278),0.3037551679333992,0.7083829383440796,0.8212290502793296,0.9840656882874692,1.0,5/20,18.13%,SETD7;KMT5A;EHMT2;EHMT1;SETD3
prerank,NADP binding (GO:0050661),0.2690976240858241,0.7072102574026754,0.8538587848932676,0.9829337654774636,1.0,10/32,19.22%,GMDS;DPYD;NOX1;MTRR;TM7SF2;PGD;LBR;DECR1;CRYZ;DUS2
prerank,neuropeptide hormone activity (GO:0005184),0.2918940263289475,0.706114331395985,0.846830985915493,0.9815902089018412,1.0,4/22,17.81%,AGRP;SPX;NPFF;NMB
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),-0.25575161678778435,-0.7054207719675593,0.8860465116279069,0.9857695150231014,1.0,4/24,12.19%,ZDHHC9;ZDHHC2;GOLGA7;ZDHHC14
prerank,DNA polymerase binding (GO:0070182),0.3016111238524365,0.7048230266975605,0.8214936247723132,0.9803068644966558,1.0,3/18,7.87%,ACD;FANCI;SMARCA4
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.306382888674847,0.6995418815198607,0.8074766355140187,0.98143637377633,1.0,3/16,10.86%,ATP6V0E1;ATP6V0B;ATP6V1D
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.306382888674847,0.6995418815198607,0.8074766355140187,0.98143637377633,1.0,3/16,10.86%,ATP6V0E1;ATP6V0B;ATP6V1D
prerank,protein phosphatase regulator activity (GO:0019888),0.24288995379876707,0.6951895316646964,0.8990683229813664,0.9837132881674822,1.0,11/53,17.26%,PPP2R2B;PPP4R4;DMPK;EIF2AK2;PPP2R1B;PHACTR4;PPP2R5E;LGALS3;PPP4R2;SAG;PPP6R3
prerank,microtubule motor activity (GO:0003777),0.24173926287873052,0.6944392773112695,0.9043887147335423,0.9818870748538123,1.0,6/51,10.59%,KIF13B;KIF2A;KIF3C;KIF1B;KIF1C;KIFC1
prerank,adenyl nucleotide binding (GO:0030554),-0.31292937527345677,-0.693005743387908,0.836,0.9906463433356273,1.0,3/11,21.33%,HSPH1;BAG5;BAG2
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),-0.31292937527345677,-0.693005743387908,0.836,0.9906463433356273,1.0,3/11,21.33%,HSPH1;BAG5;BAG2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.25612923281815214,0.6926921286044507,0.9064039408866995,0.98114764221027,1.0,12/40,23.45%,DNMT3A;HNMT;LRTOMT;TPMT;ASMT;SETD3;GNMT;METTL4;N6AMT1;METTL9;PCMT1;ICMT
prerank,Hsp90 protein binding (GO:0051879),0.2583601535764633,0.6924230618716697,0.8680445151033387,0.9788393612981542,1.0,3/33,3.05%,PTGES3L;PPEF2;HDAC8
prerank,3'-5' exonuclease activity (GO:0008408),0.2538449537144238,0.6923840309345514,0.8944,0.9762646489736263,1.0,11/45,17.78%,POLG;ERI3;EXOSC7;ERI2;PNLDC1;NOCT;RAD50;DIS3;EXD1;EXOSC3;DIS3L
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.32438343989791935,0.6904205424570938,0.8169291338582677,0.975766834746033,1.0,6/12,27.79%,LARP1;GEMIN5;NCBP3;AGO2;CYFIP2;EIF4E2
prerank,NF-kappaB binding (GO:0051059),-0.24531740228081855,-0.688230201576341,0.9154929577464789,0.9914851724178729,1.0,7/24,24.27%,NFKBIA;GSK3B;TAF4B;MTDH;NPM1;SETD6;RELA
prerank,CCR chemokine receptor binding (GO:0048020),0.26753498032441875,0.6877330300928051,0.8743633276740238,0.9761306346550632,1.0,5/28,18.37%,DEFB1;CCL25;CCL15;CCR2;MSMP
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.314395303548938,0.6873708794023178,0.8253676470588235,0.9739468070137769,1.0,3/14,13.69%,AK4;NME6;AK8
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.2623274398013428,0.6862864725947683,0.8739205526770294,0.9725018594153434,1.0,1/34,0.75%,UBE2E2
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.2662656922896053,0.6842281317406707,0.8762541806020067,0.9720758204176484,1.0,3/30,8.32%,SLC30A10;SLC30A2;SLC39A13
prerank,E-box binding (GO:0070888),-0.22512091511377383,-0.6788935823138098,0.9090909090909091,0.9962901962396823,1.0,19/34,37.42%,HES1;SREBF2;ATOH8;TWIST1;TAL1;TFAP4;ZEB1;SNAI2;TCF3;BHLHE40;AHR;PER1;PRMT5;ASCL1;GATA3;NEUROD2;PPARG;CIART;HES3
prerank,NAD-retinol dehydrogenase activity (GO:0004745),-0.2821221597533815,-0.6785621315928158,0.8863636363636364,0.9925493049857406,1.0,2/14,11.12%,RDH10;ADH1A
prerank,methyltransferase activity (GO:0008168),0.24125520036865167,0.6724077913491173,0.9135399673735726,0.9815314012595666,1.0,12/46,21.02%,LRTOMT;COQ5;ASMT;MGMT;EHMT1;METTL27;BUD23;NSUN4;AMT;NDUFAF7;METTL4;N6AMT1
prerank,carboxy-lyase activity (GO:0016831),0.26953007225344355,0.6690048406938754,0.8852739726027398,0.9823233581670818,1.0,7/23,22.26%,AZIN1;MLYCD;ACOD1;ECHDC1;AZIN2;MVD;GGCX
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.2706979398053899,0.6678230896259426,0.8929765886287625,0.9809090901156516,1.0,7/27,24.16%,POLR2A;POLR2D;POLR3A;POLR2G;POLRMT;POLR2F;POLR3H
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.31983358138017187,0.6650079867841737,0.8722222222222222,0.9809139397961649,1.0,2/11,18.08%,CHRNA5;CHRNB1
prerank,mannose binding (GO:0005537),-0.2754628072922673,-0.6598196727435313,0.8863157894736842,1.0,1.0,3/12,19.10%,LMAN2L;LMAN2;CLN5
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.2858610292415079,0.6562122322222852,0.8909774436090225,0.9862343511929571,1.0,1/16,2.34%,MACROD1
prerank,FMN binding (GO:0010181),-0.28759923863371667,-0.6561144992838758,0.8811659192825112,1.0,1.0,2/11,12.55%,NOS3;NOS1
prerank,thioesterase binding (GO:0031996),0.30396529586105403,0.6549722617543694,0.8366141732283464,0.9847970487430151,1.0,2/11,10.98%,ADRA2A;CDC42
prerank,antiporter activity (GO:0015297),0.27112089171812437,0.6549205782527773,0.878839590443686,0.9822947220087564,1.0,4/20,15.46%,TMEM241;SLC25A11;SLC35D1;SLC25A10
prerank,Lys48-specific deubiquitinase activity (GO:1990380),-0.2694359025962842,-0.6545078926926099,0.9039301310043668,1.0,1.0,4/14,19.43%,OTUD7B;USP13;YOD1;MINDY1
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.2728304099265393,-0.652590628363079,0.8888888888888888,0.998098154014142,1.0,6/13,36.71%,METTL1;THUMPD2;TRMT11;TRMT10C;TRMT5;TRMT10A
prerank,organic cation transmembrane transporter activity (GO:0015101),0.28187037254178293,0.6490982582470018,0.8883071553228621,0.984791889497403,1.0,5/16,19.78%,SLC22A5;SLC25A42;SLC25A17;SLC25A26;SLC22A4
prerank,MHC protein binding (GO:0042287),-0.24134690295294747,-0.6445550561610629,0.9323144104803494,1.0,1.0,13/20,53.95%,CD74;TAP1;CD81;ATP5F1B;COL2A1;CD8B;KIR3DL2;TUBB;PILRA;FCRL6;CD4;ATP5F1A;TUBB4B
prerank,glutathione transferase activity (GO:0004364),0.2589498671439927,0.6408359066704523,0.9123434704830053,0.9891361154798327,1.0,2/23,10.40%,GSTT1;GSTA3
prerank,DNA replication origin binding (GO:0003688),-0.2316968045556177,-0.6393261995462005,0.9408983451536643,1.0,1.0,5/23,17.60%,POLA1;ORC5;DHX9;ORC2;CDC45
prerank,ribonuclease activity (GO:0004540),0.2247862430743379,0.6372566731785124,0.9537037037037037,0.9895743809090692,1.0,12/56,22.32%,ZC3H12B;SAMHD1;EXOSC7;SND1;DICER1;ZC3H12C;NYNRIN;CPSF3;EXOSC3;RNASE12;SMG6;AGO1
prerank,kinesin binding (GO:0019894),-0.22569190000747508,-0.6362769008833408,0.934010152284264,0.9982668618056872,1.0,9/27,29.29%,ACTB;SNCA;NEFH;SPAG9;CLSTN1;NEK6;PRC1;TTBK2;AP1AR
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.2975958822421694,0.6315054994444965,0.8943396226415095,0.9916406294447754,1.0,11/11,70.26%,FBXO11;NDUFAF7;PRMT2;PRMT7;PRMT6;CARM1;PRMT9;PRMT3;PRMT1;PRMT5;PRMT8
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.29548552290480096,0.6305462361732492,0.8700787401574803,0.9899710236060186,1.0,2/12,6.32%,FRS2;GAB2
prerank,channel activity (GO:0015267),-0.1990191605896876,-0.6288473223834568,0.9685863874345549,0.9992508042166357,1.0,8/41,18.49%,AQP4;AQP11;TRPV4;MCUB;CHRNA7;TMEM266;PANX1;TRPA1
prerank,single-stranded RNA binding (GO:0003727),0.22831494286337486,0.6286685721607393,0.9410801963993454,0.9888314349275387,1.0,15/43,26.22%,DDX3X;ZCCHC13;POLR2D;JMJD6;DDX60;DHX58;ILF3;SNRPC;FMR1;POLR2G;U2AF2;AGO1;LACTB2;AGO2;AGO4
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.294400109409072,0.6266603035981279,0.8982035928143712,0.9877392467057641,1.0,2/10,10.41%,NOX1;NOX4
prerank,death domain binding (GO:0070513),-0.269520826742475,-0.6191281792103079,0.926530612244898,1.0,1.0,3/11,17.04%,DAPL1;CRADD;DAP
prerank,neuropeptide binding (GO:0042923),0.2616682304604891,0.6149951539228117,0.889273356401384,0.9934992078897902,1.0,2/18,9.43%,SSTR3;NMUR1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.2869040283254968,0.6142109641446027,0.9144486692015209,0.9915260559656802,1.0,3/12,10.99%,ATM;PIK3CA;PIK3R3
prerank,NADPH binding (GO:0070402),0.28604898938697465,0.6116913345911841,0.9009345794392524,0.9907786503701378,1.0,5/13,19.22%,MTRR;LBR;DECR1;CRYZ;DUS2
prerank,sequence-specific mRNA binding (GO:1990825),-0.27190801304883716,-0.611413889527909,0.941544885177453,1.0,1.0,3/10,25.78%,SHFL;DHX9;RBM24
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.244137784899078,-0.6066634297776565,0.944,1.0,1.0,3/14,10.54%,NCF2;AIFM1;CYBA
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),-0.2527727150524217,-0.5983342167526357,0.9476082004555809,1.0,1.0,4/14,17.85%,CAPN2;CAPN10;CAPNS1;CAPN6
prerank,transferrin receptor binding (GO:1990459),-0.26515680662423646,-0.5974995923155887,0.9362549800796812,0.9975471721858998,1.0,3/10,28.69%,IKBKB;CD81;SNX4
prerank,acetylcholine receptor activity (GO:0015464),0.2420075842362074,0.59328085102519,0.9495652173913044,0.9995438971497698,1.0,3/22,8.41%,CHRNA5;CHRNG;ANXA9
prerank,retinoic acid receptor binding (GO:0042974),-0.23459678882249363,-0.5900558001158842,0.9488372093023256,0.9972630258885025,1.0,1/17,0.93%,ACTN4
prerank,thiol-dependent deubiquitinase (GO:0004843),0.19159497434846537,0.5884822992364384,0.9900142653352354,0.9996842164336132,1.0,29/83,24.90%,USP3;USP9X;USP24;USP11;USP34;USP49;USP12;USP7;DESI2;USP18;USP37;UFD1;USP39;USP1;USP48;USP33;USP35;TANK;MPND;USP21;USP16;OTUD3;USP5;USP20;OTUD4;USP9Y;OTUB2;USP45;USP19
prerank,H4 histone acetyltransferase activity (GO:0010485),0.2784687302760627,0.5879758653059359,0.9005964214711729,0.9974591365919955,1.0,4/10,24.93%,ATF2;EP300;MSL3;NAA50
prerank,telomerase RNA binding (GO:0070034),0.2414544039586357,0.5857728543076417,0.9475524475524476,0.996111496094395,1.0,7/22,23.30%,TEP1;TERT;HNRNPC;TENT4B;SMG6;XRN1;PINX1
prerank,RNA cap binding (GO:0000339),-0.22928699209737077,-0.5851552404923923,0.9535864978902954,0.9957007972642358,1.0,5/16,24.20%,EIF4E;EIF4A1;LSM1;EIF3D;NCBP2
prerank,endodeoxyribonuclease activity (GO:0004520),-0.21830058769443852,-0.5842008933999977,0.958997722095672,0.9923436554045432,1.0,4/20,19.17%,RPS3;ERCC1;ENDOV;DNA2
prerank,snRNA binding (GO:0017069),0.20455228204572523,0.5647175163641858,0.9827044025157232,1.0,1.0,10/42,22.68%,SNRNP70;CCNT2;LARP7;HEXIM2;EFTUD2;PRPF31;SNRPC;SNRPA1;TUT1;RNPC3
prerank,mRNA methyltransferase activity (GO:0008174),-0.24838235152887883,-0.5634886380835671,0.9578059071729957,0.9968397182140117,1.0,2/12,15.32%,TRMT61B;METTL3
prerank,exonuclease activity (GO:0004527),0.20531855107674096,0.563468449017248,0.9740458015267176,1.0,1.0,11/46,20.06%,POLG;ENPP3;EXOSC7;RAD50;REXO5;CPSF3;EXD1;EXOSC3;FEN1;DXO;RAD9A
prerank,MHC class I protein binding (GO:0042288),-0.23422688178793397,-0.558721234948795,0.9686888454011742,0.9949621469138493,1.0,13/13,76.60%,TAP1;ATP5F1B;CD8B;TUBB;PILRA;ATP5F1A;TUBB4B;CD8A;LILRB1;TAP2;TAPBP;ABCB9;DERL1
prerank,four-way junction DNA binding (GO:0000400),0.24056658507973627,0.5539464963922185,0.9508196721311475,1.0,1.0,5/17,21.63%,FANCM;ABL1;XRCC3;RAD51D;YY1
prerank,tumor necrosis factor receptor binding (GO:0005164),0.2531577471957476,0.5484441309634945,0.9457364341085271,1.0,1.0,1/12,3.91%,BABAM2
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.2524033880742759,0.537914158487003,0.9516728624535316,1.0,1.0,5/12,23.27%,HDAC1;TBP;TAF1;GTF2A1;TBPL1
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.21271545297250205,-0.5368888631495145,0.9787234042553191,0.9981390670577404,1.0,5/15,28.40%,P2RY12;P2RY1;GPR34;P2RY14;P2RX7
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.23085081051729617,0.5356032822632828,0.9705340699815838,1.0,1.0,2/18,12.83%,DHRS11;SRD5A2
prerank,metalloaminopeptidase activity (GO:0070006),0.23660388727138087,0.5337539159976608,0.9701230228471002,1.0,1.0,5/16,16.87%,NPEPPS;MMP14;ERAP1;ANPEP;XPNPEP1
prerank,damaged DNA binding (GO:0003684),0.19257982876532442,0.533591354371234,0.9904458598726115,0.9995738761329764,1.0,11/44,19.45%,RBBP8;PNKP;TDG;DDB2;SDE2;CREBBP;OGG1;NBN;APTX;FEN1;XPA
prerank,pseudouridine synthase activity (GO:0009982),-0.22413893665481283,-0.5302309178521448,0.9730290456431535,0.9962345935836244,1.0,8/13,39.99%,PUS1;TRUB1;PUS7;DKC1;RPUSD3;RPUSD2;TRUB2;PUS7L
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.23448823119181095,-0.5230155682813826,0.967280163599182,0.9943802978003682,1.0,5/10,38.78%,DPYSL5;OPLAH;DPEP1;DPYS;DPYSL2
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.23760200878844945,0.5229704246054959,0.9571150097465887,1.0,1.0,12/12,76.26%,CRYZ;CRYZL1;CBR4;AIFM2;NQO1;ADH4;AKR1C1;CBR1;DHRS4;NQO2;DCXR;NDUFS7
prerank,nuclear localization sequence binding (GO:0008139),0.20706873499931705,0.49554589214981604,0.985663082437276,1.0,1.0,2/18,10.90%,TNPO1;KPNA6
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.1812384539509323,0.47923682094156483,0.9936,1.0,1.0,10/35,23.27%,TP53;SMARCA4;HDAC1;TAF4;TBP;TAF1;GTF2A1;SMARCB1;AGO1;TBPL1
prerank,microtubule minus-end binding (GO:0051011),-0.19674806955866658,-0.469492794565368,0.996,1.0,1.0,13/13,80.35%,TUBGCP2;HAUS4;TUBGCP6;CAMSAP3;CEP290;TUBGCP3;CAMSAP2;HAUS7;NUMA1;MACF1;TUBGCP5;CAMSAP1;TUBGCP4
prerank,U6 snRNA binding (GO:0017070),0.21132596685082855,0.4693717416458084,0.9885496183206107,1.0,1.0,14/14,78.89%,LARP7;TUT1;LSM3;DDX39B;PRPF4;METTL16;SART3;EIF5A;PRPF8;LSM2;RBM22;LSM8;LSM7;LSM4
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.214281129686176,0.4646115202982361,0.9714285714285714,1.0,1.0,4/12,22.54%,CISD3;ISCA1;SDHB;CISD2
prerank,5'-3' exonuclease activity (GO:0008409),-0.18850789189828485,-0.4634762652931168,0.9890829694323144,0.9975206726969964,1.0,3/14,22.05%,TRIR;XRN2;DCP2
prerank,exoribonuclease activity (GO:0004532),0.21236660389202763,0.45468267575743676,0.985239852398524,1.0,1.0,12/12,78.78%,EXOSC7;EXOSC3;EXOSC8;EXOSC9;CNOT6;EXOSC5;ZC3H12A;EXOSC2;EXOSC1;EXOSC4;EXOSC10;CNOT7
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),-0.1929334029580044,-0.4306241171259682,0.9872611464968153,0.9969270057156271,1.0,5/10,39.22%,CDKN1A;CDKN2B;HEXIM1;CDKN2D;CDKN1B
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.16199396530047763,0.4304635065778916,1.0,1.0,1.0,34/34,83.84%,NDUFS1;NDUFV2;NDUFS4;NDUFA2;NDUFS5;NDUFB2;NDUFA9;NDUFS2;NDUFA12;NDUFB4;NDUFS8;NDUFV3;NDUFB9;NDUFA1;NDUFA10;NDUFV1;NDUFA5;NDUFS3;NDUFB6;NDUFA4;NDUFA3;NDUFC1;NDUFB3;NDUFC2;NDUFB10;NDUFA8;NDUFA7;NDUFA13;NDUFB8;NDUFA6;NDUFS7;NDUFB5;NDUFS6;NDUFB7
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.16199396530047763,0.4304635065778916,1.0,1.0,1.0,34/34,83.84%,NDUFS1;NDUFV2;NDUFS4;NDUFA2;NDUFS5;NDUFB2;NDUFA9;NDUFS2;NDUFA12;NDUFB4;NDUFS8;NDUFV3;NDUFB9;NDUFA1;NDUFA10;NDUFV1;NDUFA5;NDUFS3;NDUFB6;NDUFA4;NDUFA3;NDUFC1;NDUFB3;NDUFC2;NDUFB10;NDUFA8;NDUFA7;NDUFA13;NDUFB8;NDUFA6;NDUFS7;NDUFB5;NDUFS6;NDUFB7
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.14903212088875328,0.3690346851929798,0.9982905982905983,1.0,1.0,6/28,20.12%,DICER1;RPP21;PRORP;POP7;FEN1;POP1
prerank,phosphatase inhibitor activity (GO:0019212),0.1548977412648983,0.36147061240523753,0.9982014388489209,1.0,1.0,6/20,24.68%,STYX;LGALS3;SAG;PPP1R1B;PPME1;ARPP19
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.13450916394677384,0.27286371675703036,1.0,1.0,1.0,10/10,86.56%,DESI2;OTUD4;STAMBP;STAMBPL1;ATXN3;OTUD5;USP27X;TNFAIP3;CYLD;YOD1
